RCAT Red Cat Holdings Inc

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

FORM 10-Q

 

(Mark One)

 

☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended October 31, 2024

 

or

 

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from ________ to _________

 

Commission File Number:  001-40202

 

Red Cat Holdings, Inc.

(Exact name of registrant as specified in its charter)

 

Nevada		88-0490034
(State or other jurisdiction of incorporation or organization)		(I.R.S. Employer Identification No.)

 

15 Ave. Munoz Rivera, Ste 2200 San Juan, PR		00901
(Address of principal executive offices)		(Zip Code)

 

(833) 373-3228

(Registrant’s telephone number, including area code)

 

Not applicable

(Former name, former address and former fiscal year, if changed since last report)

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class		Trading Symbol(s)		Name of each exchange on which registered
Common stock, par value $0.001		RCAT		The Nasdaq Stock Market LLC

 

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☑ No ☐

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☑ No ☐

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer	☐	Accelerated filer	☐
Non-accelerated filer	☑	Smaller reporting company	☑
		Emerging growth company	☐

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☑

 

As of December 13, 2024 , there were 80,160,782 shares of the registrant’s common stock outstanding.

  

TABLE OF CONTENTS

 

PART I - FINANCIAL INFORMATION		Page
ITEM 1.	Financial Statements	3
	Condensed Consolidated Balance Sheets as of October 31, 2024 (Unaudited) and April 30, 2024	3
	Condensed Consolidated Statements of Operations and Comprehensive Income for the Three and Six Months Ended October 31, 2024 and 2023 (Unaudited)	4
	Condensed Consolidated Statements Stockholders' Equity for the Three and Six Months Ended October 31, 2024 and 2023 (Unaudited)	5
	Condensed Consolidated Statements of Cash Flows for the Six Months Ended October 31, 2024 and 2023 (Unaudited)	6
	Notes to Unaudited Condensed Consolidated Financial Statements	7
ITEM 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	23
ITEM 3.	Quantitative and Qualitative Disclosures About Market Risk	29
ITEM 4.	Controls and Procedures	29
PART II - OTHER INFORMATION
ITEM 1.	Legal Proceedings	31
ITEM 1A.	Risk Factors	31
ITEM 2.	Unregistered Sales of Equity Securities and Use of Proceeds	31
ITEM 3.	Defaults Upon Senior Securities	31
ITEM 4.	Mine Safety Disclosures	31
ITEM 5.	Other Information	31
ITEM 6.	Exhibits	32
SIGNATURES		33

 

 

CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS AND INDUSTRY DATA

 

This Quarterly Report on Form 10-Q contains certain forward-looking statements which are made pursuant to the safe harbor provisions of Section 27A of the Securities Act of 1933, as amended (the “Securities Act”), and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). Any statements in this Quarterly Report on Form 10-Q about our expectations, beliefs, plans, objectives, assumptions or future events or performance are not historical facts and are forward-looking statements. These statements are often, but not always, made through the use of words or phrases such as “may,” “should,” “believes,” “will,” “expects,” “anticipates,” “estimates,” “predicts,” “potential,” “continues,” “intends,” “plans” and “would” or the negative of these terms or other comparable terminology. For example, statements concerning financial condition, possible or assumed future results of operations, growth opportunities, and plans are all forward-looking statements. Our forward-looking statements are based on a series of expectations, assumptions, estimates and projections about our company, are not guarantees of future results or performance and involve substantial risks and uncertainty. They involve known and unknown risks, uncertainties and assumptions that may cause actual results, levels of activity, performance or achievements to differ materially from any results, levels of activity, performance or achievements expressed or implied by any forward-looking statement. We may not actually achieve the plans, intentions or expectations disclosed in these forward-looking statements. Our business and our forward-looking statements involve substantial known and unknown risks and uncertainties, including the risks and uncertainties inherent in our statements regarding:

•

the market and sales success of our existing and any new products;

 

•

our ability to raise capital when needed and on acceptable terms;

 

•

our ability to make acquisitions and integrate acquired businesses into our company;

 

•

our ability to attract and retain management;

 

•

the intensity of competition;

 

•

changes in the political and regulatory environment and in business and economic conditions in the United States and globally; and

 

•

geopolitical conflicts throughout the world, including those in Ukraine and Israel.

 

All of our forward-looking statements are as of the date of this Quarterly Report on Form 10-Q only. In each case, actual results may differ materially from such forward-looking information. We can give no assurance that such expectations or forward-looking statements will prove to be correct. An occurrence of, or any material adverse change in, one or more of the risk factors or risks and uncertainties referred to in this Quarterly Report on Form 10-Q or included in our other public disclosures or our other periodic reports or other documents or filings filed with or furnished to the U.S. Securities and Exchange Commission (the “SEC”) could materially and adversely affect our business, prospects, financial condition and results of operations. Except as required by law, we do not undertake or plan to update or revise any such forward-looking statements to reflect actual results, changes in plans, assumptions, estimates or projections or other circumstances affecting such forward-looking statements occurring after the date of this Quarterly Report on Form 10-Q, even if such results, changes or circumstances make it clear that any forward-looking information will not be realized. Any public statements or disclosures by us following this Quarterly Report on Form 10-Q that modify or impact any of the forward-looking statements contained in this Quarterly Report on Form 10-Q will be deemed to modify or supersede such statements in this Quarterly Report on Form 10-Q.

 

This Quarterly Report on Form 10-Q may include market data and certain industry data and forecasts, which we may obtain from internal company surveys, market research, consultant surveys, publicly available information, reports of governmental agencies and industry publications, articles and surveys. Industry surveys, publications, consultant surveys and forecasts generally state that the information contained therein has been obtained from sources believed to be reliable, but the accuracy and completeness of such information is not guaranteed. While we believe that such studies and publications are reliable, we have not independently verified market and industry data from third-party sources. Given these uncertainties, readers of this Quarterly Report on Form 10-Q are cautioned not to place undue reliance on such forward-looking statements. We disclaim any obligation to update any such factors or to publicly announce the result of any revisions to any of the forward-looking statements contained herein to reflect future events or developments.

 

All references in this Quarterly Report on Form 10-Q to the “Company”, “we”, “us”, or “our”, are to Red Cat Holdings, Inc., a Nevada corporation, including its wholly owned consolidated subsidiaries, Teal Drones, Inc. (“Teal”), Red Cat Propware, Inc. (“Propware”), Skypersonic, Inc. (“Skypersonic”), and FW Acquisition, Inc. (“FlightWave”), as well as Rotor Riot LLC (“Rotor Riot”), Fat Shark Holdings, Ltd. (“Fat Shark”), which were wholly owned subsidiaries until February 16, 2024.

 

 

 

PART I - FINANCIAL INFORMATION

 

ITEM 1. FINANCIAL STATEMENTS 

 

 RED CAT HOLDINGS, INC.

Condensed Consolidated Balance Sheets

(Unaudited)

		October 31,				April 30,
		2024				2024
ASSETS
Current assets
Cash		$	4,611,092			$	6,067,169
Accounts receivable, net			1,121,398				4,361,090
Inventory			12,165,260				8,007,237
Other			3,015,413				3,962,053
Total current assets			20,913,163				22,397,549
Goodwill (Note 3)			22,964,065				9,088,550
Intangible assets, net (Note 3)			3,439,731				3,794,389
Equity method investee			—				5,142,500
Note receivable			—				4,000,000
Property and equipment, net			1,972,859				2,340,684
Other			309,823				293,126
Operating lease right-of-use assets			1,492,747				1,480,814
Total long-term assets			30,179,225				26,140,063
TOTAL ASSETS		$	51,092,388			$	48,537,612
LIABILITIES AND STOCKHOLDERS' EQUITY
Current liabilities
Accounts payable		$	1,591,488			$	1,580,422
Accrued expenses			1,431,908				1,069,561
Debt obligations - short term			356,964				751,570
Customer deposits			221,380				53,939
Operating lease liabilities			337,628				195,638
Convertible notes payable - short term			3,733,338				—
Acquisition consideration payable			7,000,000				—
Total current liabilities			14,672,706				3,651,130
Operating lease liabilities			1,213,688				1,321,952
Convertible notes payable - long term			8,177,969				—
Total long-term liabilities			9,391,657				1,321,952
Total liabilities			24,064,363				4,973,082
Commitments and contingencies (Note 19)
Stockholders' equity
Series B preferred stock - shares authorized 4,300,000; issued and outstanding 4,676 and 4,676			47				47
Common stock - shares authorized 500,000,000; issued and outstanding 78,025,403 and 74,289,351			78,025				74,289
Additional paid-in capital			133,831,679				124,616,305
Accumulated deficit			(106,881,726	)			(81,130,732	)
Accumulated other comprehensive income			—				4,621
Total stockholders' equity			27,028,025				43,564,530
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY		$	51,092,388			$	48,537,612

 

 

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

 

 

 RED CAT HOLDINGS, INC.

Condensed Consolidated Statements of Operations and Comprehensive Income 

(Unaudited)

		Three months ended October 31,								Six months ended October 31,
		2024				2023				2024				2023
						(As Restated)								(As Restated)
Revenues		$	1,534,727			$	3,930,868			$	4,311,262			$	5,678,997
Cost of goods sold			1,558,202				2,730,286				4,818,128				4,303,750
Gross (loss) profit			(23,475	)			1,200,582				(506,866	)			1,375,247
Operating Expenses
Research and development			2,231,470				2,222,137				3,857,910				3,575,688
Sales and marketing			2,343,779				1,032,645				4,385,290				2,321,405
General and administrative			4,517,695				2,838,080				8,000,790				5,701,838
Impairment loss			—				—				93,050				—
Total operating expenses			9,092,944				6,092,862				16,337,040				11,598,931
Operating loss			(9,116,419	)			(4,892,280	)			(16,843,906	)			(10,223,684	)
Other (income) expense
Convertible notes payable fair value adjustment			4,230,307				—				4,230,307				—
Loss on sale of equity method investment			—				—				4,008,357				—
Equity method loss			—				—				734,143				—
Investment loss, net			—				333,867				—				573,357
Interest (income) expense, net			(14,634	)			19,696				(39,188	)			41,553
Other, net			2,526				(1,544	)			(26,531	)			—
Other expense			4,218,199				352,019				8,907,088				614,910
Net loss from continuing operations			(13,334,618	)			(5,244,299	)			(25,750,994	)			(10,838,594	)
Loss from discontinued operations			—				(599,511	)			—				(842,084	)
Net loss		$	(13,334,618	)			(5,843,810	)		$	(25,750,994	)		$	(11,680,678	)
Other comprehensive income (loss)
Change in foreign currency translation adjustments			—				1,376				(4,621	)			3,022
Unrealized gain on marketable securities			—				363,663				—				653,052
Other comprehensive loss		$	(13,334,618	)			(5,478,771	)		$	(25,755,615	)		$	(11,024,604	)
Loss per share - basic and diluted
Continuing operations		$	(0.18	)			(0.10	)		$	(0.34	)		$	(0.19	)
Discontinued operations			—				(0.01	)			—				(0.02	)
Loss per share - basic and diluted		$	(0.18	)			(0.11	)		$	(0.34	)		$	(0.21	)
Weighted average shares outstanding - basic and diluted			76,184,777				55,606,336				75,342,629				55,270,838

 

 

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

 

 

RED CAT HOLDINGS, INC.

Condensed Consolidated Statements of Stockholders’ Equity

(Unaudited)

		Series B																Additional								Accumulated Other
		Preferred Stock								Common Stock								Paid-in				Accumulated				Comprehensive				Total
		Shares				Amount				Shares				Amount				Capital				Deficit				Income (Loss)				Equity
Balances, April 30, 2023, as restated			986,676			$	9,867				54,568,065			$	54,568			$	112,642,726			$	(57,078,103	)		$	(861,117	)		$	54,767,941
Stock based compensation			—				—				—				—				911,606				—				—				911,606
Vesting of restricted stock units			—				—				155,476				155				(8,675	)			—				—				(8,520	)
Conversion of preferred stock			(982,000	)			(9,820	)			818,334				818				9,002				—				—				—
Unrealized gain on marketable securities			—				—				—				—				—				—				289,389				289,389
Currency translation adjustments			—				—				—				—				—				—				1,646				1,646
Net loss			—				—				—				—				—				(5,836,868	)			—				(5,836,868	)
Balances, July 31, 2023			4,676			$	47				55,541,875			$	55,541			$	113,554,659			$	(62,914,971	)		$	(570,082	)		$	50,125,194
Stock based compensation			—				—				—				—				1,196,325				—				—				1,196,325
Vesting of restricted stock units			—				—				54,786				55				(7,826	)			—				—				(7,771	)
Issuance of common stock through ATM facility, net			—				—				53,235				53				9,159				—				—				9,212
Unrealized gain on marketable securities			—				—				—				—				—				—				363,663				363,663
Currency translation adjustments			—				—				—				—				—				—				1,376				1,376
Net loss			—				—				—				—				—				(5,843,810	)			—				(5,843,810	)
Balances, October 31, 2023			4,676			$	47				55,649,896			$	55,649			$	114,752,317			$	(68,758,781	)		$	(205,043	)		$	45,844,189
Balances, April 30, 2024			4,676			$	47				74,289,351			$	74,289			$	124,616,305			$	(81,130,732	)		$	4,621			$	43,564,530
Stock based compensation			—				—				—				—				1,446,038				—				—				1,446,038
Vesting of restricted stock units			—				—				293,302				293				(134,330	)			—				—				(134,037	)
Exercise of warrants			—				—				307,595				308				(308	)			—				—				—
Currency translation adjustments			—				—				—				—				—				—				(4,621	)			(4,621	)
Net loss			—				—				—				—				—				(12,416,376	)			—				(12,416,376	)
Balances, July 31, 2024			4,676			$	47				74,890,248			$	74,890			$	125,927,705			$	(93,547,108	)		$	—			$	32,455,534
Stock based compensation			—				—				—				—				1,304,037				—				—				1,304,037
Vesting of restricted stock units			—				—				308,735				309				(412,203	)			—				—				(411,894	)
Exercise of warrants			—				—				222,983				223				(223	)			—				—				—
Exercise of options			—				—				58,446				58				14,908				—				—				14,966
Acquisition of FlightWave			—				—				2,544,991				2,545				6,997,455				—				—				7,000,000
Net loss			—				—				—				—				—				(13,334,618	)			—				(13,334,618	)
Balances, October 31, 2024			4,676			$	47				78,025,403			$	78,025			$	133,831,679			$	(106,881,726	)		$	—			$	27,028,025

 

 

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

  

  

RED CAT HOLDINGS, INC.

Condensed Consolidated Statements of Cash Flows

(Unaudited)

		Six months ended October 31,
		2024				2023
						(As Restated)
Cash Flows from Operating Activities
Net loss		$	(25,750,994	)		$	(11,680,678	)
Net loss from discontinued operations			—				(842,084	)
Net loss from continuing operations			(25,750,994	)			(10,838,594	)
Adjustments to reconcile net loss to net cash used in operations:
Stock based compensation - options			815,632				1,606,305
Stock based compensation - restricted units			1,934,443				501,626
Amortization of intangible assets			354,658				434,735
Realized loss from sale of marketable securities			—				646,300
Depreciation			491,618				222,431
Loss on sale of equity method investment and note receivable			4,008,357				—
Equity method loss			734,143				—
Impairment on goodwill and intangible assets			93,050				—
Convertible note payable fair value adjustment			4,230,307				—
Changes in operating assets and liabilities
Accounts receivable			3,394,692				(2,269,192	)
Inventory			(3,860,393	)			(335,125	)
Other			999,423				(1,576,157	)
Operating lease right-of-use assets and liabilities			(7,913	)			(1,115	)
Customer deposits			(29,035	)			(94,181	)
Accounts payable			9,887				225,801
Accrued expenses			94,412				236,807
Net cash used in operating activities of continuing operations			(12,487,713	)			(11,240,359	)
Cash Flows from Investing Activities
Purchases of property and equipment			(123,793	)			(139,860	)
Proceeds from sale of marketable securities			—				10,205,501
Proceeds from sale of equity method investment and note receivable			4,400,000				—
Net cash provided by investing activities of continuing operations			4,276,207				10,065,641
Cash Flows from Financing Activities
Proceeds from issuance of convertible notes payable, net of issuance costs			7,681,000				—
Payments under debt obligations			(394,606	)			(279,126	)
Payments of taxes related to equity transactions			(530,965	)			(16,292	)
Proceeds from issuance of common stock through ATM facility, net			—				9,212
Net cash provided by (used in) financing activities of continuing operations			6,755,429				(286,206	)
Discontinued operations
Operating activities			—				(550,120	)
Investing activities			—				—
Financing activities			—				166,026
Net cash used in discontinued operations			—				(384,094	)
Net decrease in Cash			(1,456,077	)			(1,845,018	)
Cash, beginning of period			6,067,169				3,260,305
Cash, end of period			4,611,092				1,415,287
Less: Cash of discontinued operations			—				(6,310	)
Cash of continuing operations, end of period		$	4,611,092			$	1,408,977
Cash paid for interest		$	14,564			$	42,031
Cash paid for income taxes		$	—			$	—
Non-cash transactions
Fair value of shares issued in acquisition		$	7,000,000			$	—
Acquisition consideration payable		$	7,000,000			$	—
Net assets assumed in acquisition		$	31,435			$	—
Unrealized gain on marketable securities		$	—			$	653,052
Conversion of preferred stock into common stock		$	—			$	9,820

 

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

 

 

RED CAT HOLDINGS, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

 (Unaudited) 

 

 

Note 1 – The Business  

 

The Company was originally incorporated in February 1984. Since April 2016, the Company’s primary business has been to provide products, services, and solutions to the drone industry which it presently does through its wholly owned operating subsidiaries. Beginning in January 2020, the Company expanded the scope of its drone products and services through five acquisitions, including: 

 

A.

In January 2020, the Company acquired Rotor Riot, a provider of First Person View (“FPV”) drones and equipment, primarily to consumers. The purchase price was $1,995,114.

 

B.

In November 2020, the Company acquired Fat Shark Holdings, Ltd. (“Fat Shark”), a provider of FPV video goggles to the drone industry. The purchase price was $8,354,076.

   

C.

In May 2021, the Company acquired Skypersonic which provided hardware and software solutions that enable drones to complete inspection services in locations where GPS is either denied or not available, yet still record and transmit data even while being operated from thousands of miles away. The purchase price was $2,791,012.

 

	D.	In August 2021, the Company acquired Teal Drones, Inc. (“Teal”), a leader in commercial and government Unmanned Aerial Vehicles (“UAV”) technology. The purchase price was $10,011,279.
	E.	In September 2024, the Company acquired FlightWave Aerospace Systems Corporation, an industry-leading provider of VTOL drone, sensor and software solutions, under an Asset Purchase Agreement (the “APA”). As part of the acquisition, the Company created a new subsidiary, FW Acquisition Inc. (“FlightWave”) for ongoing operations. The purchase price was $14,000,000. See Note 3 for additional information.

 

Following the Teal acquisition in August 2021, we concentrated on integrating and organizing these businesses. Effective May 1, 2022, we established the Enterprise segment (“Enterprise”) and the Consumer segment (“Consumer”) to focus on the unique opportunities in each sector. Enterprise's initial strategy was to provide UAVs to commercial enterprises, and the military, to navigate dangerous military environments and confined industrial and commercial interior spaces. Subsequently, Enterprise narrowed its near-term attention on the military and other government agencies. Skypersonic's technology has been redirected to military applications and its operations consolidated into Teal.

 

On February 16, 2024, we closed the sale of our Consumer segment, consisting of Rotor Riot and Fat Shark, to Unusual Machines. The sale reflects the Company's decision to focus its efforts and capital on defense where it believes that there are more opportunities to create long term shareholder value. See Note 4 and Note 8.

  

 

Note 2 – Summary of Significant Accounting Policies

 

Basis of Presentation – The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States (“GAAP”) for interim financial information and with the instructions of Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements. In the opinion of management, all adjustments, consisting only of normal recurring adjustments necessary for a fair presentation with respect to the interim financial statements have been included. The results of operations for the six months ended October 31, 2024 are not necessarily indicative of the results for the full year. For further information, refer to the consolidated financial statements and footnotes thereto for the year ended April 30, 2024, included in the Company’s Annual Report on Form 10-K. In September 2024, the Company’s Board of Directors approved a change in fiscal year end from April 30 to December 31. 

 

7

 

Restatement of Previously Issued Consolidated Financial Statements – The Company’s Condensed Consolidated Statement of Operations and Stockholders’ Equity for the six months ended October 31, 2023, which were originally filed with the U.S. Securities and Exchange Commission (the “SEC”) on December 15, 2023, have been restated. The Company revised its financial statements to remove derivative liabilities due to erroneously reporting warrants from our convertible note financings, as described in Note 16, as having a derivative component.

 

The impacts of these restatements are detailed in the tables below:

		Condensed Consolidated Statement of Operations For the three months ended October 31, 2023
		Originally Reported				As Restated				Change
Change in fair value of derivative liability		$	(162,482	)		$	—			$	(162,482	)
Net loss		$	(5,681,328	)		$	(5,843,810	)		$	(162,482	)

 

		Condensed Consolidated Statement of Operations For the six months ended October 31, 2023
		Originally Reported				As Restated				Change
Change in fair value of derivative liability		$	(189,002	)		$	—			$	(189,002	)
Net loss		$	(11,491,676	)		$	(11,680,678	)		$	(189,002	)

 

		Condensed Consolidated Statement of Stockholders’ Equity For the six months ended October 31, 2023
		Originally Reported				As Restated				Change
Additional paid-in capital		$	112,102,691			$	114,752,317			$	2,649,626
Accumulated deficit		$	(66,078,469	)		$	(68,758,781	)		$	(2,680,312	)
Total equity		$	45,874,875			$	45,844,189			$	(30,686	)

  

 

Principles of Consolidation – Our condensed consolidated financial statements include the accounts of our wholly owned subsidiaries which include Teal, FlightWave (beginning on September 5, 2024), Skypersonic, as well as Rotor Riot and Fat Shark through the sale date of February 16, 2024. Non-majority owned investments, including the formerly wholly owned subsidiaries Rotor Riot and Fat Shark, are accounted for using the equity method when the Company is able to significantly influence the operating policies of the investee. Intercompany transactions and balances have been eliminated.

 

The Consumer segment businesses are characterized as discontinued operations in these financial statements.  The operating results and cash flows of discontinued operations are separately stated in those respective financial statements. See Note 4.

 

Use of Estimates – The preparation of financial statements in accordance with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates. Significant estimates reflected in these financial statements include those used to (i) complete purchase price accounting for acquisitions, (ii) the evaluation of long-term assets, including goodwill, for impairment, (iii) the evaluation of other-than-temporary-impairment of equity method investments, and (iv) valuations of convertible notes payable.

 

Concentration of Credit Risk – Financial instruments, which potentially subject the Company to concentrations of credit risk, include trade receivables. In the normal course of business, the Company provides credit terms to its customers. Accordingly, the Company performs ongoing credit evaluations of its customers, generally does not require collateral and considers the credit risk profile of the customer from which the receivable is due in further evaluating collection risk. Customers that accounted for 10% or greater of accounts receivable, net as of October 31, 2024 and April 30, 2024 were as follows:

 

8

 

 

		October 31, 2024				April 30, 2024
Customer A			38	%			*
Customer B			25	%			*
Customer C			*				53	%
Customer D			*				24	%

   

* Accounts Receivable was less than 10%

 

During the six months ended October 31, 2024, two customers accounted for equal to or greater than 10% of total revenue, totaling 21% and 19%, respectively. During the six months ended October 31, 2023, three customers accounted for equal to or greater than 10% of total revenue, totaling 13%, 12% and 10%, respectively. The Company does not believe the loss of one or more of these customers would be significant to operations.

 

Equity Method Investment – The equity method of accounting is applied to investments in which the Company has an ownership interest of between 20% and 50%. The Company evaluates its equity method investments each reporting period for evidence of a loss in value that is other than a temporary decline. Evidence of a loss in value might include, but would not necessarily be limited to, absence of an ability to recover the carrying amount of the investment or the inability of the investee to sustain an earnings capacity that would justify the carrying amount of the investment. The Company performed this analysis and concluded that its investment in UMAC was other-than-temporarily impaired and recognized an impairment charge of $11,353,875 for the year ended April 30, 2024. See Note 8 for additional information.

 

Fair Values, Inputs and Valuation Techniques for Financial Assets and Liabilities, and Related Disclosures – The fair value measurements and disclosure guidance defines fair value and establishes a framework for measuring fair value. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability (an exit price) in an orderly transaction between market participants at the measurement date. In accordance with this guidance, the Company has categorized its recurring basis financial assets and liabilities into a three-level fair value hierarchy based on the priority of the inputs to the valuation technique.

 

The fair value hierarchy gives the highest priority to quoted prices in active markets for identical assets or liabilities (Level 1) and the lowest priority to unobservable inputs (Level 3). The inputs used to measure fair value may fall into different levels of the fair value hierarchy. In such cases, the level in the fair value hierarchy within which the fair value measurement in its entirety falls has been determined based on the lowest level input that is significant to the fair value measurement in its entirety. The Company's assessment of the significance of a particular input to the fair value measurement in its entirety requires judgment and considers factors specific to the asset or liability.

 

The guidance establishes three levels of the fair value hierarchy as follows:

 

Level 1: Inputs are unadjusted, quoted prices in active markets for identical assets or liabilities at the measurement date;

Level 2: Inputs are observable, unadjusted quoted prices in active markets for similar assets or liabilities, unadjusted quoted prices for identical or similar assets or liabilities in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the related assets or liabilities; and 

Level 3: Unobservable inputs that are significant to the measurement of the fair value of the assets or liabilities that are supported by little or no market data. 

   

The Company’s financial instruments mainly consist of cash, accounts receivable, current assets, accounts payable, accrued expenses, notes payable, and convertible notes payable. The recorded carrying amounts of cash, accounts receivable, current assets, accounts payable, accrued expenses, and notes payable are considered to approximate their estimated fair values due to their short-term nature. Liabilities recognized at fair value on a recurring basis in the consolidated balance sheets consist of convertible notes payable. These items are categorized based upon the level of judgment associated with the inputs used to measure their fair values. Fair value is defined as the price that would be paid to transfer a liability in an orderly transaction between market participants at the measurement date.

 

The following table summarizes the Company’s financial instruments at fair value based on the fair value hierarchy for each class of instrument:

 

9

 

		Level 1				Level 2				Level 3				Total
Convertible notes payable		$	—			$	—			$	11,911,307			$	11,911,307

 

Convertible Notes Payable

 

The Company measures its convertible notes payable at fair value based on significant inputs not observable in the market, which caused them to be classified as Level 3 measurements within the fair value hierarchy. Changes in the fair value of the convertible notes payable related to updated assumptions and estimates were recognized as a convertible notes payable fair value adjustment within the consolidated statements of operations and comprehensive loss.

 

In determining the fair value of the convertible notes payable as of October 31, 2024, the Company used a market-based approach. The valuation method utilized a negotiated discount rate and a market yield rate which are unobservable inputs.

 

An increase or decrease in any of the unobservable inputs in isolation could result in a material increase or decrease in the estimated fair value. In the future, depending on the weight of evidence and valuation approaches used, these or other inputs may have a more significant impact on the estimated fair value.

 

The Company calculated the estimated fair value of the convertible notes payable as of October 31, 2024 using the following assumptions:

 

		October 31, 2024
Issuance date			10/1/2024
Maturity date			10/1/2026
Stock price			3.06
Expected volatility factor			92.8	%
Risk-free interest rate			5.21	%

 

The following table presents changes in the Level 3 convertible notes payable measured at fair value for the six months ended October 31, 2024:

Balance, May 1, 2024		$	—
Additions			7,681,000
Fair value measurement adjustments			4,230,307
Balance, October 31, 2024		$	11,911,307

 

Warrants

 

The fair value of the warrants as of October 31, 2024 was estimated using a Monte Carlo simulation model. The significant unobservable inputs for the Monte Carlo model include the stock price, exercise price, risk-free rate of return, time to expiration, and the volatility. An increase or decrease in the unobservable inputs in isolation could result in a material increase or decrease in the estimated fair value. In the future, depending on the weight of evidence and valuation approaches used, these or other inputs may have a more significant impact on the estimated fair value. Additionally, if certain provisions are triggered, reset adjustments may be required in the future.  For the quarter ended October 31, 2024, no value was assigned to the warrants due to the fair market value of the convertible note payable being in excess of the proceeds received.

 

Revenue Recognition – The Company recognizes revenue in accordance with ASC Topic 606 - Revenue from Contracts with Customers, issued by the Financial Accounting Standards Board (“FASB”). This standard includes a comprehensive evaluation of factors to be considered regarding revenue recognition including (i) identifying the promised goods, (ii) evaluating performance obligations, (iii) measuring the transaction price, (iv) allocating the transaction price to the performance obligations if there are multiple components, and (v) recognizing revenue as each obligation is satisfied. The Company’s revenue transactions include the shipment of goods to customers as orders are fulfilled, completion of non-recurring engineering, completion of training, and customer support services. The Company recognizes revenue upon shipment of product or prototypes unless otherwise specified in the purchase order or contract. Customer deposits totaled $221,380 and $53,939 at October 31, 2024 and April 30, 2024, respectively. From time to time, non-recurring engineering contracts may involve the capitalization of engineering prototypes, classified as contract assets. Contract assets totaled $0 and $1,477,859 at October 31, 2024 and April 30, 2024, respectively.

 

10

 

The following table presents the Company’s revenue disaggregated by revenue type: 

		Three months ended October 31,								Six months ended October 31,
		2024				2023				2024				2023
Contract related		$	—			$	529,437			$	886,440			$	840,318
Product related			1,534,727				3,401,431				3,424,822				4,838,679
Total		$	1,534,727			$	3,930,868			$	4,311,262			$	5,678,997

  

 

Product Warranty - The Company accrues an estimate of its exposure to warranty claims based upon both current and historical product sales data and warranty costs incurred. Product warranty reserves are recorded in current liabilities under accrued expenses. Warranty liability was approximately $587,000 and $372,000 as of October 31, 2024 and April 30, 2024 respectively.

 

Recent Accounting Pronouncements   – Management does not believe that recently issued, but not yet effective accounting pronouncements, if adopted, would have a material effect on the accompanying consolidated financial statements.

 

Comprehensive Loss – Comprehensive loss consists of net loss and other comprehensive loss. Other comprehensive loss refers to gains and losses that are recorded as an element of stockholders' equity but are excluded from net loss. Our other comprehensive loss is comprised of foreign currency translation adjustments and unrealized gains or losses on available-for-sale securities. During the six months ended October 31, 2024 and October 31, 2023, comprehensive loss was $4,621 higher and $656,074 lower than net loss, respectively, related to unrealized gains on available-for-sale securities totaling $0 and $653,052, respectively, and foreign currency translation adjustments of $4,621 and $3,022, respectively.

 

Basic and Diluted Net Loss per Share – Basic and diluted net loss per share has been calculated by dividing net loss by the weighted average number of shares of common stock outstanding during the period. Common stock equivalents were excluded from the computation of diluted net loss per share of common stock because they were anti-dilutive. The conversion or exercise of these common stock equivalents would dilute earnings per share if we become profitable in the future. Outstanding securities not included in the computation of diluted net loss per share because their effect would have been anti-dilutive include:

 

		October 31, 2024				October 31, 2023
Series B Preferred Stock, as converted			3,896				3,896
Stock options			7,896,903				6,861,517
Warrants			2,292,207				1,539,999
Restricted stock			1,758,313				779,850
Total			11,951,319				9,185,262

 

 

 

Related Parties – Parties are considered to be related to us if they have control or significant influence, directly or indirectly, over us, including key management personnel and members of the Board of Directors or are direct relatives of key management personnel of members of the Board of Directors. Related Party transactions are disclosed in Note 18.

 

Liquidity and Going Concern  – The Company has never been profitable and has incurred net losses related to acquisitions, as well as costs incurred to pursue its long-term growth strategy. During the six months ended October 31, 2024, the Company incurred a net loss of approximately $25,750,000 and used cash in operating activities of approximately $12,500,000. As of October 31, 2024, working capital totaled approximately $6,240,000. These financial results and our financial position at October 31, 2024 raise substantial doubt about our ability to continue as a going concern. However, the Company has recently taken actions to strengthen its liquidity. In November 2024, the Company was selected as the winner of the U.S.  Army’s Short Range Reconnaissance (SRR) Program of Record. The Company’s manufacturing facility is scaling production of its most recent products and gross profits are projected to increase. As described in Note 13 and Note 20, the Company closed financings with proceeds of approximately $8,000,000 and $6,000,000 in September 2024 and November 2024, respectively. Additionally, the Company’s Form S-3 became effective on December 11, 2024. If necessary, the Company will seek additional equity financing for which there can be no guarantee. Management has concluded that these recent positive developments alleviate any substantial doubt about the Company’s ability to continue its operations, and meet its financial obligations, for twelve months from the date these consolidated financial statements are issued.

 

 

Note 3 – Business Combination

 

On September 4, 2024, the Company entered into an Asset Purchase Agreement (the “APA”) with FlightWave Aerospace Systems Corporation (the “Seller”) to broaden the Company’s range of drone products. The seller sold certain assets used in designing, developing, manufacturing, and selling long range, AI-powered UAVs for commercial use. Pursuant to the APA, the Company has acquired substantially all of the assets owned, controlled or used by the Seller for an aggregate purchase price of $14,000,000 worth of shares of the Company’s common stock, and as such, the asset purchase will be treated as a business combination. The purchase price is payable as follows:

 

	•	$7 million worth of the Company’s common stock issued on September 30, 2024, totaling 2,544,991 shares, equal to the VWAP on such date.
	•	$7 million worth of the Company’s common stock to be issued on December 31, 2024, at a price per share equal to the VWAP on such date, of which (i) $2 million will be payable to preferred shareholders of the Seller, and (ii) $5 million will be payable to common shareholders and option-holders of the Seller as set forth the APA.

 

The Company expects that the Goodwill recognized will be deductible for tax purposes.  The Company has reported net losses since its inception and is presently unable to determine when and if the tax benefit of this deduction will be realized.

 

The preliminary summary of the purchase price and its related allocation is as follows:

Shares issued		$	7,000,000
Acquisition consideration payable			7,000,000
Total Purchase Price		$	14,000,000

  

Assets acquired
Accounts receivable		$	155,000
Inventory			297,630
Operating lease right-of-use assets			128,433
Other assets			69,480
Goodwill			13,968,565
Total assets acquired			14,619,108
Liabilities assumed
Accounts payable and accrued expenses			264,493
Customer deposits			196,476
Operating lease liabilities			158,139
Total liabilities assumed			619,108
Total fair value of net assets acquired		$	14,000,000

 

The foregoing amounts reflect our current estimates of fair value as of the September 4, 2024 acquisition date. The Company expects to recognize fair values associated with the customer relationships acquired, as well as the FlightWave proprietary technology and brand name, but has not yet accumulated sufficient information to assign such values. As additional information becomes known regarding the acquired assets and assumed liabilities, management may make adjustments to the opening balance sheet of the acquired company up to the end of the measurement period, which is a one-year period following the acquisition date. The determination of the fair values of the acquired assets and liabilities assumed (and the related determination of estimated lives of depreciable tangible and intangible assets) requires significant judgment.

 

Supplemental Unaudited Pro Forma Financial Information

 

The following unaudited pro forma financial information summarizes the results of operations for the Company as though the Business Combination had occurred on May 1, 2023. The unaudited pro forma financial information has been presented for illustrative purposes only and is not necessarily indicative of results of operations that would have been achieved had the acquisition taken place on the date indicated, or the future consolidated results of operations of the Company. The information below does not include the effects of finite-lived intangible assets to be evaluated.

12

 

		Six months ended October 31, 2024
			Consolidated
Revenues		$	5,107,661
Net Loss			(26,882,328	)
Loss per share – basic and diluted			(0.36	)

  

		Six months ended October 31, 2023
			Consolidated
Revenues		$	6,461,394
Net Loss			(12,499,977	)
Loss per share – basic and diluted			(0.23	)

 

 

Note 4 – Divestiture of Consumer Segment

 

On February 16, 2024, the Company closed the sale of Rotor Riot and Fat Shark to Unusual Machines. The sale was conducted pursuant to a Share Purchase Agreement dated November 21, 2022, as amended on April 13, 2023, July 10, 2023, and December 11, 2023 (the “SPA”). The transaction closed concurrently with UMAC’s initial public offering and listing on the NYSE American exchange (“IPO”) under the symbol “UMAC.”

 

The total consideration received by the Company was valued at $20 million and consisted of i) $1 million in cash, ii) $2 million in a secured promissory note (“Promissory Note”), iii) $17 million in securities of Unusual Machines, and iv) a post-closing adjustment for excess working capital.

 

Secured Promissory Note

 

The Promissory Note from Unusual Machines bore interest at a rate of 8% per year, was due 18 months from the date of issue, and required monthly payments of interest due in arrears on the 15th day of each month.

 

Unusual Machines Securities

 

The $17 million worth of UMAC common stock was valued at the IPO price for UMAC’s common stock of $4.00 per share, resulting in 4,250,000 shares of UMAC common stock being issued to the Company (representing approximately 49% of UMAC’s issued and outstanding common stock after giving effect to the IPO and to the issuance of common stock to the Company upon closing of the IPO).

 

Working Capital

 

The purchase price was adjusted for working capital as of the closing date. Actual working capital excess amounts increased the principal amount of the Promissory Note dollar for dollar. Working capital as of closing was finalized at $2 million in July 2024. As a result, UMAC issued the Company $4,000,000 of its 8% Promissory Notes due November 30, 2025 (the “New Notes”) reflecting (i) satisfaction and settlement of working capital adjustments and (ii) a maturity date extension to November 30, 2025.

 

13

 

The Consumer segment has been classified as Discontinued Operations and reported in accordance with the applicable accounting standards. Set forth below are the results of operations for the Consumer segment for:

		Three months ended October 31,								Six months ended October 31,
		2024				2023				2024				2023
Revenues		$	—			$	1,056,932			$	—			$	2,926,151
Cost of goods sold			—				1,154,200				—				2,539,316
Gross Margin			—				(97,268	)			—				386,835
Operating Expenses
Research and development			—				31,054				—				77,303
Sales and marketing			—				287,413				—				691,517
General and administrative			—				183,807				—				437,393
Total operating expenses			—				502,274				—				1,206,213
Operating loss			—				(599,542	)			—				(819,378	)
Other (income) expense
Interest expense			—				—				—				22,856
Other, net			—				(31	)			—				(150	)
Other (income) expense			—				(31	)			—				22,706
Net loss from discontinued operations		$	—			$	(599,511	)		$	—			$	(842,084	)

 

 

Note 5 – Inventories

 

Inventories consisted of the following:

 

		October 31, 2024				April 30, 2024
Raw materials		$	6,110,038			$	5,750,324
Work-in-process			1,214,769				1,289,997
Finished goods			4,840,453				966,916
Total		$	12,165,260			$	8,007,237

 

 

Note 6 – Other Current Assets

 

Other current assets included:

 

		October 31, 2024				April 30, 2024
Prepaid expenses		$	2,626,343			$	1,206,306
Prepaid inventory			389,070				602,888
Contract asset			—				1,477,859
Grant receivable			—				675,000
Total		$	3,015,413			$	3,962,053

 

 

 

Note 7 – Intangible Assets

 

Intangible assets relate to acquisitions completed by the Company, including those described in Note 1, and were as follows:

		October 31, 2024												April 30, 2024
		Gross Value				Accumulated Amortization				Net Value				Gross Value				Accumulated Amortization				Net Value
Proprietary technology		$	4,282,001			$	(2,272,270	)		$	2,009,731			$	4,282,001			$	(1,917,612	)		$	2,364,389
Non-compete agreements			65,000				(65,000	)			—				65,000				(65,000	)			—
Total finite-lived assets			4,347,001				(2,337,270	)			2,009,731				4,347,001				(1,982,612	)			2,364,389
Brand name			1,430,000				—				1,430,000				1,430,000				—				1,430,000
Total indefinite-lived assets			1,430,000				—				1,430,000				1,430,000				—				1,430,000
Total intangible assets, net		$	5,777,001			$	(2,337,270	)		$	3,439,731			$	5,777,001			$	(1,982,612	)		$	3,794,389

 

Proprietary technology and non-compete agreements are being amortized over six years and three years, respectively. Goodwill and Brand name are not amortized but evaluated for impairment on a quarterly basis.

 

 

Note 8 – Equity Method Investment

 

On July 22, 2024, the Company sold all of its securities in UMAC to two unaffiliated third-party purchasers (the “Purchasers”). As part of the transaction, on July 22, 2024, the Company entered into an Exchange Agreement with UMAC pursuant to which the Company exchanged 4,250,000 shares of UMAC’s common stock, par value $0.001 per share, for 4,250 shares of UMAC’s newly designated Series A Convertible Preferred Stock (the “Series A”). The Company sold the Series A ownership interest ($4,408,357 at time of sale) and the Note Receivable of $4,000,000 to the Purchasers for $4.4 million in cash pursuant to a Purchase Agreement in a transaction that closed on July 22, 2024.  

 

As of April 30, 2024, the Company had owned approximately a 46% interest in Unusual Machines. The primary business operations included selling first-person-view video goggles for drone pilots, drones, parts and related equipment to the consumer marketplace. UMAC’s financial statements are prepared in accordance with GAAP. See Note 4 for additional information.

 

Financial information for UMAC prior to the sale of the Company’s equity interest was derived from UMAC’s Form 10-Q for the six months ended June 30, 2024 and was as follows:

Current assets		$	5,116,963
Long-term assets			20,083,390
Current liabilities			931,200
Long-term liabilities			4,297,332
Revenues			2,030,039
Gross profit			592,607
Net loss		$	(2,718,240	)

  

The Company’s investments in UMAC have been impacted by the following:

Initial investment, February 16, 2024		$	17,000,000
Equity method loss			(503,625	)
Impairment			(11,353,875	)
Investment balance, April 30, 2024		$	5,142,500
Equity method loss			(734,143	)
Sale of ownership interest			(4,408,357	)
Investment balance, October 31, 2024		$	—

 

The computation of both the initial investment as of February 16, 2024 and investment balance as of April 30, 2024, was based on the fair market value of UMAC’s common stock.

 

 

Note 9 – Property and Equipment

 

Property and equipment consist of assets with an estimated useful life greater than one year and are reported net of accumulated depreciation. The reported values are periodically assessed for impairment, and were as follows:

 

		October 31, 2024				April 30, 2024
Equipment and related		$	1,633,105			$	1,540,888
Leasehold improvements			1,556,139				1,547,976
Furniture and fixtures			186,703				163,290
Accumulated depreciation			(1,403,088	)			(911,470	)
Net carrying value		$	1,972,859			$	2,340,684

 

Depreciation expense totaled $491,618 and $222,431 for the six months ended October 31, 2024 and 2023, respectively.

 

 

Note 10 – Other Long-Term Assets

 

Other long-term assets included:

 

		October 31, 2024				April 30, 2024
SAFE agreement		$	250,000			$	250,000
Security deposits			43,126				43,126
Total		$	293,126			$	293,126

  

In November 2022, the Company entered into a SAFE (Simple Agreement for Future Equity) agreement with Firestorm Labs, Inc. (“Firestorm”) under which it made a payment of $250,000 to Firestorm in exchange for the right to certain shares of Firestorm stock. The SAFE permits the Company to participate in a future equity financing of Firestorm by converting the $250,000 into shares of Preferred Stock of Firestorm. If there is a change in control of Firestorm or a public offering of shares of its stock, then the Company shall have the right to receive cash payments, or shares of stock, whichever has greater value. The Company’s investment in the SAFE agreement has been recorded on the cost method of accounting. The Company evaluates the investment for any indications of impairment in value on a quarterly basis. No factors indicative of impairment were identified during the six months ended October 31, 2024.

 

 

Note 11 – Right of Use Assets and Liabilities

 

As of October 31, 2024, the Company had operating type leases for real estate and no finance type leases. The Company’s leases have remaining lease terms of up to 6.17 years, including options to extend certain leases for up to six years. Operating lease expense totaled $262,912 and $170,505 for the six months ended October 31, 2024 and 2023, respectively.

 

Leases on which the Company made rent payments during the reporting period included:

 

Location		Monthly Rent				Expiration
South Salt Lake, Utah		$	23,340				December 2030
Santa Monica, California		$	16,697				June 2025
San Juan, Puerto Rico		$	6,186				June 2027
Grantsville, Utah		$	1,000				December 2026

        

Supplemental information related to operating leases for the six months ended October 31, 2024 was:

 

Operating cash paid to settle lease liabilities			$215,922
Weighted average remaining lease term (in years)			2.50
Weighted average discount rate			12%

 

 

 

Note 12 – Debt Obligations

 

A.

Decathlon Capital

On August 31, 2021, Teal entered into an Amended and Restated Loan and Security Agreement with Decathlon Alpha IV, L.P. (“DA4”) in the amount of $1,670,294 (the “Loan”), representing the outstanding principal amount previously due and owing by Teal to DA4. Interest on the Loan accrues at a rate of ten (10%) percent per annum. Principal and interest is payable in monthly installments of $49,275. The balance outstanding at April 30, 2024 totaled $370,537. The balance was paid off in September 2024.

  

B.

Pelion Note

In May 2021, Teal entered into a note agreement totaling $350,000 which is payable upon demand. The Note bears interest at the applicable Federal Rate as of the date of the Note which was 0.13% on the date of issuance. Accrued interest at October 31, 2024 and April 30, 2024 totaled $1,563 and $1,334, respectively.

 

C.

Corporate Equity

Beginning in October 2021, and amended in January 2022, Teal financed a total of $120,000 of leasehold improvements with Corporate Equity, LLC. The loan bears interest at 8.25% annually and requires monthly payments of $3,595 through December 2024. The balance outstanding at October 31, 2024 and April 30, 2024 totaled $6,706 and $27,495 respectively.

  

D.

Ascentium Capital

In September 2021, Teal entered into a financing agreement with Ascentium Capital to fund the purchase of a fixed asset totaling $24,383. Monthly payments are $656. The balance outstanding at October 31, 2024 and April 30, 2024 totaled $259 and $3,538, respectively.

 

E.

Summary

 

Future annual principal payments at October 31, 2024 were as follows:

 

	Fiscal Year Ended:
	2025				356,964
	Thereafter				—
	Total			$	356,964

 

 

Note 13 – Convertible Notes Payable

 

In September 2024, the Company entered into a Securities Purchase Agreement (the “SPA”) with Lind Global Asset Management X LLC (“Lind”). Under the SPA, the Company received approximately $8 million in funding from Lind in exchange for a Senior Secured Convertible Promissory Note in the amount of $9,600,000 (the “Note”) and a Common Stock Purchase Warrant for the purchase of 750,000 shares of our common stock at a price of $6.50 per share, exercisable for five years (the “Warrant”). The Note is secured by substantially all assets of the Company. As additional consideration to Lind, the Company paid a commitment fee in the amount of $280,000.

 

The Note, which does not accrue interest, will be repaid in eighteen consecutive monthly installments in the amount of $533,334 beginning six months from the issuance date. At the Company’s option, monthly payments can be increased up to $1,000,000 so long as the Company’s market capitalization is at least $50 million. In addition, if the Repayment Share Price (as defined below) is equal to or greater than $2.00, Lind can, at its option, increase the monthly payment amount up to $1,300,000 for up to two months. The monthly payments due under the Note may be made by the issuance of common stock valued at the Repayment Share Price, cash in an amount equal to 1.025 times the required payment amount, or a combination thereof. The Repayment Share Price is defined in the Note as ninety percent (90%) of the average of the five (5) consecutive lowest daily VWAPs for our common stock during the twenty (20) trading days prior to the payment date, subject to a floor price of $0.75 per share.

 

17

 

The Note may be converted by Lind upon issuance a price of $6.50 per share (the “Conversion Price”). The dollar amount of any conversions by Lind will be applied toward upcoming Note payments in chronological order. The Note may be prepaid in whole upon 5 days’ notice, but in the event of a prepayment notice, Lind may convert up to 25% of principal amount due at the lesser of the Repayment Share Price (but only if the Repayment Share Price is equal to or greater than $2.00) or the Conversion Price.

The fair value of the convertible note and related warrants were estimated using a Monte Carlo simulation model. No value was assigned to the warrant liability due to the fair market value of the convertible note payable being in excess of the proceeds received. The Company’s convertible notes payable balance at October 31, 2024 was $11,911,307.

Subsequent to quarter end, on November 26, 2024, we entered into a First Amendment to our SPA with Lind. Additionally, on December 13, 2024, Lind provided notice to the Company to convert $1,300,000 of the note payable into 200,000 shares of Common Stock which will be issued on December 16, 2024. On December 16, 2024, Lind provided notices to the Company to convert an additional $2,600,000 and $3,250,000 of the note payable into 400,000 and 500,000 shares of Common Stock, respectively. See Note 20 for further information.

 

 

Note 14 – Common Stock

 

Our common stock has a par value of $0.001 per share. We are authorized to issue 500,000,000 shares of common stock. Each share of common stock is entitled to one vote. A summary of shares of common stock issued by the Company since April 30, 2023 is as follows:

 

Description of Shares		Shares Issued
Shares outstanding as of April 30, 2023			54,568,065
Vesting of restricted stock to employees, net of shares withheld of 27,189 to pay taxes			192,742
Vesting of restricted stock to Board of Directors			252,214
Vesting of restricted stock to consultants			1,761
Conversion of preferred stock			818,334
Issuance of common stock through ATM facilities			53,235
Issuance of common stock through public offering			18,400,000
Exercise of stock options			3,000
Shares outstanding as of April 30, 2024			74,289,351
Vesting of restricted stock to employees, net of shares withheld of 138,744 to pay taxes			540,590
Vesting of restricted stock to Board of Directors			61,447
Exercise of stock options			58,446
Exercise of warrants			530,578
FlightWave acquisition			2,544,991
Shares outstanding as of October 31, 2024			78,025,403

    

See note 20 for subsequent events. 

 

Public Offering

 

In December 2023, the Company entered into an underwriting agreement with ThinkEquity LLC, as representative of the underwriters, pursuant to which the Company agreed to sell to the underwriters in a firm commitment underwritten public offering (the “Offering”) an aggregate of 16,000,000 shares of the Company’s common stock, par value $0.001 per share, at a public offering price of $0.50 per share. The Company also granted the underwriters a 45-day option to purchase up to an additional 2,400,000 shares of Common Stock to cover over-allotments. 

  

The Offering closed on December 11, 2023, resulting in the issuance of 18,400,000 shares of Common Stock which generated gross proceeds of $9,200,000. Net proceeds to the Company from the Offering, after deducting the underwriting discount, the underwriters’ fees and expenses and the Company’s estimated Offering expenses, were approximately $8,400,000. 

 

 

Note 15 – Preferred Stock

 

Our preferred stock has a par value of $0.001 per share. Series B Preferred Stock (“Series B Stock”) is convertible into common stock at a ratio of 0.8334 shares of common stock for each share of Series B Stock held and votes together with the common stock on an as-if-converted basis. 982,000 shares of Series B Stock were converted into 818,334 shares of common stock in June 2023. Shares outstanding at October 31, 2024 totaled 4,676 which are convertible into 3,896 shares of common stock.

18

 

  

 

Note 16 – Warrants

 

The Company issued 5 year warrants to investors in connection with two convertible note financings. The warrants have an exercise price of $1.50. The warrants were valued using the multinominal lattice The value of the warrants was included in the determination of the initial accounting for each financing.

 

A summary of the warrants issued were: 

 

				Upon Issuance
Date of Transaction				Number of Warrants				Initial Fair Value
	October 2020				399,998			$	267,999
	January 2021				675,000			$	2,870,666

   

As of October 31, 2024, we have received $301,248 related to the exercise of 268,332 warrants.

 

In May 2021, the Company issued warrants to purchase 200,000 shares of common stock to the placement agent of its common stock offering. The warrants have a five-year term and an exercise price of $5.00.

   

In July 2021, the Company issued warrants to purchase 533,333 shares of common stock to the placement agent of its common stock offering. The warrants have a five-year term and an exercise price of $5.625.

 

In December 2023, the Company issued warrants to purchase 736,000 shares of common stock to the placement agent of its common stock offering. The warrants have a five-year term and an exercise price of $0.625.

 

In September 2024, the Company issued warrants to purchase 750,000 shares of common stock to Lind, as further described in Note 13. The warrants have a five-year term and an exercise price of $6.50. No value was assigned to the warrants under the Monte Carlo simulation model due to the fair market value of the convertible note payable being in excess of the proceeds received.

 

The following table summarizes the changes in warrants outstanding since April 30, 2023.

 

				Number of Shares			Weighted-average Exercise Price per Share				Weighted-average Remaining Contractual Term (in years)				Aggregate Intrinsic Value
	Balance as of April 30, 2023			1,539,999				3.38				2.89			$	—
	Granted			736,000			$	0.63
	Exercised			—				—
	Outstanding as of April 30, 2024			2,275,999				2.49				2.77			$	—
	Granted			750,000				6.50				5.00
	Exercised			(733,792	)			0.63
	Outstanding at October 31, 2024			2,292,207			$	4.40				2.51			$	1,263,775

 

 

Note 17 – Share Based Awards

 

The 2019 Equity Incentive Plan (the “2019 Plan”) and the 2024 Omnibus Equity Incentive Plan (the “2024 Plan”) (collectively, the “Plans”) allow us to incentivize key employees, consultants, and directors with long term compensation awards such as stock options, restricted stock, and restricted stock units (collectively, the “Awards”). The number of shares issuable in connection with Awards under the 2019 Plan were not to exceed 11,750,000. However, no shares are issuable under the 2019 Plan after the 2024 Plan became effective on October 15, 2024. The number of shares issuable in connection with Awards under the 2024 Plan may not exceed 11,250,000 plus any underlying forfeited 2019 Plan awards.

  

19

 

A.

Options

 

The range of assumptions used to calculate the fair value of options granted during the six months ended October 31 was:

 

			2024				2023
Exercise Price		$	1.15 – 2.45			$	0.95 – 1.12
Stock price on date of grant			1.20 – 2.56				0.95 – 1.12
Risk-free interest rate			3.54 – 4.44%				3.47 – 4.34%
Dividend yield			—				—
Expected term (years)			5.17 – 5.73				6.00 – 8.25
Volatility			191.43 – 199.03%				242.38 – 260.22%

        

A summary of options activity under the Plans since April 30, 2023 was:

 

		Shares				Weighted-Average Exercise Price				Weighted-Average Remaining Contractual Term				Aggregate Intrinsic Value
Outstanding as of April 30, 2023			4,784,809			$	1.88				8.72				74,586
Granted			2,903,542				1.02
Exercised			(3,000	)			0.89
Forfeited or expired			(905,417	)			2.27
Outstanding as of April 30, 2024			6,779,934				1.46				8.02				2,762,242
Granted			1,333,500				1.94
Exercised			(97,414	)			1.60
Forfeited or expired			(119,117	)			1.47
Outstanding as of October 31, 2024			7,896,903				1.54				7.55				12,438,946
Exercisable as of October 31, 2024			4,557,077			$	1.63				6.45			$	6,959,111

  

The aggregate intrinsic value of outstanding options represents the excess of the stock price at the indicated date over the exercise price of each option. As of October 31, 2024, there was $2,674,589 of unrecognized stock-based compensation expense related to unvested stock options which is expected to be recognized over the weighted average periods of 1.12 years.

 

B.

Restricted Stock

 

A summary of restricted stock activity under the Plans since April 30, 2023 was:

 

		Shares				Weighted Average Grant-Date Fair Value Per Share
Unvested and outstanding as of April 30, 2023			781,060			$	2.44
Granted			298,643				1.06
Vested			(485,024	)			1.92
Forfeited			(419,549	)			2.09
Unvested and outstanding as of April 30, 2024			175,130				2.09
Granted			2,497,599				1.10
Vested			(914,416	)			1.18
Forfeited			—				—
Unvested and outstanding as of October 31, 2024			1,758,313			$	1.16

    

20

 

C.

Stock Compensation

 

Stock compensation expense by functional operating expense was:

		Three months ended October 31,								Six months ended October 31,
		2024				2023				2024				2023
Research and development		$	80,093			$	147,629			$	174,515			$	275,046
Sales and marketing			130,264				208,903				246,807				374,212
General and administrative			1,093,680				839,793				2,328,753				1,458,673
Total		$	1,304,037			$	1,196,325			$	2,750,075			$	2,107,931

 

Stock compensation expense pertaining to options totaled$815,632 and $1,606,305 for the six months ended October 31, 2024 and 2023, respectively. Stock compensation expense pertaining to restricted stock units totaled $1,934,443 and $501,626 for the six months ended October 31, 2024 and 2023, respectively.

 

 

Note 18 - Related-Party Transactions

 

In February 2024, the Company sold Rotor Riot and Fat Shark to Unusual Machines, as further described in Note 4 and Note 8. UMAC’s Chief Executive Officer is a direct relative of a member of the Company’s management.

 

 

Note 19 – Commitments and Contingencies   

 

Legal Proceedings

 

In the ordinary course of business, we may be involved, at times, in various legal proceedings involving a variety of matters. We do not believe there are any pending legal proceedings that will have a material adverse effect on our business, consolidated financial position, results of operations, or cash flows. However, the outcome of such legal matters is inherently unpredictable and subject to significant uncertainties. We have not recorded any litigation reserves as of October 31, 2024.

 

One pending legal matter is an action filed against Teal in a U.S. District Court in Delaware. The complaint asserts claims for breach of contract which management denies. We are asserting vigorous defenses to the complaint. Additionally, the Company has filed a lawsuit against the complainant for Tortious Interference with Contractual Relations and Prospective Contractual Relations. No discovery or other significant developments in the lawsuit have occurred.

 

 

Note 20 – Subsequent Events  

 

Subsequent events have been evaluated through the date of this filing and there are no subsequent events which require disclosure, except as follows:

 

Subsequent to October 31, 2024, approximately 2,000,000 shares of Common Stock were issued for the exercise of options, warrants, and vested RSUs. 

 

On November 26, 2024, we entered into a First Amendment to our Securities Purchase Agreement (the “SPA Amendment”) with Lind. The SPA Amendment amends the terms of our original Securities Purchase Agreement with Lind dated September 23, 2024. Upon closing of the SPA Amendment, we will receive an additional $6,000,000 in funding from Lind in exchange for our issuance to Lind of a Senior Secured Convertible Promissory Note in the amount of $7,200,000 (the “Note”) and a Common Stock Purchase Warrant for the purchase of 326,000 shares of our common stock at a price of $9.20 per share, exercisable for 5 years (the “Warrant”). As additional consideration to Lind, we have agreed to pay a commitment fee in the amount of $210,000, which may be paid by deduction from the funding to be received.

 

21

 

The Note, which does not accrue interest, shall be repaid in eighteen (18) consecutive monthly installments in the amount of $400,000 beginning six months from the issuance date. At our option, monthly payments can be increased up to $750,000 so long as our market capitalization is at least $50 million. In addition, if the Repayment Share Price (as defined below) is equal to or greater than $2.00, Lind can, at its option, increase the monthly payment amount up to $975,000 for up to two months. The monthly payments due under the Note may be made by the issuance of common stock valued at the Repayment Share Price, cash in an amount equal to 1.025 times the required payment amount, or a combination thereof. The Repayment Share Price is defined in the Note as ninety percent (90%) of the average of the five (5) consecutive lowest daily VWAPs for our common stock during the twenty (20) trading days prior to the payment date, subject to a floor price of $0.75 per share.

 

The Note may be converted by Lind from time to time at a price of $9.20 per share (the “Conversion Price”). The dollar amount of any conversions by Lind will be applied toward upcoming Note payments in chronological order. The Note may be prepaid in whole upon 5 days’ notice, but in the event of a prepayment notice, Lind may convert up to 25% of principal amount due at the lesser of the Repayment Share Price (but only if the Repayment Share Price is equal to or greater than $2.00) or the Conversion Price.   

 

On December 13, 2024, Lind provided notice to the Company to convert $1,300,000 of the note payable into 200,000 shares of Common Stock which will be issued on December 16, 2024. Additionally, on December 16, 2024, Lind provided notice to the Company to convert an additional $2,600,000 of the note payable into 400,000 shares of Common Stock.

 

 

ITEM 2.  MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

 

You should read the following discussion and analysis of our financial condition and results of operations together with our financial statements and the related notes appearing elsewhere in this Quarterly Report on Form 10-Q. In addition to historical information, this discussion and analysis contains forward-looking statements that involve risks, uncertainties and assumptions. Our actual results may differ materially from those discussed below. Factors that could cause or contribute to such differences include, but are not limited to, those identified below, and those discussed in the section titled “Risk Factors” included in our Annual Report on Form 10-K for the fiscal year ended April 30, 2024 as may be amended, supplemented or superseded from time to time by other reports we file with the SEC. All amounts in this report are in U.S. dollars, unless otherwise noted.

 

Overview

 

We are a technology company focused on developing products, services, and solutions to the drone industry. We were originally incorporated under the laws of the State of Colorado in 1984 under the name “Oravest International, Inc.” In November 2016, we changed our name to “TimefireVR, Inc.” and re-incorporated in Nevada. In May 2019, we completed a share exchange agreement with Propware which resulted in the Propware shareholders acquiring an 83% ownership interest, and management control, of the Company. In connection with the share exchange agreement, we changed our name to “Red Cat Holdings, Inc.”, and our operating focus to the drone industry.

 

Prior to the share exchange agreement, Propware was focused on the research and development of software solutions that could provide secure cloud-based analytics, storage and services for the drone industry. Following the share exchange agreement and name change, we have completed a series of acquisitions and financings which have broadened the scope of our activities in the drone industry.

 

Recent Developments

 

On September 4, 2024, the Company entered into an Asset Purchase Agreement (the “APA”) with FlightWave Aerospace Systems Corporation (the “Seller”). The seller sold certain assets used in designing, developing, manufacturing, and selling long range, AI-powered UAVs for commercial use. Pursuant to the APA, the Company has acquired substantially all of the assets owned, controlled or used by the Seller for an aggregate purchase price of $14,000,000 worth of shares of the Company’s common stock. See Note 3 for further information.

 

On September 23, 2024, we entered into a Securities Purchase Agreement (the “SPA”) with Lind Global Asset Management X LLC (“Lind”). Under the SPA, we received $8 million in funding from Lind in exchange for our issuance to Lind of a Senior Secured Convertible Promissory Note in the amount of $9,600,000 (the “Note”) and a Common Stock Purchase Warrant for the purchase of 750,000 shares of our common stock at a price of $6.50 per share, exercisable for 5 years (the “Warrant”). As additional consideration to Lind, we paid a commitment fee in the amount of $280,000, which was paid by deduction from the funding to be received. The Note, which does not accrue interest, shall be repaid in eighteen (18) consecutive monthly installments in the amount of $533,334 beginning March 23, 2024. See Note 13 for further information.

 

On November 26, 2024, we entered into a First Amendment to our Securities Purchase Agreement (the “SPA Amendment”) with Lind. The SPA Amendment amends the terms of our original Securities Purchase Agreement with Lind dated September 23, 2024. Upon closing of the SPA Amendment, we received an additional $6,000,000 in funding from Lind in exchange for our issuance to Lind of a Senior Secured Convertible Promissory Note in the amount of $7,200,000 (the “Note”) and a Common Stock Purchase Warrant for the purchase of 326,000 shares of our common stock at a price of $9.20 per share, exercisable for 5 years (the “Warrant”). As additional consideration to Lind, we have agreed to pay a commitment fee in the amount of $210,000, which may be paid by deduction from the funding to be received. See Note 20 for further information. 

 

Plan of Operations 

 

Since April 2016, our primary business has been to provide products, services, and solutions to the drone industry which we presently do through our three wholly owned subsidiaries Skypersonic, Teal, and Propware. Beginning in January 2020, we expanded the scope of our drone products and services through five acquisitions, including:

 

A.

In January 2020, we acquired Rotor Riot, a provider of First Person View (FPV) drones and equipment, primarily to the consumer marketplace. The purchase price was $1,995,114.

 

B.

In November 2020, we acquired Fat Shark Holdings, a provider of FPV video goggles to the drone industry. The purchase price was $8,354,076.

   

C.

In May 2021, we acquired Skypersonic which provides hardware and software solutions that enable drones to complete inspection services in locations where GPS is not available, yet still record and transmit data even while being operated from thousands of miles away. The purchase price was $2,791,012.

 

	D.	In August 2021, we acquired Teal, a leader in commercial and government UAV technology, primarily drones, to government and commercial enterprises, most notably, the military. Teal manufactures drones approved by the U.S. Department of Defense for reconnaissance, public safety, and inspection applications. The purchase price was $10,011,279.
	E.	In September 2024, the Company acquired FlightWave Aerospace Systems Corporation, an industry-leading provider of VTOL drone, sensor and software solutions, under an Asset Purchase Agreement. As part of the acquisition, the Company created a new subsidiary, FW Acquisition Inc. for ongoing operations The purchase price was $14,000,000.

 

Following the Teal acquisition in August 2021, we concentrated on integrating and organizing these businesses. Effective May 1, 2022, we established the Enterprise segment (“Enterprise”) and the Consumer segment (“Consumer”) to focus on the unique opportunities in each sector. Enterprise's initial strategy was to provide UAVs to commercial enterprises, and the military, to navigate dangerous military environments and confined industrial and commercial interior spaces. Subsequently, Enterprise narrowed its near-term attention on the military and other government agencies. Skypersonic's technology has been redirected to military applications and its operations consolidated into Teal.

 

The Enterprise segment’s current business strategy is focused on providing integrated robotic hardware and software for use across a variety of applications. Its solutions provide critical situational awareness and actionable intelligence to on-the-ground warfighters and battlefield commanders as well as firefighters and public safety officials. Our Enterprise segment’s efforts are centered on developing and scaling an American made family of systems. We have since completed construction of a manufacturing facility in Salt Lake City, Utah and believe that an increased focus by the United States government and American businesses on purchasing products that are “Made in America” provide our Enterprise segment with a competitive advantage.

 

On February 16, 2024, we closed the sale of our Consumer segment, consisting of Rotor Riot and Fat Shark, to Unusual Machines. The sale reflects our decision to focus our efforts and capital on defense where we believe there are more opportunities to create long term shareholder value.

 

Results of Operations

 

The analysis of our results of operations for the three and six months ended October 31, 2024 compared to the three and six months ended October 31, 2023 includes only our Enterprise segment as our Consumer segment was divested in February 2024.

 

Discussion and Analysis of Three Months Ended October 31, 2024 compared to Three Months Ended October 31, 2023

 

Revenues

 

Consolidated revenues totaled $1,534,727 during the three months ended October 31, 2024 (or the “2024 period”) compared to $3,930,868 during the three months ended October 31, 2023 (or the “2023 period”) representing a decrease of $2,396,141, or 61%. The decrease related to lower product revenue and lower contract revenue as the Company has begun shifting manufacturing focus from the Teal 2 to the Black Widow. Product revenue totaled $1,524,791 during the quarter ended October 31, 2024 compared to $3,383,238 during the quarter ended October 31, 2023 representing a decrease of $1,858,447, or 55%. There were no contract revenues during the 2024 period compared to $529,438 during the 2023 period, representing a decrease of $529,438, or 100%. Contract revenues are primarily sourced through government agencies and can fluctuate from period to period based on the timing of award deliverables and amendments.

 

Gross Profit

 

Consolidated gross loss totaled $23,475 during the 2024 period compared to a gross profit of $1,200,582 during the 2023 period representing a decrease of $1,224,057, or 102%. On a percentage basis, gross loss was 2% during the 2024 period compared to a gross profit of 31% during the 2023 period. The gross loss in the 2024 period was due to lower-than-planned manufacturing levels due to the transition to the Black Widow which resulted in higher relative overhead costs compared to the 2023 period. Our manufacturing facility is presently producing drones at a lower level than it is designed for, and these lower production levels, combined with higher overhead costs, continue to result in lower than targeted gross margins.

 

Operating Expenses

 

Research and development expenses totaled $2,231,470 during the 2024 period compared to $2,222,137 during the 2023 period, representing an increase of $9,333, or 0.5%.

 

Sales and marketing costs totaled $2,343,779 during the 2024 period compared to $1,032,645 during the 2023 period, representing an increase of $1,311,134 or 127%. The increase was driven by higher payroll expenses due to an increased headcount and an increase in tradeshow attendance in efforts to spread awareness of new products and the Red Cat Futures Initiative.

 

General and administrative expenses totaled $4,517,695 during the 2024 period compared to $2,838,080 during the 2023 period, representing an increase of $1,679,615 or 59%. The increase was mainly due to a higher headcount, including the addition of employees from the FlightWave acquisition. In anticipation of winning the production contract under the Army’s Short Range Reconnaissance program of record, the Company increased investment in personnel necessary to fulfill the contract as well as anticipated demands for future products.

 

During the 2024 period, we incurred stock-based compensation costs of $1,304,037 compared to $1,196,325 in the 2023 period, resulting in an increase of $107,712 or 9%.

 

Other Income

 

Other expense totaled $4,218,199 during the 2024 period compared to $352,019 during the 2023 period, representing an increase of $3,866,180 or more than 10 times. This increase is primarily related to a loss of $4,230,307 recognized in the 2024 period on the issuance of the Note to Lind, based on its fair value.

 

Net Loss from Continuing Operations

 

Net loss from continuing operations totaled $13,334,618 for the 2024 period compared to $5,244,299 for the 2023 period, resulting in an increase of $8,090,319 or 154%. Total operating expenses totaled $9,092,944 for the 2024 period compared to $6,092,862 for the 2023 period. This increase of $3,000,082 or 49%, related to the increase in sales and marketing expenses and general and administrative expenses.

 

Discussion and Analysis of Six Months Ended October 31, 2024 compared to Six Months Ended October 31, 2023

 

Revenues

 

Consolidated revenues totaled $4,311,262 during the six months ended October 31, 2024 (or the “2024 period”) compared to $5,678,997 during the six months ended October 31, 2023 (or the “2023 period”) representing a decrease of $1,367,735, or 24%. The decrease related to lower product revenue. Product revenue totaled $3,359,991 during the 2024 period compared to $4,796,365 during the 2023 period representing a decrease of $1,436,374, or 30%.

 

Gross Profit

 

Consolidated gross loss totaled $506,866 during the 2024 period compared to a gross profit of $1,375,247 during the 2023 period representing a decrease of $1,882,113, or 137%. On a percentage basis, gross loss was 12% during the 2024 period compared to a gross profit of 24% during the 2023 period. The gross loss in the 2024 period was due primarily to the delivery of final prototypes under the Short Range Reconnaissance Tranche 2 contract with the U.S. Army which occurred in the first quarter. This is also due to lower-than-planned manufacturing levels in the transition to the Black Widow which resulted in higher relative overhead costs compared to the 2023 period. Our manufacturing facility is presently producing drones at a lower level than it is designed for, and these lower production levels, combined with higher overhead costs, continue to result in lower than targeted gross margins.

 

Operating Expenses

 

Research and development expenses totaled $3,857,910 during the 2024 period compared to $3,575,688 during the 2023 period, representing an increase of $282,222, or 8%. The increase was primarily driven by the increased investment in the development of new products as well as the FlightWave acquisition.

 

Sales and marketing costs totaled $4,385,290 during the 2024 period compared to $2,321,405 during the 2023 period, representing an increase of $2,063,885 or 89%. The increase was driven by higher payroll expenses due to an increased headcount and an increase in tradeshow attendance in efforts to spread awareness of new products and the Red Cat Futures Initiative.

 

General and administrative expenses totaled $8,000,790 during the 2024 period compared to $5,701,838 during the 2023 period, representing an increase of $2,298,952 or 40%. The increase was mainly due to a higher headcount, including the addition of employees from the FlightWave acquisition. In anticipation of winning the production contract under the Army’s Short Range Reconnaissance program of record, the Company increased investment in personnel necessary to fulfill the contract as well as anticipated demands for future products.

 

During the 2024 period, we incurred stock-based compensation costs of $2,750,075 compared to $2,107,931 in the 2023 period, resulting in an increase of $642,144 or 30%.

 

Other Income

 

Other expense totaled $8,907,088 during the 2024 period compared to $614,910 during the 2023 period, representing an increase of $8,292,178 or more than 13 times. This increase is primarily related to a loss incurred on the sale of our equity method investment of $4,008,357 as well as a loss of $4,230,307 recognized on the issuance of the Note to Lind, based on its fair value.

 

Net Loss from Continuing Operations

 

Net loss from continuing operations totaled $25,750,994 for the 2024 period compared to $10,838,594 for the 2023 period, resulting in an increase of $14,912,400 or 138%. Total operating expenses totaled $16,337,040 for the 2024 period compared to $11,598,931 for the 2023 period. This increase of $4,738,109 or 41%, related to the increase in sales and marketing expenses and general and administrative expenses.

 

Cash Flows

  

Operating Activities

 

Net cash used in operating activities was $12,487,713 during the 2024 period compared to net cash used in operating activities of $11,240,359 during the 2023 period, representing an increase of $1,247,354 or 11%. The increased use of cash primarily related to timing of accounts receivable receipts for government customers. Net cash used in operations, net of non-cash expenses, totaled $13,088,786 during the 2024 period, compared to $7,427,197 during the 2023 period, resulting in an increase of $5,661,589, or 76%. Net cash used related to changes in operating assets and liabilities totaled $601,073 during the 2024 period, compared to negative $3,813,162 during the 2023 period, representing an increase of $4,414,235 or 116%. Changes in operating assets and liabilities can fluctuate significantly from period to period depending upon the timing and level of multiple factors, including inventory purchases, vendor payments, and customer collections.

  

Investing Activities

 

Net cash provided by investing activities was $4,276,207 during the 2024 period compared to net cash provided by investing activities of $10,065,641 during the 2023 period, resulting in a decrease of $5,789,434 or 58%. During the 2023 period, proceeds of marketable securities were approximately $10,200,000 compared to $0 during the 2024 period. During the 2024 period, we received proceeds of $4,400,000 from the sale of equity method investment.

 

Financing Activities

 

Net cash provided by financing activities totaled $6,755,429 during the 2024 period compared to net cash used in financing activities of $286,206 during the 2023 period. The increase related to the proceeds from the issuance of convertible notes payable during the 2024 period.

 

Liquidity and Capital Resources

 

At October 31, 2024, we reported current assets totaling $20,913,163, current liabilities totaling $14,672,706 and net working capital of $6,240,457. Cash totaled $4,611,092 at October 31, 2024. Inventory related balances, including pre-paid inventory, totaled $12,554,330.

  

Going Concern

 

We have never been profitable and have incurred net losses related to acquisitions, as well as costs incurred to pursue its long-term growth strategy. During the six months ended October 31, 2024, we incurred a net loss of approximately $25,750,000 and used cash in operating activities of approximately $12,500,000. As of October 31, 2024, working capital totaled approximately $6,240,000. These financial results and our financial position at October 31, 2024 raise substantial doubt about our ability to continue as a going concern. However, we have recently taken actions to strengthen our liquidity.  In November 2024, the Company was selected as the winner of the U.S.  Army’s Short Range Reconnaissance (SRR) Program of Record. The Company’s manufacturing facility is scaling production of its most recent products and gross profits are projected to increase. As described in Note 13 and Note 20, the Company closed financings with proceeds of approximately $8,000,000 and $6,000,000 in September 2024 and November 2024, respectively. Additionally, the Company’s Form S-3 became effective on December 11, 2024. If necessary, the Company will seek additional equity financing for which there can be no guarantee. Management has concluded that these recent positive developments alleviate any substantial doubt about the Company’s ability to continue its operations, and meet its financial obligations, for twelve months from the date these consolidated financial statements are issued.

 

Critical Accounting Policies and Estimates

 

Our financial statements and accompanying notes have been prepared in accordance with GAAP applied on a consistent basis. The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting periods.

 

We regularly evaluate the accounting policies and estimates that we use to prepare our financial statements. A complete summary of these policies is included in the notes to our financial statements. In general, management's estimates are based on historical experience, information from third party professionals, and on various other assumptions that are believed to be reasonable under the facts and circumstances. Actual results could differ from those estimates made by management. 

 

Significant estimates reflected in these financial statements include those used to (i) complete purchase price accounting for acquisitions, (ii) the evaluation of long-term assets, including goodwill, for impairment, (iii) the evaluation of other-than-temporary-impairment of equity method investments, and (iv) valuations of convertible notes payable.

  

Goodwill and Long-lived Assets – Goodwill represents the future economic benefit arising from other assets acquired in an acquisition that are not individually identified and separately recognized. We test goodwill for impairment in accordance with the provisions of ASC 350, Intangibles – Goodwill and Other, (“ASC 350”). Goodwill is tested for impairment at least annually at the reporting unit level or whenever events or changes in circumstances indicate that goodwill might be impaired. ASC 350 provides that an entity has the option to first assess qualitative factors to determine whether the existence of events or circumstances leads to a determination that it is more likely than not that the fair value of a reporting unit is less than its carrying amount. If, after assessing the totality of events or circumstances, an entity determines it is not more likely than not that the fair value of a reporting unit is less than its carrying amount, then additional impairment testing is not required. However, if an entity concludes otherwise, then it is required to perform an impairment test. The impairment test involves comparing the estimated fair value of a reporting unit with its book value, including goodwill. If the estimated fair value exceeds book value, goodwill is considered not to be impaired. If, however, the fair value of the reporting unit is less than book value, then an impairment loss is recognized in an amount equal to the amount that the book value of the reporting unit exceeds its fair value, not to exceed the total amount of goodwill allocated to the reporting unit.

 

The estimate of fair value of a reporting unit is computed using either an income approach, a market approach, or a combination of both. Under the income approach, we utilize the discounted cash flow method to estimate the fair value of a reporting unit. Significant assumptions inherent in estimating the fair values include the estimated future cash flows, growth assumptions for future revenues (including gross profit, operating expenses, and capital expenditures), and a rate used to discount estimated future cash flow projections to their present value based on estimated weighted average cost of capital (i.e., the selected discount rate). Our assumptions are based on historical data, supplemented by current and anticipated market conditions, estimated growth rates, and management’s plans. Under the market approach, fair value is derived from metrics of publicly traded companies or historically completed transactions of comparable businesses. The selection of comparable businesses is based on the markets in which the reporting units operate and consider risk profiles, size, geography, and diversity of products and services. 

 

Fair Values, Inputs and Valuation Techniques for Financial Assets and Liabilities and Related Disclosures – The fair value measurements and disclosure guidance defines fair value and establishes a framework for measuring fair value. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability (an exit price) in an orderly transaction between market participants at the measurement date. In accordance with this guidance, we have categorized our recurring basis financial assets and liabilities into a three-level fair value hierarchy based on the priority of the inputs to the valuation technique.

  

The fair value hierarchy gives the highest priority to quoted prices in active markets for identical assets or liabilities (Level 1) and the lowest priority to unobservable inputs (Level 3). The inputs used to measure fair value may fall into different levels of the fair value hierarchy. In such cases, the level in the fair value hierarchy within which the fair value measurement in its entirety falls has been determined based on the lowest level input that is significant to the fair value measurement in its entirety. Our assessment of the significance of a particular input to the fair value measurement in its entirety requires judgment and considers factors specific to the asset or liability.

   

The guidance establishes three levels of the fair value hierarchy as follows:

 

Level 1: Inputs are unadjusted, quoted prices in active markets for identical assets or liabilities at the measurement date;

Level 2: Inputs are observable, unadjusted quoted prices in active markets for similar assets or liabilities, unadjusted quoted prices for identical or similar assets or liabilities in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the related assets or liabilities; and

Level 3: Unobservable inputs that are significant to the measurement of the fair value of the assets or liabilities that are supported by little or no market data.

 

Financial Instruments

 

Our financial instruments mainly consist of cash, accounts receivable, current assets, accounts payable, accrued expenses, notes payable, and convertible notes payable. The recorded carrying amounts of cash, accounts receivable, current assets, accounts payable, accrued expenses, and notes payable are considered to approximate their estimated fair values due to their short-term nature. Liabilities recognized at fair value on a recurring basis in the consolidated balance sheets consist of convertible notes payable. These items are categorized based upon the level of judgment associated with the inputs used to measure their fair values. Fair value is defined as the price that would be paid to transfer a liability in an orderly transaction between market participants at the measurement date.

 

Recently Issued Accounting Pronouncements

 

We have implemented all new accounting pronouncements that are in effect. These pronouncements did not have any material impact on the financial statements unless otherwise disclosed, and we do not believe that there are any other new accounting pronouncements that have been issued that might have a material impact on our financial position or results of operations. 

 

 

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

 

We are not required to provide the information required by this Item as we are a “smaller reporting company,” as defined in Rule 12b-2 of the Exchange Act.

 

 

ITEM 4. CONTROLS AND PROCEDURES

 

Evaluation of Disclosure Controls and Procedures

 

Our principal executive officer and principal financial officer evaluated the effectiveness of our “disclosure controls and procedures” as of October 31, 2024, the end of the period covered by this Quarterly Report on Form 10-Q. The term “disclosure controls and procedures,” as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act, means controls and other procedures of a company that are designed to ensure that information required to be disclosed by a company in the reports that it files under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the SEC’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by a company in the reports that it files under the Exchange Act is accumulated and communicated to a company’s management, including its principal executive officer and principal financial officer, as appropriate to allow timely decisions regarding required disclosure. Based on the evaluation of our disclosure controls and procedures as of October 31, 2024, our Chief Executive Officer and our Chief Financial Officer concluded that, as of such date, our disclosure controls and procedures were not effective, specifically pertaining to the quarter ended October 31, 2023 for which we restated items related to the removal of the derivative liabilities.

 

Management's quarterly report on internal control over financial reporting.

 

Our management is responsible for establishing and maintaining adequate internal control over financial reporting. Our internal control over financial reporting is designed to provide reasonable assurances regarding the reliability of financial reporting and the preparation of our consolidated financial statements in accordance with GAAP. Our accounting policies and internal controls over financial reporting, established and maintained by management, are under the general oversight of the Board’s audit committee.

 

Our internal control over financial reporting includes those policies and procedures that:

 

	•	pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of our assets;
	•	provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with GAAP, and that receipts and expenditures are being made only in accordance with authorizations of our management and directors; and
	•	provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of assets that could have a material effect on the financial statements.

 

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree or compliance with the policies or procedures may deteriorate.

 

Management assessed our internal control over financial reporting as of October 31, 2024. The standard measures adopted by management in making its evaluation are the measures in the Internal-Control Integrated Framework published by the Committee of Sponsoring Organizations (“COSO”) of the Treadway Commission.

 

Based on management’s assessment using the COSO criteria, our CEO and CFO concluded that our internal control over financial reporting was not effective, specifically pertaining to the quarter ended October 31, 2023 for which we restated items related to the removal of the derivative liabilities. The Company is currently in the process of formalizing narratives and processes which are expected to mitigate these weaknesses, and has hired additional personnel to strengthen the internal control environment.

 

Changes In Controls Over Financial Reporting

 

There were no changes in our internal control over financial reporting (as defined in Rule 13a-15(f) of the Exchange Act) that occurred during the three months ended October 31, 2024, that have materially affected, or are reasonably likely to materially affect, our internal controls over financial reporting.  

 

Limitations on Effectiveness of Controls and Procedures

 

In designing and evaluating the disclosure controls and procedures, management recognizes that any controls and procedures, no matter how well designed and operated, cannot provide absolute assurance that the objectives of the controls system are met, and no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, within a company have been detected. In addition, the design of disclosure controls and procedures must reflect the fact that there are resource constraints and that management is required to apply judgment in evaluating the benefits of possible controls and procedures relative to their costs.

 

 

PART II - OTHER INFORMATION

 

ITEM 1. LEGAL PROCEEDINGS 

 

From time to time, we are involved in various legal proceedings, lawsuits and claims incidental to the conduct of our business, some of which may be material. Our businesses are also subject to extensive regulation, which may result in regulatory proceedings against us. Other than as described below, we do not believe that the outcome of any of our current legal proceedings will have a material adverse impact on our business, financial condition and results of operations.

 

On May 9, 2024, Autonodyne LLC filed a complaint against wholly-owned Red Cat subsidiary Teal Drones, Inc. in the Superior Court of the State of Delaware. The Complaint alleges a single cause of action, asserting that Teal breached a Software Licensing Agreement between it and Autonodyne (the “SLA”) by disclosing confidential information contained in the SLA. Autonodyne alleges that it rightfully terminated the SLA, and at that point it became entitled to $8.25 million of accelerated payments, pursuant to section 14.4(e) of the SLA. Teal Drones has answered the Complaint. Autonodyne filed a motion for judgment on the pleadings, which was opposed by Red Cat’s outside counsel. The court heard oral arguments on October 10, 2024. At the conclusion of the hearing, the court advised the parties that the arguments and briefs would be taken under advisement, and a decision issued later; a ruling is yet to be issued. As any litigation is subject to many uncertainties, it is not possible to predict the ultimate outcome of this claim or to estimate the loss, if any, which may result. Accordingly, the outcome of the claim is not yet determinable, and the extent to which an outflow of funds may be required to settle this possible obligation cannot be reliably determined. The Company plans to vigorously assert defenses to the complaint.

 

 

ITEM 1A. RISK FACTORS

 

Risk factors that affect our business and financial results are discussed in Part I, Item 1A “Risk Factors,” in our Annual Report on Form 10-K for the year ended April 30, 2024, as filed with the SEC on August 8, 2024 (“Annual Report”). There have been no material changes in our risk factors from those previously disclosed in our Annual Report. You should carefully consider the risks described in our Annual Report which could materially affect our business, financial condition or future results. The risks described in our Annual Report are not the only risks we face. Additional risks and uncertainties not currently known to us or that we currently deem to be immaterial also may materially adversely affect our business, financial condition, and/or operating results. If any of the risks actually occur, our business, financial condition, and/or results of operations could be negatively affected.

 

 

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS 

 

None. 

 

 

ITEM 3. DEFAULTS UPON SENIOR SECURITIES

 

None.

 

 

ITEM 4. MINE SAFETY DISCLOSURES

 

Not applicable

 

 

ITEM 5. OTHER INFORMATION 

 

Rule 10b5-1 Trading Plans

 

During the three months ended October 31, 2024, none of our directors or officers adopted or terminated any contract, instruction or written plan for the purchase or sale of Company securities that was intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) or any “non-Rule 10b5-1 trading arrangement.” 

 

Resignation of Chief Financial Officer

 

On December 11, 2024, Leah Lunger informed the Board of Directors of her intention to resign as Chief Financial Officer of the Company, effective January 10, 2025. Ms. Lunger’s resignation is for personal and family reasons and is not based on any disagreement with the Company’s accounting principles, practices or financial statement disclosures.

 

ITEM 6. EXHIBITS 

 

Exhibit No.		Description
10.1		2019 Equity Incentive Plan, as amended (incorporated by reference to Exhibit 10.1 to the Registration Statement on Form S-8 filed on August 27, 2024)
10.2		Asset Purchase Agreement, dated September 4, 2024 (incorporated by reference to Exhibit 10.1 to the Current Report on Form 8-K filed on September 9, 2024).
10.3		Form of Joinder Agreement (incorporated by reference to Exhibit 10.2 to the Current Report on Form 8-K filed on September 9, 2024)
10.4		Form of Escrow Agreement (incorporated by reference to Exhibit 10.3 to the Current Report on Form 8-K filed on September 9, 2024)
10.5		Form of Key Employee Non-Competition Agreement (incorporated by reference to Exhibit 10.4 to the Current Report on Form 8-K filed on September 9, 2024)
10.6		Securities Purchase Agreement (incorporated by reference to Exhibit 10.7 to the Quarterly Report on Form 10-Q filed on September 23, 2024)
10.7		Senior Secured Convertible Promissory Note (incorporated by reference to Exhibit 10.8 to the Quarterly Report on Form 10-Q filed on September 23, 2024)
10.8		Common Stock Purchase Warrant (incorporated by reference to Exhibit 10.9 to the Quarterly Report on Form 10-Q filed on September 23, 2024)
10.9		Security Agreement (incorporated by reference to Exhibit 10.10 to the Quarterly Report on Form 10-Q filed on September 23, 2024)
31.1*		Certification of Principal Executive Officer pursuant to Exchange Act Rules 13a-14(a) and 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
31.2*		Certification of Principal Financial and Accounting Officer pursuant to Exchange Act Rules 13a-14(a) and 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
32.1**		Certification of Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
32.2**		Certification of Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
101.INS*		Inline XBRL Instance Document
101.SCH*		Inline XBRL Schema Document
101.CAL*		Inline XBRL Calculation Linkbase Document
101.LAB*		Inline XBRL Label Linkbase Document
101.PRE*		Inline XBRL Presentation Linkbase Document
101.DEF*		Inline XBRL Definition Linkbase Document
104*		Cover Page Interactive Data File - the cover page from the Registrant’s Quarterly Report on Form 10-Q for the quarter ended October 31, 2024 is formatted in Inline XBRL

 

* Filed herewith.

** Furnished herewith.

+ Certain schedules, appendices and exhibits to this agreement have been omitted in accordance with Item 601(b)(2) of Regulation S-K. A copy of any omitted schedule and/or exhibit will be furnished supplementally to the SEC staff upon request.

  

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

		RED CAT HOLDINGS, INC.
Date: December 16, 2024		By: /s/ Jeffrey Thompson
		Jeffrey Thompson Chief Executive Officer (Principal Executive Officer)
Date: December 16, 2024		By: /s/ Leah Lunger
		Leah Lunger Chief Financial Officer (Principal Financial and Accounting Officer)

 

 

33

EXHIBIT 31.1

 

CERTIFICATION OF CHIEF EXECUTIVE OFFICER

PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT AND RULE 13A-14(A)

OR 15D-14(A) UNDER THE SECURITIES EXCHANGE ACT OF 1934

 

I, Jeffrey Thompson, certify that:

 

1.	I have reviewed this Quarterly Report on Form 10-Q of Red Cat Holdings, Inc.
2.	Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.	Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.	I am responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

	(a)	Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under my supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to me by others within those entities, particularly during the period in which this report is being prepared;
	(b)	Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under my supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
	(c)	Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report my conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
	(d)	Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5.	I have disclosed, based on my most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of registrant’s board of directors (or persons performing the equivalent functions):

 

	(a)	All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
	(b)	Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: December 16, 2024	/s/ Jeffrey Thompson
	Chief Executive Officer (Principal Executive Officer)

EXHIBIT 31.2

 

CERTIFICATION OF CHIEF FINANCIAL OFFICER

PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT AND RULE 13A-14(A)

OR 15D-14(A) UNDER THE SECURITIES EXCHANGE ACT OF 1934

 

I, Leah Lunger, certify that:

 

1.	I have reviewed this Quarterly Report on Form 10-Q of Red Cat Holdings, Inc.
2.	Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.	Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.	I am responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

	(a)	Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under my supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to me by others within those entities, particularly during the period in which this report is being prepared;
	(b)	Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under my supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
	(c)	Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report my conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
	(d)	Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5.	I have disclosed, based on my most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of registrant’s board of directors (or persons performing the equivalent functions):

 

	(a)	All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
	(b)	Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: December 16, 2024	/s/ Leah Lunger
	Chief Financial Officer (Principal Financial and Accounting Officer)

EXHIBIT 32.1

 

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the Quarterly Report on Form 10-Q of Red Cat Holdings, Inc. (the “Company”), for the quarter ended October 31, 2024, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Jeffrey Thompson, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

 

(1)

The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

(2)

The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

 

Date: December 16, 2024	By:	/s/ Jeffrey Thompson
	Name:	Jeffrey Thompson
	Title:	Chief Executive Officer
		(Principal Executive Officer)

EXHIBIT 32.2

 

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the Quarterly Report on Form 10-Q of Red Cat Holdings, Inc. (the “Company”), for the quarter ended October 31, 2024, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Leah Lunger, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

 

(1)

The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

(2)

The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

 

Date: December 16, 2024	By:	/s/ Leah Lunger
	Name:	Leah Lunger
	Title:	Chief Financial Officer
		(Principal Financial and Accounting Officer)

 

 

v3.24.4

Cover - shares	6 Months Ended
	Oct. 31, 2024	Dec. 13, 2024
Cover [Abstract]
Document Type	10-Q
Amendment Flag	false
Document Quarterly Report	true
Document Transition Report	false
Document Period End Date	Oct. 31, 2024
Document Fiscal Period Focus	Q2
Document Fiscal Year Focus	2025
Current Fiscal Year End Date	--04-30
Entity File Number	001-40202
Entity Registrant Name	Red Cat Holdings, Inc.
Entity Central Index Key	0000748268
Entity Tax Identification Number	88-0490034
Entity Incorporation, State or Country Code	NV
Entity Address, Address Line One	15 Ave. Munoz Rivera
Entity Address, Address Line Two	Ste 2200
Entity Address, City or Town	San Juan
Entity Address, Country	PR
Entity Address, Postal Zip Code	00901
City Area Code	(833)
Local Phone Number	373-3228
Title of 12(b) Security	Common stock, par value $0.001
Trading Symbol	RCAT
Security Exchange Name	NASDAQ
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		80,160,782

v3.24.4

Condensed Consolidated Balance Sheets (Unaudited) - USD ($)	Oct. 31, 2024	Apr. 30, 2024
Current assets
Cash	$ 4,611,092	$ 6,067,169
Accounts receivable, net	1,121,398	4,361,090
Inventory	12,165,260	8,007,237
Other	3,015,413	3,962,053
Total current assets	20,913,163	22,397,549
Goodwill (Note 3)	22,964,065	9,088,550
Intangible assets, net (Note 3)	3,439,731	3,794,389
Equity method investee		5,142,500
Note receivable		4,000,000
Property and equipment, net	1,972,859	2,340,684
Other	309,823	293,126
Operating lease right-of-use assets	1,492,747	1,480,814
Total long-term assets	30,179,225	26,140,063
TOTAL ASSETS	51,092,388	48,537,612
Current liabilities
Accounts payable	1,591,488	1,580,422
Accrued expenses	1,431,908	1,069,561
Debt obligations - short term	356,964	751,570
Customer deposits	221,380	53,939
Operating lease liabilities	337,628	195,638
Convertible notes payable - short term	3,733,338
Acquisition consideration payable	7,000,000
Total current liabilities	14,672,706	3,651,130
Operating lease liabilities	1,213,688	1,321,952
Convertible notes payable - long term	8,177,969
Total long-term liabilities	9,391,657	1,321,952
Total liabilities	24,064,363	4,973,082
Stockholders' equity
Series B preferred stock - shares authorized 4,300,000; issued and outstanding 4,676 and 4,676	47	47
Common stock - shares authorized 500,000,000; issued and outstanding 78,025,403 and 74,289,351	78,025	74,289
Additional paid-in capital	133,831,679	124,616,305
Accumulated deficit	(106,881,726)	(81,130,732)
Total stockholders' equity	27,028,025	43,564,530
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY	$ 51,092,388	$ 48,537,612

v3.24.4

Condensed Consolidated Statements of Operations and Comprehensive Income (Unaudited) - USD ($)	3 Months Ended		6 Months Ended
	Oct. 31, 2024	Oct. 31, 2023	Oct. 31, 2024	Oct. 31, 2023
Income Statement [Abstract]
Revenues	$ 1,534,727	$ 3,930,868	$ 4,311,262	$ 5,678,997
Cost of goods sold	1,558,202	2,730,286	4,818,128	4,303,750
Gross (loss) profit	(23,475)	1,200,582	(506,866)	1,375,247
Operating Expenses
Research and development	2,231,470	2,222,137	3,857,910	3,575,688
Sales and marketing	2,343,779	1,032,645	4,385,290	2,321,405
General and administrative	4,517,695	2,838,080	8,000,790	5,701,838
Impairment loss			93,050
Total operating expenses	9,092,944	6,092,862	16,337,040	11,598,931
Operating loss	(9,116,419)	(4,892,280)	(16,843,906)	(10,223,684)
Other (income) expense
Convertible notes payable fair value adjustment	4,230,307		4,230,307
Loss on sale of equity method investment			4,008,357
Equity method loss			734,143
Investment loss, net		333,867		573,357
Interest (income) expense, net	(14,634)	19,696	(39,188)	41,553
Other, net	2,526	(1,544)	(26,531)
Other expense	4,218,199	352,019	8,907,088	614,910
Net loss from continuing operations	(13,334,618)	(5,244,299)	(25,750,994)	(10,838,594)
Loss from discontinued operations		(599,511)		(842,084)
Net loss	(13,334,618)	(5,843,810)	(25,750,994)	(11,680,678)
Other comprehensive income (loss)
Change in foreign currency translation adjustments		1,376	(4,621)	3,022
Unrealized gain on marketable securities		363,663		653,052
Other comprehensive loss	$ (13,334,618)	$ (5,478,771)	$ (25,755,615)	$ (11,024,604)
Loss per share - basic and diluted
Continuing operations	$ (0.18)	$ (0.10)	$ (0.34)	$ (0.19)
Discontinued operations		$ (0.01)		$ (0.02)
Weighted average shares outstanding - basic and diluted	76,184,777	55,606,336	75,342,629	55,270,838

v3.24.4

Condensed Consolidated Statements of Shareholders' Equity (Unaudited) - USD ($)	Series B Preferred Stock 1 [Member]	Common Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	AOCI Attributable to Parent [Member]	Total
Beginning balance, value at Apr. 30, 2023	$ 9,867	$ 54,568	$ 112,642,726	$ (57,078,103)	$ (861,117)	$ 54,767,941
Shares, Outstanding, Beginning Balance at Apr. 30, 2023	986,676	54,568,065
Stock based compensation			911,606			911,606
Vesting of restricted stock units		$ 155	(8,675)			(8,520)
Restricted Stock, Shares Issued Net of Shares for Tax Withholdings		155,476
Conversion of preferred stock	$ (9,820)	$ 818	9,002
Stock Issued During Period, Shares, Conversion of Convertible Securities	(982,000)	(818,334)
Stock Issued During Period, Shares, Conversion of Convertible Securities	982,000	818,334
Unrealized gain on marketable securities					289,389	289,389
Currency translation adjustments					1,646	1,646
Net loss				(5,836,868)		(5,836,868)
[custom:StockIssuedDuringPeriodSharesStockWarrantsExercised]		307,595
Ending balance, value at Jul. 31, 2023	$ 47	$ 55,541	113,554,659	(62,914,971)	(570,082)	50,125,194
Shares, Outstanding, Ending Balance at Jul. 31, 2023	4,676	55,541,875
Beginning balance, value at Apr. 30, 2023	$ 9,867	$ 54,568	112,642,726	(57,078,103)	(861,117)	54,767,941
Shares, Outstanding, Beginning Balance at Apr. 30, 2023	986,676	54,568,065
Net loss						(11,680,678)
Acquisition of FlightWave
Ending balance, value at Oct. 31, 2023	$ 47	$ 55,649	114,752,317	(68,758,781)	(205,043)	45,844,189
Shares, Outstanding, Ending Balance at Oct. 31, 2023	4,676	55,649,896
Beginning balance, value at Apr. 30, 2023	$ 9,867	$ 54,568	112,642,726	(57,078,103)	(861,117)	54,767,941
Shares, Outstanding, Beginning Balance at Apr. 30, 2023	986,676	54,568,065
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period		3,000
Ending balance, value at Apr. 30, 2024	$ 47	$ 74,289	124,616,305	(81,130,732)	4,621	43,564,530
Shares, Outstanding, Ending Balance at Apr. 30, 2024	4,676	74,289,351
Beginning balance, value at Jul. 31, 2023	$ 47	$ 55,541	113,554,659	(62,914,971)	(570,082)	50,125,194
Shares, Outstanding, Beginning Balance at Jul. 31, 2023	4,676	55,541,875
Stock based compensation			1,196,325			1,196,325
Vesting of restricted stock units		$ 55	(7,826)			(7,771)
Restricted Stock, Shares Issued Net of Shares for Tax Withholdings		54,786
Unrealized gain on marketable securities					363,663	363,663
Currency translation adjustments					1,376	1,376
Net loss				(5,843,810)		(5,843,810)
Issuance of common stock through ATM facility, net		$ 53	9,159			9,212
[custom:IssuanceOfCommonStockATMFacilityNetShares]		53,235
Ending balance, value at Oct. 31, 2023	$ 47	$ 55,649	114,752,317	(68,758,781)	(205,043)	45,844,189
Shares, Outstanding, Ending Balance at Oct. 31, 2023	4,676	55,649,896
Beginning balance, value at Apr. 30, 2024	$ 47	$ 74,289	124,616,305	(81,130,732)	4,621	43,564,530
Shares, Outstanding, Beginning Balance at Apr. 30, 2024	4,676	74,289,351
Stock based compensation			1,446,038			1,446,038
Vesting of restricted stock units		$ 293	(134,330)			(134,037)
Restricted Stock, Shares Issued Net of Shares for Tax Withholdings		293,302
Currency translation adjustments					(4,621)	(4,621)
Net loss				(12,416,376)		(12,416,376)
Exercise of warrants		308	(308)
Ending balance, value at Jul. 31, 2024	$ 47	$ 74,890	125,927,705	(93,547,108)		32,455,534
Shares, Outstanding, Ending Balance at Jul. 31, 2024	4,676	74,890,248
Beginning balance, value at Apr. 30, 2024	$ 47	$ 74,289	124,616,305	(81,130,732)	4,621	43,564,530
Shares, Outstanding, Beginning Balance at Apr. 30, 2024	4,676	74,289,351
Net loss						(25,750,994)
[custom:StockIssuedDuringPeriodSharesStockWarrantsExercised]		530,578
Exercise of options		$ 58,446
Acquisition of FlightWave						7,000,000
Ending balance, value at Oct. 31, 2024	$ 47	$ 78,025	133,831,679	(106,881,726)		27,028,025
Shares, Outstanding, Ending Balance at Oct. 31, 2024	4,676	78,025,403
Beginning balance, value at Jul. 31, 2024	$ 47	$ 74,890	125,927,705	(93,547,108)		32,455,534
Shares, Outstanding, Beginning Balance at Jul. 31, 2024	4,676	74,890,248
Stock based compensation			1,304,037			1,304,037
Vesting of restricted stock units		$ 309	(412,203)			(411,894)
Restricted Stock, Shares Issued Net of Shares for Tax Withholdings		308,735
Net loss				(13,334,618)		(13,334,618)
Exercise of warrants		$ 223	(223)
[custom:StockIssuedDuringPeriodSharesStockWarrantsExercised]		222,983
Exercise of options		$ 58	14,908			14,966
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period		58,446
Acquisition of FlightWave		$ 2,545	6,997,455			7,000,000
Stock Issued During Period, Shares, Acquisitions		2,544,991
Ending balance, value at Oct. 31, 2024	$ 47	$ 78,025	$ 133,831,679	$ (106,881,726)		$ 27,028,025
Shares, Outstanding, Ending Balance at Oct. 31, 2024	4,676	78,025,403

v3.24.4

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	3 Months Ended				6 Months Ended		12 Months Ended
	Oct. 31, 2024	Jul. 31, 2024	Oct. 31, 2023	Jul. 31, 2023	Oct. 31, 2024	Oct. 31, 2023	Apr. 30, 2024
Cash Flows from Operating Activities
Net loss	$ (13,334,618)	$ (12,416,376)	$ (5,843,810)	$ (5,836,868)	$ (25,750,994)	$ (11,680,678)
Net loss from discontinued operations						(842,084)
Net loss from continuing operations					(25,750,994)	(10,838,594)
Adjustments to reconcile net loss to net cash used in operations:
Stock based compensation - options					815,632	1,606,305
Stock based compensation - restricted units					1,934,443	501,626
Amortization of intangible assets					354,658	434,735
Realized loss from sale of marketable securities						646,300
Depreciation					491,618	222,431
Loss on sale of equity method investment and note receivable					4,008,357
Equity method loss					734,143
Impairment on goodwill and intangible assets					93,050
Convertible note payable fair value adjustment	4,230,307				4,230,307
Changes in operating assets and liabilities
Accounts receivable					3,394,692	(2,269,192)
Inventory					(3,860,393)	(335,125)
Other					999,423	(1,576,157)
Operating lease right-of-use assets and liabilities					(7,913)	(1,115)
Customer deposits					(29,035)	(94,181)
Accounts payable					9,887	225,801
Accrued expenses					94,412	236,807
Net cash used in operating activities of continuing operations					(12,487,713)	(11,240,359)
Cash Flows from Investing Activities
Purchases of property and equipment					(123,793)	(139,860)
Proceeds from sale of marketable securities						10,205,501
Proceeds from sale of equity method investment and note receivable					4,400,000
Net cash provided by investing activities of continuing operations					4,276,207	10,065,641
Cash Flows from Financing Activities
Proceeds from issuance of convertible notes payable, net of issuance costs					7,681,000
Payments under debt obligations					(394,606)	(279,126)
Payments of taxes related to equity transactions					(530,965)	(16,292)
Proceeds from issuance of common stock through ATM facility, net						9,212
Net cash provided by (used in) financing activities of continuing operations					6,755,429	(286,206)
Discontinued operations
Operating activities						(550,120)
Investing activities
Financing activities						166,026
Net cash used in discontinued operations						(384,094)
Net decrease in Cash					(1,456,077)	(1,845,018)
Cash, beginning of period		$ 6,067,169		$ 3,260,305	6,067,169	3,260,305	$ 3,260,305
Cash, end of period	4,611,092		1,415,287		4,611,092	1,415,287	$ 6,067,169
Less: Cash of discontinued operations			(6,310)			(6,310)
Cash of continuing operations, end of period	4,611,092		$ 1,408,977		4,611,092	1,408,977
Cash paid for interest					14,564	42,031
Cash paid for income taxes
Non-cash transactions
Fair value of shares issued in acquisition	$ 7,000,000				7,000,000
Acquisition consideration payable					7,000,000
Net assets assumed in acquisition					31,435
Unrealized gain on marketable securities						653,052
Conversion of preferred stock into common stock						$ 9,820

v3.24.4

Note 1 – The Business	6 Months Ended
	Oct. 31, 2024
Accounting Policies [Abstract]
Note 1 – The Business	Note 1 – The Business     The Company was originally incorporated in February 1984. Since April 2016, the Company’s primary business has been to provide products, services, and solutions to the drone industry which it presently does through its wholly owned operating subsidiaries. Beginning in January 2020, the Company expanded the scope of its drone products and services through five acquisitions, including:      A. In January 2020, the Company acquired Rotor Riot, a provider of First Person View (“FPV”) drones and equipment, primarily to consumers. The purchase price was $1,995,114.     B. In November 2020, the Company acquired Fat Shark Holdings, Ltd. (“Fat Shark”), a provider of FPV video goggles to the drone industry. The purchase price was $8,354,076.       C. In May 2021, the Company acquired Skypersonic which provided hardware and software solutions that enable drones to complete inspection services in locations where GPS is either denied or not available, yet still record and transmit data even while being operated from thousands of miles away. The purchase price was $2,791,012.     D. In August 2021, the Company acquired Teal Drones, Inc. (“Teal”), a leader in commercial and government Unmanned Aerial Vehicles (“UAV”) technology. The purchase price was $10,011,279.         E. In September 2024, the Company acquired FlightWave Aerospace Systems Corporation, an industry-leading provider of VTOL drone, sensor and software solutions, under an Asset Purchase Agreement (the “APA”). As part of the acquisition, the Company created a new subsidiary, FW Acquisition Inc. (“FlightWave”) for ongoing operations. The purchase price was $14,000,000. See Note 3 for additional information.   Following the Teal acquisition in August 2021, we concentrated on integrating and organizing these businesses. Effective May 1, 2022, we established the Enterprise segment (“Enterprise”) and the Consumer segment (“Consumer”) to focus on the unique opportunities in each sector. Enterprise's initial strategy was to provide UAVs to commercial enterprises, and the military, to navigate dangerous military environments and confined industrial and commercial interior spaces. Subsequently, Enterprise narrowed its near-term attention on the military and other government agencies. Skypersonic's technology has been redirected to military applications and its operations consolidated into Teal.   On February 16, 2024, we closed the sale of our Consumer segment, consisting of Rotor Riot and Fat Shark, to Unusual Machines. The sale reflects the Company's decision to focus its efforts and capital on defense where it believes that there are more opportunities to create long term shareholder value. See Note 4 and Note 8.

v3.24.4

Note 2 – Summary of Significant Accounting Policies	6 Months Ended
	Oct. 31, 2024
Accounting Policies [Abstract]
Note 2 – Summary of Significant Accounting Policies	Note 2 – Summary of Significant Accounting Policies   Basis of Presentation – The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States (“GAAP”) for interim financial information and with the instructions of Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements. In the opinion of management, all adjustments, consisting only of normal recurring adjustments necessary for a fair presentation with respect to the interim financial statements have been included. The results of operations for the six months ended October 31, 2024 are not necessarily indicative of the results for the full year. For further information, refer to the consolidated financial statements and footnotes thereto for the year ended April 30, 2024, included in the Company’s Annual Report on Form 10-K. In September 2024, the Company’s Board of Directors approved a change in fiscal year end from April 30 to December 31.    Restatement of Previously Issued Consolidated Financial Statements – The Company’s Condensed Consolidated Statement of Operations and Stockholders’ Equity for the six months ended October 31, 2023, which were originally filed with the U.S. Securities and Exchange Commission (the “SEC”) on December 15, 2023, have been restated. The Company revised its financial statements to remove derivative liabilities due to erroneously reporting warrants from our convertible note financings, as described in Note 16, as having a derivative component.   The impacts of these restatements are detailed in the tables below:                   Condensed Consolidated Statement of Operations For the three months ended October 31, 2023         Originally Reported   As Restated   Change Change in fair value of derivative liability   $ (162,482 )   $ —       $ (162,482 ) Net loss   $ (5,681,328 )   $ (5,843,810 )   $ (162,482 )                     Condensed Consolidated Statement of Operations For the six months ended October 31, 2023         Originally Reported   As Restated   Change Change in fair value of derivative liability   $ (189,002 )   $ —       $ (189,002 ) Net loss   $ (11,491,676 )   $ (11,680,678 )   $ (189,002 )                     Condensed Consolidated Statement of Stockholders’ Equity For the six months ended October 31, 2023         Originally Reported   As Restated   Change Additional paid-in capital   $ 112,102,691     $ 114,752,317     $ 2,649,626   Accumulated deficit   $ (66,078,469 )   $ (68,758,781 )   $ (2,680,312 ) Total equity   $ 45,874,875     $ 45,844,189     $ (30,686 )      Principles of Consolidation – Our condensed consolidated financial statements include the accounts of our wholly owned subsidiaries which include Teal, FlightWave (beginning on September 5, 2024), Skypersonic, as well as Rotor Riot and Fat Shark through the sale date of February 16, 2024. Non-majority owned investments, including the formerly wholly owned subsidiaries Rotor Riot and Fat Shark, are accounted for using the equity method when the Company is able to significantly influence the operating policies of the investee. Intercompany transactions and balances have been eliminated.   The Consumer segment businesses are characterized as discontinued operations in these financial statements.  The operating results and cash flows of discontinued operations are separately stated in those respective financial statements. See Note 4.   Use of Estimates – The preparation of financial statements in accordance with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates. Significant estimates reflected in these financial statements include those used to (i) complete purchase price accounting for acquisitions, (ii) the evaluation of long-term assets, including goodwill, for impairment, (iii) the evaluation of other-than-temporary-impairment of equity method investments, and (iv) valuations of convertible notes payable.   Concentration of Credit Risk – Financial instruments, which potentially subject the Company to concentrations of credit risk, include trade receivables. In the normal course of business, the Company provides credit terms to its customers. Accordingly, the Company performs ongoing credit evaluations of its customers, generally does not require collateral and considers the credit risk profile of the customer from which the receivable is due in further evaluating collection risk. Customers that accounted for 10% or greater of accounts receivable, net as of October 31, 2024 and April 30, 2024 were as follows:         October 31, 2024   April 30, 2024 Customer A     38 %     * Customer B     25 %     * Customer C     *     53 % Customer D     *     24 %     * Accounts Receivable was less than 10%   During the six months ended October 31, 2024, two customers accounted for equal to or greater than 10% of total revenue, totaling 21% and 19%, respectively. During the six months ended October 31, 2023, three customers accounted for equal to or greater than 10% of total revenue, totaling 13%, 12% and 10%, respectively. The Company does not believe the loss of one or more of these customers would be significant to operations.   Equity Method Investment – The equity method of accounting is applied to investments in which the Company has an ownership interest of between 20% and 50%. The Company evaluates its equity method investments each reporting period for evidence of a loss in value that is other than a temporary decline. Evidence of a loss in value might include, but would not necessarily be limited to, absence of an ability to recover the carrying amount of the investment or the inability of the investee to sustain an earnings capacity that would justify the carrying amount of the investment. The Company performed this analysis and concluded that its investment in UMAC was other-than-temporarily impaired and recognized an impairment charge of $11,353,875 for the year ended April 30, 2024. See Note 8 for additional information.   Fair Values, Inputs and Valuation Techniques for Financial Assets and Liabilities, and Related Disclosures – The fair value measurements and disclosure guidance defines fair value and establishes a framework for measuring fair value. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability (an exit price) in an orderly transaction between market participants at the measurement date. In accordance with this guidance, the Company has categorized its recurring basis financial assets and liabilities into a three-level fair value hierarchy based on the priority of the inputs to the valuation technique.   The fair value hierarchy gives the highest priority to quoted prices in active markets for identical assets or liabilities (Level 1) and the lowest priority to unobservable inputs (Level 3). The inputs used to measure fair value may fall into different levels of the fair value hierarchy. In such cases, the level in the fair value hierarchy within which the fair value measurement in its entirety falls has been determined based on the lowest level input that is significant to the fair value measurement in its entirety. The Company's assessment of the significance of a particular input to the fair value measurement in its entirety requires judgment and considers factors specific to the asset or liability.   The guidance establishes three levels of the fair value hierarchy as follows:   Level 1: Inputs are unadjusted, quoted prices in active markets for identical assets or liabilities at the measurement date; Level 2: Inputs are observable, unadjusted quoted prices in active markets for similar assets or liabilities, unadjusted quoted prices for identical or similar assets or liabilities in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the related assets or liabilities; and  Level 3: Unobservable inputs that are significant to the measurement of the fair value of the assets or liabilities that are supported by little or no market data.      The Company’s financial instruments mainly consist of cash, accounts receivable, current assets, accounts payable, accrued expenses, notes payable, and convertible notes payable. The recorded carrying amounts of cash, accounts receivable, current assets, accounts payable, accrued expenses, and notes payable are considered to approximate their estimated fair values due to their short-term nature. Liabilities recognized at fair value on a recurring basis in the consolidated balance sheets consist of convertible notes payable. These items are categorized based upon the level of judgment associated with the inputs used to measure their fair values. Fair value is defined as the price that would be paid to transfer a liability in an orderly transaction between market participants at the measurement date.   The following table summarizes the Company’s financial instruments at fair value based on the fair value hierarchy for each class of instrument:       Level 1   Level 2   Level 3   Total Convertible notes payable   $ —       $ —       $ 11,911,307     $ 11,911,307     Convertible Notes Payable   The Company measures its convertible notes payable at fair value based on significant inputs not observable in the market, which caused them to be classified as Level 3 measurements within the fair value hierarchy. Changes in the fair value of the convertible notes payable related to updated assumptions and estimates were recognized as a convertible notes payable fair value adjustment within the consolidated statements of operations and comprehensive loss.   In determining the fair value of the convertible notes payable as of October 31, 2024, the Company used a market-based approach. The valuation method utilized a negotiated discount rate and a market yield rate which are unobservable inputs.   An increase or decrease in any of the unobservable inputs in isolation could result in a material increase or decrease in the estimated fair value. In the future, depending on the weight of evidence and valuation approaches used, these or other inputs may have a more significant impact on the estimated fair value.   The Company calculated the estimated fair value of the convertible notes payable as of October 31, 2024 using the following assumptions:       October 31, 2024 Issuance date     10/1/2024   Maturity date     10/1/2026   Stock price     3.06   Expected volatility factor     92.8 % Risk-free interest rate     5.21 %   The following table presents changes in the Level 3 convertible notes payable measured at fair value for the six months ended October 31, 2024:       Balance, May 1, 2024   $ —     Additions     7,681,000   Fair value measurement adjustments     4,230,307   Balance, October 31, 2024   $ 11,911,307     Warrants   The fair value of the warrants as of October 31, 2024 was estimated using a Monte Carlo simulation model. The significant unobservable inputs for the Monte Carlo model include the stock price, exercise price, risk-free rate of return, time to expiration, and the volatility. An increase or decrease in the unobservable inputs in isolation could result in a material increase or decrease in the estimated fair value. In the future, depending on the weight of evidence and valuation approaches used, these or other inputs may have a more significant impact on the estimated fair value. Additionally, if certain provisions are triggered, reset adjustments may be required in the future.  For the quarter ended October 31, 2024, no value was assigned to the warrants due to the fair market value of the convertible note payable being in excess of the proceeds received.   Revenue Recognition – The Company recognizes revenue in accordance with ASC Topic 606 - Revenue from Contracts with Customers, issued by the Financial Accounting Standards Board (“FASB”). This standard includes a comprehensive evaluation of factors to be considered regarding revenue recognition including (i) identifying the promised goods, (ii) evaluating performance obligations, (iii) measuring the transaction price, (iv) allocating the transaction price to the performance obligations if there are multiple components, and (v) recognizing revenue as each obligation is satisfied. The Company’s revenue transactions include the shipment of goods to customers as orders are fulfilled, completion of non-recurring engineering, completion of training, and customer support services. The Company recognizes revenue upon shipment of product or prototypes unless otherwise specified in the purchase order or contract. Customer deposits totaled $221,380 and $53,939 at October 31, 2024 and April 30, 2024, respectively. From time to time, non-recurring engineering contracts may involve the capitalization of engineering prototypes, classified as contract assets. Contract assets totaled $0 and $1,477,859 at October 31, 2024 and April 30, 2024, respectively.   The following table presents the Company’s revenue disaggregated by revenue type:                        Three months ended October 31,   Six months ended October 31,     2024   2023   2024   2023 Contract related   $ —       $ 529,437     $ 886,440     $ 840,318   Product related     1,534,727       3,401,431       3,424,822       4,838,679   Total   $ 1,534,727     $ 3,930,868     $ 4,311,262     $ 5,678,997        Product Warranty - The Company accrues an estimate of its exposure to warranty claims based upon both current and historical product sales data and warranty costs incurred. Product warranty reserves are recorded in current liabilities under accrued expenses. Warranty liability was approximately $587,000 and $372,000 as of October 31, 2024 and April 30, 2024 respectively.   Recent Accounting Pronouncements   – Management does not believe that recently issued, but not yet effective accounting pronouncements, if adopted, would have a material effect on the accompanying consolidated financial statements.   Comprehensive Loss – Comprehensive loss consists of net loss and other comprehensive loss. Other comprehensive loss refers to gains and losses that are recorded as an element of stockholders' equity but are excluded from net loss. Our other comprehensive loss is comprised of foreign currency translation adjustments and unrealized gains or losses on available-for-sale securities. During the six months ended October 31, 2024 and October 31, 2023, comprehensive loss was $4,621 higher and $656,074 lower than net loss, respectively, related to unrealized gains on available-for-sale securities totaling $0 and $653,052, respectively, and foreign currency translation adjustments of $4,621 and $3,022, respectively.   Basic and Diluted Net Loss per Share – Basic and diluted net loss per share has been calculated by dividing net loss by the weighted average number of shares of common stock outstanding during the period. Common stock equivalents were excluded from the computation of diluted net loss per share of common stock because they were anti-dilutive. The conversion or exercise of these common stock equivalents would dilute earnings per share if we become profitable in the future. Outstanding securities not included in the computation of diluted net loss per share because their effect would have been anti-dilutive include:       October 31, 2024   October 31, 2023 Series B Preferred Stock, as converted     3,896       3,896   Stock options     7,896,903       6,861,517   Warrants     2,292,207       1,539,999   Restricted stock     1,758,313       779,850   Total     11,951,319       9,185,262         Related Parties – Parties are considered to be related to us if they have control or significant influence, directly or indirectly, over us, including key management personnel and members of the Board of Directors or are direct relatives of key management personnel of members of the Board of Directors. Related Party transactions are disclosed in Note 18.   Liquidity and Going Concern  – The Company has never been profitable and has incurred net losses related to acquisitions, as well as costs incurred to pursue its long-term growth strategy. During the six months ended October 31, 2024, the Company incurred a net loss of approximately $25,750,000 and used cash in operating activities of approximately $12,500,000. As of October 31, 2024, working capital totaled approximately $6,240,000. These financial results and our financial position at October 31, 2024 raise substantial doubt about our ability to continue as a going concern. However, the Company has recently taken actions to strengthen its liquidity. In November 2024, the Company was selected as the winner of the U.S.  Army’s Short Range Reconnaissance (SRR) Program of Record. The Company’s manufacturing facility is scaling production of its most recent products and gross profits are projected to increase. As described in Note 13 and Note 20, the Company closed financings with proceeds of approximately $8,000,000 and $6,000,000 in September 2024 and November 2024, respectively. Additionally, the Company’s Form S-3 became effective on December 11, 2024. If necessary, the Company will seek additional equity financing for which there can be no guarantee. Management has concluded that these recent positive developments alleviate any substantial doubt about the Company’s ability to continue its operations, and meet its financial obligations, for twelve months from the date these consolidated financial statements are issued.

v3.24.4

Note 3 – Business Combination	6 Months Ended
	Oct. 31, 2024
Business Combination and Asset Acquisition [Abstract]
Note 3 – Business Combination	Note 3 – Business Combination   On September 4, 2024, the Company entered into an Asset Purchase Agreement (the “APA”) with FlightWave Aerospace Systems Corporation (the “Seller”) to broaden the Company’s range of drone products. The seller sold certain assets used in designing, developing, manufacturing, and selling long range, AI-powered UAVs for commercial use. Pursuant to the APA, the Company has acquired substantially all of the assets owned, controlled or used by the Seller for an aggregate purchase price of $14,000,000 worth of shares of the Company’s common stock, and as such, the asset purchase will be treated as a business combination. The purchase price is payable as follows:     • $7 million worth of the Company’s common stock issued on September 30, 2024, totaling 2,544,991 shares, equal to the VWAP on such date.   • $7 million worth of the Company’s common stock to be issued on December 31, 2024, at a price per share equal to the VWAP on such date, of which (i) $2 million will be payable to preferred shareholders of the Seller, and (ii) $5 million will be payable to common shareholders and option-holders of the Seller as set forth the APA.   The Company expects that the Goodwill recognized will be deductible for tax purposes.  The Company has reported net losses since its inception and is presently unable to determine when and if the tax benefit of this deduction will be realized.   The preliminary summary of the purchase price and its related allocation is as follows:     Shares issued   $ 7,000,000   Acquisition consideration payable     7,000,000   Total Purchase Price   $ 14,000,000      Assets acquired     Accounts receivable   $ 155,000   Inventory     297,630   Operating lease right-of-use assets     128,433   Other assets     69,480   Goodwill     13,968,565   Total assets acquired     14,619,108   Liabilities assumed         Accounts payable and accrued expenses     264,493   Customer deposits     196,476   Operating lease liabilities     158,139   Total liabilities assumed     619,108   Total fair value of net assets acquired   $ 14,000,000     The foregoing amounts reflect our current estimates of fair value as of the September 4, 2024 acquisition date. The Company expects to recognize fair values associated with the customer relationships acquired, as well as the FlightWave proprietary technology and brand name, but has not yet accumulated sufficient information to assign such values. As additional information becomes known regarding the acquired assets and assumed liabilities, management may make adjustments to the opening balance sheet of the acquired company up to the end of the measurement period, which is a one-year period following the acquisition date. The determination of the fair values of the acquired assets and liabilities assumed (and the related determination of estimated lives of depreciable tangible and intangible assets) requires significant judgment.   Supplemental Unaudited Pro Forma Financial Information   The following unaudited pro forma financial information summarizes the results of operations for the Company as though the Business Combination had occurred on May 1, 2023. The unaudited pro forma financial information has been presented for illustrative purposes only and is not necessarily indicative of results of operations that would have been achieved had the acquisition taken place on the date indicated, or the future consolidated results of operations of the Company. The information below does not include the effects of finite-lived intangible assets to be evaluated.           Six months ended October 31, 2024       Consolidated   Revenues   $ 5,107,661             Net Loss     (26,882,328 )           Loss per share – basic and diluted     (0.36 )        Six months ended October 31, 2023       Consolidated   Revenues   $ 6,461,394             Net Loss     (12,499,977 )           Loss per share – basic and diluted     (0.23 )

v3.24.4

Note 4 – Divestiture of Consumer Segment	6 Months Ended
	Oct. 31, 2024
Discontinued Operations and Disposal Groups [Abstract]
Note 4 – Divestiture of Consumer Segment	Note 4 – Divestiture of Consumer Segment   On February 16, 2024, the Company closed the sale of Rotor Riot and Fat Shark to Unusual Machines. The sale was conducted pursuant to a Share Purchase Agreement dated November 21, 2022, as amended on April 13, 2023, July 10, 2023, and December 11, 2023 (the “SPA”). The transaction closed concurrently with UMAC’s initial public offering and listing on the NYSE American exchange (“IPO”) under the symbol “UMAC.”   The total consideration received by the Company was valued at $20 million and consisted of i) $1 million in cash, ii) $2 million in a secured promissory note (“Promissory Note”), iii) $17 million in securities of Unusual Machines, and iv) a post-closing adjustment for excess working capital.   Secured Promissory Note   The Promissory Note from Unusual Machines bore interest at a rate of 8% per year, was due 18 months from the date of issue, and required monthly payments of interest due in arrears on the 15th day of each month.   Unusual Machines Securities   The $17 million worth of UMAC common stock was valued at the IPO price for UMAC’s common stock of $4.00 per share, resulting in 4,250,000 shares of UMAC common stock being issued to the Company (representing approximately 49% of UMAC’s issued and outstanding common stock after giving effect to the IPO and to the issuance of common stock to the Company upon closing of the IPO).   Working Capital   The purchase price was adjusted for working capital as of the closing date. Actual working capital excess amounts increased the principal amount of the Promissory Note dollar for dollar. Working capital as of closing was finalized at $2 million in July 2024. As a result, UMAC issued the Company $4,000,000 of its 8% Promissory Notes due November 30, 2025 (the “New Notes”) reflecting (i) satisfaction and settlement of working capital adjustments and (ii) a maturity date extension to November 30, 2025.   The Consumer segment has been classified as Discontinued Operations and reported in accordance with the applicable accounting standards. Set forth below are the results of operations for the Consumer segment for:                       Three months ended October 31,   Six months ended October 31,     2024   2023   2024   2023 Revenues   $ —       $ 1,056,932     $ —       $ 2,926,151                                     Cost of goods sold     —         1,154,200       —         2,539,316                                     Gross Margin     —         (97,268 )     —         386,835                                     Operating Expenses                                 Research and development     —         31,054       —         77,303   Sales and marketing     —         287,413       —         691,517   General and administrative     —         183,807       —         437,393   Total operating expenses     —         502,274       —         1,206,213   Operating loss     —         (599,542 )     —         (819,378 )                                   Other (income) expense                                 Interest expense     —         —         —         22,856   Other, net     —         (31 )     —         (150 ) Other (income) expense     —         (31 )     —         22,706                                     Net loss from discontinued operations   $ —       $ (599,511 )   $ —       $ (842,084 )

v3.24.4

Note 5 – Inventories	6 Months Ended
	Oct. 31, 2024
Inventory Disclosure [Abstract]
Note 5 – Inventories	Note 5 – Inventories   Inventories consisted of the following:       October 31, 2024   April 30, 2024 Raw materials   $ 6,110,038     $ 5,750,324   Work-in-process     1,214,769       1,289,997   Finished goods     4,840,453       966,916   Total   $ 12,165,260     $ 8,007,237

v3.24.4

Note 6 – Other Current Assets	6 Months Ended
	Oct. 31, 2024
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]
Note 6 – Other Current Assets	Note 6 – Other Current Assets   Other current assets included:       October 31, 2024   April 30, 2024 Prepaid expenses   $ 2,626,343     $ 1,206,306   Prepaid inventory     389,070       602,888   Contract asset     —         1,477,859   Grant receivable     —         675,000   Total   $ 3,015,413     $ 3,962,053

v3.24.4

Note 7 – Intangible Assets	6 Months Ended
	Oct. 31, 2024
Goodwill and Intangible Assets Disclosure [Abstract]
Note 7 – Intangible Assets	Note 7 – Intangible Assets   Intangible assets relate to acquisitions completed by the Company, including those described in Note 1, and were as follows:                                     October 31, 2024   April 30, 2024     Gross Value   Accumulated Amortization   Net Value   Gross Value   Accumulated Amortization   Net Value Proprietary technology   $ 4,282,001     $ (2,272,270 )   $ 2,009,731     $ 4,282,001     $ (1,917,612 )   $ 2,364,389   Non-compete agreements     65,000       (65,000 )     —         65,000       (65,000 )     —     Total finite-lived assets     4,347,001       (2,337,270 )     2,009,731       4,347,001       (1,982,612 )     2,364,389   Brand name     1,430,000       —         1,430,000       1,430,000       —         1,430,000   Total indefinite-lived assets     1,430,000       —         1,430,000       1,430,000       —         1,430,000   Total intangible assets, net   $ 5,777,001     $ (2,337,270 )   $ 3,439,731     $ 5,777,001     $ (1,982,612 )   $ 3,794,389     Proprietary technology and non-compete agreements are being amortized over six years and three years, respectively. Goodwill and Brand name are not amortized but evaluated for impairment on a quarterly basis.

v3.24.4

Note 8 – Equity Method Investment	6 Months Ended
	Oct. 31, 2024
Equity Method Investments and Joint Ventures [Abstract]
Note 8 – Equity Method Investment	Note 8 – Equity Method Investment   On July 22, 2024, the Company sold all of its securities in UMAC to two unaffiliated third-party purchasers (the “Purchasers”). As part of the transaction, on July 22, 2024, the Company entered into an Exchange Agreement with UMAC pursuant to which the Company exchanged 4,250,000 shares of UMAC’s common stock, par value $0.001 per share, for 4,250 shares of UMAC’s newly designated Series A Convertible Preferred Stock (the “Series A”). The Company sold the Series A ownership interest ($4,408,357 at time of sale) and the Note Receivable of $4,000,000 to the Purchasers for $4.4 million in cash pursuant to a Purchase Agreement in a transaction that closed on July 22, 2024.     As of April 30, 2024, the Company had owned approximately a 46% interest in Unusual Machines. The primary business operations included selling first-person-view video goggles for drone pilots, drones, parts and related equipment to the consumer marketplace. UMAC’s financial statements are prepared in accordance with GAAP. See Note 4 for additional information.   Financial information for UMAC prior to the sale of the Company’s equity interest was derived from UMAC’s Form 10-Q for the six months ended June 30, 2024 and was as follows:       Current assets   $ 5,116,963   Long-term assets     20,083,390   Current liabilities     931,200   Long-term liabilities     4,297,332   Revenues     2,030,039   Gross profit     592,607   Net loss   $ (2,718,240 )    The Company’s investments in UMAC have been impacted by the following: Initial investment, February 16, 2024   $ 17,000,000   Equity method loss     (503,625 ) Impairment     (11,353,875 ) Investment balance, April 30, 2024   $ 5,142,500   Equity method loss     (734,143 ) Sale of ownership interest     (4,408,357 ) Investment balance, October 31, 2024   $ —       The computation of both the initial investment as of February 16, 2024 and investment balance as of April 30, 2024, was based on the fair market value of UMAC’s common stock.

v3.24.4

Note 9 – Property and Equipment	6 Months Ended
	Oct. 31, 2024
Property, Plant and Equipment [Abstract]
Note 9 – Property and Equipment	Note 9 – Property and Equipment   Property and equipment consist of assets with an estimated useful life greater than one year and are reported net of accumulated depreciation. The reported values are periodically assessed for impairment, and were as follows:       October 31, 2024   April 30, 2024 Equipment and related   $ 1,633,105     $ 1,540,888   Leasehold improvements     1,556,139       1,547,976   Furniture and fixtures     186,703       163,290   Accumulated depreciation     (1,403,088 )     (911,470 ) Net carrying value   $ 1,972,859     $ 2,340,684     Depreciation expense totaled $491,618 and $222,431 for the six months ended October 31, 2024 and 2023, respectively.

v3.24.4

Note 10 – Other Long-Term Assets	6 Months Ended
	Oct. 31, 2024
Note 10 Other Long-term Assets
Note 10 – Other Long-Term Assets	Note 10 – Other Long-Term Assets   Other long-term assets included:       October 31, 2024   April 30, 2024 SAFE agreement   $ 250,000     $ 250,000   Security deposits     43,126       43,126   Total   $ 293,126     $ 293,126      In November 2022, the Company entered into a SAFE (Simple Agreement for Future Equity) agreement with Firestorm Labs, Inc. (“Firestorm”) under which it made a payment of $250,000 to Firestorm in exchange for the right to certain shares of Firestorm stock. The SAFE permits the Company to participate in a future equity financing of Firestorm by converting the $250,000 into shares of Preferred Stock of Firestorm. If there is a change in control of Firestorm or a public offering of shares of its stock, then the Company shall have the right to receive cash payments, or shares of stock, whichever has greater value. The Company’s investment in the SAFE agreement has been recorded on the cost method of accounting. The Company evaluates the investment for any indications of impairment in value on a quarterly basis. No factors indicative of impairment were identified during the six months ended October 31, 2024.

v3.24.4

Note 11 – Right of Use Assets and Liabilities	6 Months Ended
	Oct. 31, 2024
Leases [Abstract]
Note 11 – Right of Use Assets and Liabilities	Note 11 – Right of Use Assets and Liabilities   As of October 31, 2024, the Company had operating type leases for real estate and no finance type leases. The Company’s leases have remaining lease terms of up to 6.17 years, including options to extend certain leases for up to six years. Operating lease expense totaled $262,912 and $170,505 for the six months ended October 31, 2024 and 2023, respectively.   Leases on which the Company made rent payments during the reporting period included:   Location   Monthly Rent   Expiration South Salt Lake, Utah   $ 23,340       December 2030   Santa Monica, California   $ 16,697       June 2025   San Juan, Puerto Rico   $ 6,186       June 2027   Grantsville, Utah   $ 1,000       December 2026            Supplemental information related to operating leases for the six months ended October 31, 2024 was:         Operating cash paid to settle lease liabilities   $215,922   Weighted average remaining lease term (in years)     2.50   Weighted average discount rate     12%

v3.24.4

Note 12 – Debt Obligations	6 Months Ended
	Oct. 31, 2024
Debt Disclosure [Abstract]
Note 12 – Debt Obligations	Note 12 – Debt Obligations     A.  Decathlon Capital On August 31, 2021, Teal entered into an Amended and Restated Loan and Security Agreement with Decathlon Alpha IV, L.P. (“DA4”) in the amount of $1,670,294 (the “Loan”), representing the outstanding principal amount previously due and owing by Teal to DA4. Interest on the Loan accrues at a rate of ten (10%) percent per annum. Principal and interest is payable in monthly installments of $49,275. The balance outstanding at April 30, 2024 totaled $370,537. The balance was paid off in September 2024.      B.  Pelion Note In May 2021, Teal entered into a note agreement totaling $350,000 which is payable upon demand. The Note bears interest at the applicable Federal Rate as of the date of the Note which was 0.13% on the date of issuance. Accrued interest at October 31, 2024 and April 30, 2024 totaled $1,563 and $1,334, respectively.     C.  Corporate Equity Beginning in October 2021, and amended in January 2022, Teal financed a total of $120,000 of leasehold improvements with Corporate Equity, LLC. The loan bears interest at 8.25% annually and requires monthly payments of $3,595 through December 2024. The balance outstanding at October 31, 2024 and April 30, 2024 totaled $6,706 and $27,495 respectively.      D.  Ascentium Capital In September 2021, Teal entered into a financing agreement with Ascentium Capital to fund the purchase of a fixed asset totaling $24,383. Monthly payments are $656. The balance outstanding at October 31, 2024 and April 30, 2024 totaled $259 and $3,538, respectively.     E.  Summary   Future annual principal payments at October 31, 2024 were as follows:     Fiscal Year Ended:       2025       356,964     Thereafter       —       Total     $ 356,964

v3.24.4

Note 13 – Convertible Notes Payable	6 Months Ended
	Oct. 31, 2024
Note 13 Convertible Notes Payable
Note 13 – Convertible Notes Payable	Note 13 – Convertible Notes Payable   In September 2024, the Company entered into a Securities Purchase Agreement (the “SPA”) with Lind Global Asset Management X LLC (“Lind”). Under the SPA, the Company received approximately $8 million in funding from Lind in exchange for a Senior Secured Convertible Promissory Note in the amount of $9,600,000 (the “Note”) and a Common Stock Purchase Warrant for the purchase of 750,000 shares of our common stock at a price of $6.50 per share, exercisable for five years (the “Warrant”). The Note is secured by substantially all assets of the Company. As additional consideration to Lind, the Company paid a commitment fee in the amount of $280,000.   The Note, which does not accrue interest, will be repaid in eighteen consecutive monthly installments in the amount of $533,334 beginning six months from the issuance date. At the Company’s option, monthly payments can be increased up to $1,000,000 so long as the Company’s market capitalization is at least $50 million. In addition, if the Repayment Share Price (as defined below) is equal to or greater than $2.00, Lind can, at its option, increase the monthly payment amount up to $1,300,000 for up to two months. The monthly payments due under the Note may be made by the issuance of common stock valued at the Repayment Share Price, cash in an amount equal to 1.025 times the required payment amount, or a combination thereof. The Repayment Share Price is defined in the Note as ninety percent (90%) of the average of the five (5) consecutive lowest daily VWAPs for our common stock during the twenty (20) trading days prior to the payment date, subject to a floor price of $0.75 per share.   The Note may be converted by Lind upon issuance a price of $6.50 per share (the “Conversion Price”). The dollar amount of any conversions by Lind will be applied toward upcoming Note payments in chronological order. The Note may be prepaid in whole upon 5 days’ notice, but in the event of a prepayment notice, Lind may convert up to 25% of principal amount due at the lesser of the Repayment Share Price (but only if the Repayment Share Price is equal to or greater than $2.00) or the Conversion Price. The fair value of the convertible note and related warrants were estimated using a Monte Carlo simulation model. No value was assigned to the warrant liability due to the fair market value of the convertible note payable being in excess of the proceeds received. The Company’s convertible notes payable balance at October 31, 2024 was $11,911,307. Subsequent to quarter end, on November 26, 2024, we entered into a First Amendment to our SPA with Lind. Additionally, on December 13, 2024, Lind provided notice to the Company to convert $1,300,000 of the note payable into 200,000 shares of Common Stock which will be issued on December 16, 2024. On December 16, 2024, Lind provided notices to the Company to convert an additional $2,600,000 and $3,250,000 of the note payable into 400,000 and 500,000 shares of Common Stock, respectively. See Note 20 for further information.

v3.24.4

Note 14 – Common Stock	6 Months Ended
	Oct. 31, 2024
Equity [Abstract]
Note 14 – Common Stock	Note 14 – Common Stock   Our common stock has a par value of $0.001 per share. We are authorized to issue 500,000,000 shares of common stock. Each share of common stock is entitled to one vote. A summary of shares of common stock issued by the Company since April 30, 2023 is as follows:   Description of Shares   Shares Issued Shares outstanding as of April 30, 2023     54,568,065   Vesting of restricted stock to employees, net of shares withheld of 27,189 to pay taxes     192,742   Vesting of restricted stock to Board of Directors     252,214   Vesting of restricted stock to consultants     1,761   Conversion of preferred stock     818,334   Issuance of common stock through ATM facilities     53,235   Issuance of common stock through public offering     18,400,000   Exercise of stock options     3,000   Shares outstanding as of April 30, 2024     74,289,351   Vesting of restricted stock to employees, net of shares withheld of 138,744 to pay taxes     540,590   Vesting of restricted stock to Board of Directors     61,447   Exercise of stock options     58,446   Exercise of warrants     530,578   FlightWave acquisition     2,544,991   Shares outstanding as of October 31, 2024     78,025,403        See note 20 for subsequent events.    Public Offering   In December 2023, the Company entered into an underwriting agreement with ThinkEquity LLC, as representative of the underwriters, pursuant to which the Company agreed to sell to the underwriters in a firm commitment underwritten public offering (the “Offering”) an aggregate of 16,000,000 shares of the Company’s common stock, par value $0.001 per share, at a public offering price of $0.50 per share. The Company also granted the underwriters a 45-day option to purchase up to an additional 2,400,000 shares of Common Stock to cover over-allotments.     The Offering closed on December 11, 2023, resulting in the issuance of 18,400,000 shares of Common Stock which generated gross proceeds of $9,200,000. Net proceeds to the Company from the Offering, after deducting the underwriting discount, the underwriters’ fees and expenses and the Company’s estimated Offering expenses, were approximately $8,400,000.

v3.24.4

Note 15 – Preferred Stock	6 Months Ended
	Oct. 31, 2024
Equity [Abstract]
Note 15 – Preferred Stock	Note 15 – Preferred Stock   Our preferred stock has a par value of $0.001 per share. Series B Preferred Stock (“Series B Stock”) is convertible into common stock at a ratio of 0.8334 shares of common stock for each share of Series B Stock held and votes together with the common stock on an as-if-converted basis. 982,000 shares of Series B Stock were converted into 818,334 shares of common stock in June 2023. Shares outstanding at October 31, 2024 totaled 4,676 which are convertible into 3,896 shares of common stock.

v3.24.4

Note 16 – Warrants	6 Months Ended
	Oct. 31, 2024
Note 16 Warrants
Note 16 – Warrants	Note 16 – Warrants   The Company issued 5 year warrants to investors in connection with two convertible note financings. The warrants have an exercise price of $1.50. The warrants were valued using the multinominal lattice The value of the warrants was included in the determination of the initial accounting for each financing.   A summary of the warrants issued were:                              Upon Issuance Date of Transaction   Number of Warrants   Initial Fair Value   October 2020        399,998     $ 267,999     January 2021       675,000     $ 2,870,666       As of October 31, 2024, we have received $301,248 related to the exercise of 268,332 warrants.   In May 2021, the Company issued warrants to purchase 200,000 shares of common stock to the placement agent of its common stock offering. The warrants have a five-year term and an exercise price of $5.00.     In July 2021, the Company issued warrants to purchase 533,333 shares of common stock to the placement agent of its common stock offering. The warrants have a five-year term and an exercise price of $5.625.   In December 2023, the Company issued warrants to purchase 736,000 shares of common stock to the placement agent of its common stock offering. The warrants have a five-year term and an exercise price of $0.625.   In September 2024, the Company issued warrants to purchase 750,000 shares of common stock to Lind, as further described in Note 13. The warrants have a five-year term and an exercise price of $6.50. No value was assigned to the warrants under the Monte Carlo simulation model due to the fair market value of the convertible note payable being in excess of the proceeds received.   The following table summarizes the changes in warrants outstanding since April 30, 2023.         Number of Shares      Weighted-average Exercise Price per Share    Weighted-average Remaining Contractual Term (in years)      Aggregate Intrinsic Value    Balance as of April 30, 2023 1,539,999     3.38        2.89     $ —     Granted     736,000      $ 0.63                     Exercised     —     —                     Outstanding as of April 30, 2024 2,275,999     2.49       2.77     $ —     Granted  750,000       6.50        5.00             Exercised (733,792 )      0.63                     Outstanding at October 31, 2024 2,292,207    $ 4.40       2.51     $ 1,263,775

v3.24.4

Note 17 – Share Based Awards	6 Months Ended
	Oct. 31, 2024
Share-Based Payment Arrangement [Abstract]
Note 17 – Share Based Awards	Note 17 – Share Based Awards   The 2019 Equity Incentive Plan (the “2019 Plan”) and the 2024 Omnibus Equity Incentive Plan (the “2024 Plan”) (collectively, the “Plans”) allow us to incentivize key employees, consultants, and directors with long term compensation awards such as stock options, restricted stock, and restricted stock units (collectively, the “Awards”). The number of shares issuable in connection with Awards under the 2019 Plan were not to exceed 11,750,000. However, no shares are issuable under the 2019 Plan after the 2024 Plan became effective on October 15, 2024. The number of shares issuable in connection with Awards under the 2024 Plan may not exceed 11,250,000 plus any underlying forfeited 2019 Plan awards.      A. Options    The range of assumptions used to calculate the fair value of options granted during the six months ended October 31 was:         2024       2023   Exercise Price   $ 1.15 – 2.45     $ 0.95 – 1.12   Stock price on date of grant     1.20 – 2.56       0.95 – 1.12   Risk-free interest rate     3.54 – 4.44%     3.47 – 4.34%   Dividend yield     —         —     Expected term (years)     5.17 – 5.73       6.00 – 8.25   Volatility     191.43 – 199.03%     242.38 – 260.22%            A summary of options activity under the Plans since April 30, 2023 was:     Shares   Weighted-Average Exercise Price   Weighted-Average Remaining Contractual Term   Aggregate Intrinsic Value Outstanding as of April 30, 2023     4,784,809     $ 1.88       8.72        74,586    Granted     2,903,542       1.02                   Exercised     (3,000 )     0.89                   Forfeited or expired     (905,417 )      2.27                   Outstanding as of April 30, 2024     6,779,934     1.46       8.02        2,762,242    Granted     1,333,500       1.94                   Exercised     (97,414 )     1.60                   Forfeited or expired     (119,117 )      1.47                   Outstanding as of October 31, 2024     7,896,903     1.54       7.55     12,438,946   Exercisable as of October 31, 2024     4,557,077     $ 1.63       6.45     $ 6,959,111      The aggregate intrinsic value of outstanding options represents the excess of the stock price at the indicated date over the exercise price of each option. As of October 31, 2024, there was $2,674,589 of unrecognized stock-based compensation expense related to unvested stock options which is expected to be recognized over the weighted average periods of 1.12 years.     B. Restricted Stock   A summary of restricted stock activity under the Plans since April 30, 2023 was:     Shares   Weighted Average Grant-Date Fair Value Per Share Unvested and outstanding as of April 30, 2023     781,060     $ 2.44   Granted     298,643       1.06   Vested     (485,024 )     1.92   Forfeited     (419,549 )     2.09   Unvested and outstanding as of April 30, 2024     175,130       2.09   Granted     2,497,599       1.10   Vested     (914,416 )     1.18   Forfeited     —     —   Unvested and outstanding as of October 31, 2024     1,758,313     $ 1.16          C. Stock Compensation   Stock compensation expense by functional operating expense was:                       Three months ended October 31,   Six months ended October 31,     2024   2023   2024   2023 Research and development   $ 80,093     $ 147,629     $ 174,515     $ 275,046   Sales and marketing     130,264       208,903       246,807       374,212   General and administrative     1,093,680       839,793       2,328,753       1,458,673   Total   $ 1,304,037     $ 1,196,325     $ 2,750,075     $ 2,107,931     Stock compensation expense pertaining to options totaled$815,632 and $1,606,305 for the six months ended October 31, 2024 and 2023, respectively. Stock compensation expense pertaining to restricted stock units totaled $1,934,443 and $501,626 for the six months ended October 31, 2024 and 2023, respectively.

v3.24.4

Note 18 - Related-Party Transactions	6 Months Ended
	Oct. 31, 2024
Related Party Transactions [Abstract]
Note 18 - Related-Party Transactions	Note 18 - Related-Party Transactions   In February 2024, the Company sold Rotor Riot and Fat Shark to Unusual Machines, as further described in Note 4 and Note 8. UMAC’s Chief Executive Officer is a direct relative of a member of the Company’s management.

v3.24.4

Note 19 – Commitments and Contingencies	6 Months Ended
	Oct. 31, 2024
Commitments and Contingencies Disclosure [Abstract]
Note 19 – Commitments and Contingencies	Note 19 – Commitments and Contingencies      Legal Proceedings   In the ordinary course of business, we may be involved, at times, in various legal proceedings involving a variety of matters. We do not believe there are any pending legal proceedings that will have a material adverse effect on our business, consolidated financial position, results of operations, or cash flows. However, the outcome of such legal matters is inherently unpredictable and subject to significant uncertainties. We have not recorded any litigation reserves as of October 31, 2024.   One pending legal matter is an action filed against Teal in a U.S. District Court in Delaware. The complaint asserts claims for breach of contract which management denies. We are asserting vigorous defenses to the complaint. Additionally, the Company has filed a lawsuit against the complainant for Tortious Interference with Contractual Relations and Prospective Contractual Relations. No discovery or other significant developments in the lawsuit have occurred.

v3.24.4

Note 20 – Subsequent Events	6 Months Ended
	Oct. 31, 2024
Subsequent Events [Abstract]
Note 20 – Subsequent Events	Note 20 – Subsequent Events     Subsequent events have been evaluated through the date of this filing and there are no subsequent events which require disclosure, except as follows:   Subsequent to October 31, 2024, approximately 2,000,000 shares of Common Stock were issued for the exercise of options, warrants, and vested RSUs.    On November 26, 2024, we entered into a First Amendment to our Securities Purchase Agreement (the “SPA Amendment”) with Lind. The SPA Amendment amends the terms of our original Securities Purchase Agreement with Lind dated September 23, 2024. Upon closing of the SPA Amendment, we will receive an additional $6,000,000 in funding from Lind in exchange for our issuance to Lind of a Senior Secured Convertible Promissory Note in the amount of $7,200,000 (the “Note”) and a Common Stock Purchase Warrant for the purchase of 326,000 shares of our common stock at a price of $9.20 per share, exercisable for 5 years (the “Warrant”). As additional consideration to Lind, we have agreed to pay a commitment fee in the amount of $210,000, which may be paid by deduction from the funding to be received.   The Note, which does not accrue interest, shall be repaid in eighteen (18) consecutive monthly installments in the amount of $400,000 beginning six months from the issuance date. At our option, monthly payments can be increased up to $750,000 so long as our market capitalization is at least $50 million. In addition, if the Repayment Share Price (as defined below) is equal to or greater than $2.00, Lind can, at its option, increase the monthly payment amount up to $975,000 for up to two months. The monthly payments due under the Note may be made by the issuance of common stock valued at the Repayment Share Price, cash in an amount equal to 1.025 times the required payment amount, or a combination thereof. The Repayment Share Price is defined in the Note as ninety percent (90%) of the average of the five (5) consecutive lowest daily VWAPs for our common stock during the twenty (20) trading days prior to the payment date, subject to a floor price of $0.75 per share.   The Note may be converted by Lind from time to time at a price of $9.20 per share (the “Conversion Price”). The dollar amount of any conversions by Lind will be applied toward upcoming Note payments in chronological order. The Note may be prepaid in whole upon 5 days’ notice, but in the event of a prepayment notice, Lind may convert up to 25% of principal amount due at the lesser of the Repayment Share Price (but only if the Repayment Share Price is equal to or greater than $2.00) or the Conversion Price.      On December 13, 2024, Lind provided notice to the Company to convert $1,300,000 of the note payable into 200,000 shares of Common Stock which will be issued on December 16, 2024. Additionally, on December 16, 2024, Lind provided notice to the Company to convert an additional $2,600,000 of the note payable into 400,000 shares of Common Stock.

v3.24.4

Note 2 – Summary of Significant Accounting Policies (Policies)	6 Months Ended
	Oct. 31, 2024
Accounting Policies [Abstract]
Basis of Presentation	Basis of Presentation – The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States (“GAAP”) for interim financial information and with the instructions of Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements. In the opinion of management, all adjustments, consisting only of normal recurring adjustments necessary for a fair presentation with respect to the interim financial statements have been included. The results of operations for the six months ended October 31, 2024 are not necessarily indicative of the results for the full year. For further information, refer to the consolidated financial statements and footnotes thereto for the year ended April 30, 2024, included in the Company’s Annual Report on Form 10-K. In September 2024, the Company’s Board of Directors approved a change in fiscal year end from April 30 to December 31.
Restatement of Previously Issued Consolidated Financial Statements	Restatement of Previously Issued Consolidated Financial Statements – The Company’s Condensed Consolidated Statement of Operations and Stockholders’ Equity for the six months ended October 31, 2023, which were originally filed with the U.S. Securities and Exchange Commission (the “SEC”) on December 15, 2023, have been restated. The Company revised its financial statements to remove derivative liabilities due to erroneously reporting warrants from our convertible note financings, as described in Note 16, as having a derivative component.   The impacts of these restatements are detailed in the tables below:                   Condensed Consolidated Statement of Operations For the three months ended October 31, 2023         Originally Reported   As Restated   Change Change in fair value of derivative liability   $ (162,482 )   $ —       $ (162,482 ) Net loss   $ (5,681,328 )   $ (5,843,810 )   $ (162,482 )                     Condensed Consolidated Statement of Operations For the six months ended October 31, 2023         Originally Reported   As Restated   Change Change in fair value of derivative liability   $ (189,002 )   $ —       $ (189,002 ) Net loss   $ (11,491,676 )   $ (11,680,678 )   $ (189,002 )                     Condensed Consolidated Statement of Stockholders’ Equity For the six months ended October 31, 2023         Originally Reported   As Restated   Change Additional paid-in capital   $ 112,102,691     $ 114,752,317     $ 2,649,626   Accumulated deficit   $ (66,078,469 )   $ (68,758,781 )   $ (2,680,312 ) Total equity   $ 45,874,875     $ 45,844,189     $ (30,686 )
Principles of Consolidation	Principles of Consolidation – Our condensed consolidated financial statements include the accounts of our wholly owned subsidiaries which include Teal, FlightWave (beginning on September 5, 2024), Skypersonic, as well as Rotor Riot and Fat Shark through the sale date of February 16, 2024. Non-majority owned investments, including the formerly wholly owned subsidiaries Rotor Riot and Fat Shark, are accounted for using the equity method when the Company is able to significantly influence the operating policies of the investee. Intercompany transactions and balances have been eliminated.   The Consumer segment businesses are characterized as discontinued operations in these financial statements.  The operating results and cash flows of discontinued operations are separately stated in those respective financial statements. See Note 4.
Use of Estimates	Use of Estimates – The preparation of financial statements in accordance with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates. Significant estimates reflected in these financial statements include those used to (i) complete purchase price accounting for acquisitions, (ii) the evaluation of long-term assets, including goodwill, for impairment, (iii) the evaluation of other-than-temporary-impairment of equity method investments, and (iv) valuations of convertible notes payable.
Concentration of Credit Risk	Concentration of Credit Risk – Financial instruments, which potentially subject the Company to concentrations of credit risk, include trade receivables. In the normal course of business, the Company provides credit terms to its customers. Accordingly, the Company performs ongoing credit evaluations of its customers, generally does not require collateral and considers the credit risk profile of the customer from which the receivable is due in further evaluating collection risk. Customers that accounted for 10% or greater of accounts receivable, net as of October 31, 2024 and April 30, 2024 were as follows:         October 31, 2024   April 30, 2024 Customer A     38 %     * Customer B     25 %     * Customer C     *     53 % Customer D     *     24 %     * Accounts Receivable was less than 10%   During the six months ended October 31, 2024, two customers accounted for equal to or greater than 10% of total revenue, totaling 21% and 19%, respectively. During the six months ended October 31, 2023, three customers accounted for equal to or greater than 10% of total revenue, totaling 13%, 12% and 10%, respectively. The Company does not believe the loss of one or more of these customers would be significant to operations.
Equity Method Investment	Equity Method Investment – The equity method of accounting is applied to investments in which the Company has an ownership interest of between 20% and 50%. The Company evaluates its equity method investments each reporting period for evidence of a loss in value that is other than a temporary decline. Evidence of a loss in value might include, but would not necessarily be limited to, absence of an ability to recover the carrying amount of the investment or the inability of the investee to sustain an earnings capacity that would justify the carrying amount of the investment. The Company performed this analysis and concluded that its investment in UMAC was other-than-temporarily impaired and recognized an impairment charge of $11,353,875 for the year ended April 30, 2024. See Note 8 for additional information.
Fair Values, Inputs and Valuation Techniques for Financial Assets and Liabilities, and Related Disclosures	Fair Values, Inputs and Valuation Techniques for Financial Assets and Liabilities, and Related Disclosures – The fair value measurements and disclosure guidance defines fair value and establishes a framework for measuring fair value. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability (an exit price) in an orderly transaction between market participants at the measurement date. In accordance with this guidance, the Company has categorized its recurring basis financial assets and liabilities into a three-level fair value hierarchy based on the priority of the inputs to the valuation technique.   The fair value hierarchy gives the highest priority to quoted prices in active markets for identical assets or liabilities (Level 1) and the lowest priority to unobservable inputs (Level 3). The inputs used to measure fair value may fall into different levels of the fair value hierarchy. In such cases, the level in the fair value hierarchy within which the fair value measurement in its entirety falls has been determined based on the lowest level input that is significant to the fair value measurement in its entirety. The Company's assessment of the significance of a particular input to the fair value measurement in its entirety requires judgment and considers factors specific to the asset or liability.   The guidance establishes three levels of the fair value hierarchy as follows:   Level 1: Inputs are unadjusted, quoted prices in active markets for identical assets or liabilities at the measurement date; Level 2: Inputs are observable, unadjusted quoted prices in active markets for similar assets or liabilities, unadjusted quoted prices for identical or similar assets or liabilities in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the related assets or liabilities; and  Level 3: Unobservable inputs that are significant to the measurement of the fair value of the assets or liabilities that are supported by little or no market data.      The Company’s financial instruments mainly consist of cash, accounts receivable, current assets, accounts payable, accrued expenses, notes payable, and convertible notes payable. The recorded carrying amounts of cash, accounts receivable, current assets, accounts payable, accrued expenses, and notes payable are considered to approximate their estimated fair values due to their short-term nature. Liabilities recognized at fair value on a recurring basis in the consolidated balance sheets consist of convertible notes payable. These items are categorized based upon the level of judgment associated with the inputs used to measure their fair values. Fair value is defined as the price that would be paid to transfer a liability in an orderly transaction between market participants at the measurement date.   The following table summarizes the Company’s financial instruments at fair value based on the fair value hierarchy for each class of instrument:       Level 1   Level 2   Level 3   Total Convertible notes payable   $ —       $ —       $ 11,911,307     $ 11,911,307     Convertible Notes Payable   The Company measures its convertible notes payable at fair value based on significant inputs not observable in the market, which caused them to be classified as Level 3 measurements within the fair value hierarchy. Changes in the fair value of the convertible notes payable related to updated assumptions and estimates were recognized as a convertible notes payable fair value adjustment within the consolidated statements of operations and comprehensive loss.   In determining the fair value of the convertible notes payable as of October 31, 2024, the Company used a market-based approach. The valuation method utilized a negotiated discount rate and a market yield rate which are unobservable inputs.   An increase or decrease in any of the unobservable inputs in isolation could result in a material increase or decrease in the estimated fair value. In the future, depending on the weight of evidence and valuation approaches used, these or other inputs may have a more significant impact on the estimated fair value.   The Company calculated the estimated fair value of the convertible notes payable as of October 31, 2024 using the following assumptions:       October 31, 2024 Issuance date     10/1/2024   Maturity date     10/1/2026   Stock price     3.06   Expected volatility factor     92.8 % Risk-free interest rate     5.21 %   The following table presents changes in the Level 3 convertible notes payable measured at fair value for the six months ended October 31, 2024:       Balance, May 1, 2024   $ —     Additions     7,681,000   Fair value measurement adjustments     4,230,307   Balance, October 31, 2024   $ 11,911,307     Warrants   The fair value of the warrants as of October 31, 2024 was estimated using a Monte Carlo simulation model. The significant unobservable inputs for the Monte Carlo model include the stock price, exercise price, risk-free rate of return, time to expiration, and the volatility. An increase or decrease in the unobservable inputs in isolation could result in a material increase or decrease in the estimated fair value. In the future, depending on the weight of evidence and valuation approaches used, these or other inputs may have a more significant impact on the estimated fair value. Additionally, if certain provisions are triggered, reset adjustments may be required in the future.  For the quarter ended October 31, 2024, no value was assigned to the warrants due to the fair market value of the convertible note payable being in excess of the proceeds received.
Revenue Recognition	Revenue Recognition – The Company recognizes revenue in accordance with ASC Topic 606 - Revenue from Contracts with Customers, issued by the Financial Accounting Standards Board (“FASB”). This standard includes a comprehensive evaluation of factors to be considered regarding revenue recognition including (i) identifying the promised goods, (ii) evaluating performance obligations, (iii) measuring the transaction price, (iv) allocating the transaction price to the performance obligations if there are multiple components, and (v) recognizing revenue as each obligation is satisfied. The Company’s revenue transactions include the shipment of goods to customers as orders are fulfilled, completion of non-recurring engineering, completion of training, and customer support services. The Company recognizes revenue upon shipment of product or prototypes unless otherwise specified in the purchase order or contract. Customer deposits totaled $221,380 and $53,939 at October 31, 2024 and April 30, 2024, respectively. From time to time, non-recurring engineering contracts may involve the capitalization of engineering prototypes, classified as contract assets. Contract assets totaled $0 and $1,477,859 at October 31, 2024 and April 30, 2024, respectively.   The following table presents the Company’s revenue disaggregated by revenue type:                        Three months ended October 31,   Six months ended October 31,     2024   2023   2024   2023 Contract related   $ —       $ 529,437     $ 886,440     $ 840,318   Product related     1,534,727       3,401,431       3,424,822       4,838,679   Total   $ 1,534,727     $ 3,930,868     $ 4,311,262     $ 5,678,997
Product Warranty	Product Warranty - The Company accrues an estimate of its exposure to warranty claims based upon both current and historical product sales data and warranty costs incurred. Product warranty reserves are recorded in current liabilities under accrued expenses. Warranty liability was approximately $587,000 and $372,000 as of October 31, 2024 and April 30, 2024 respectively.
Recent Accounting Pronouncements	Recent Accounting Pronouncements   – Management does not believe that recently issued, but not yet effective accounting pronouncements, if adopted, would have a material effect on the accompanying consolidated financial statements.
Comprehensive Loss	Comprehensive Loss – Comprehensive loss consists of net loss and other comprehensive loss. Other comprehensive loss refers to gains and losses that are recorded as an element of stockholders' equity but are excluded from net loss. Our other comprehensive loss is comprised of foreign currency translation adjustments and unrealized gains or losses on available-for-sale securities. During the six months ended October 31, 2024 and October 31, 2023, comprehensive loss was $4,621 higher and $656,074 lower than net loss, respectively, related to unrealized gains on available-for-sale securities totaling $0 and $653,052, respectively, and foreign currency translation adjustments of $4,621 and $3,022, respectively.
Basic and Diluted Net Loss per Share	Basic and Diluted Net Loss per Share – Basic and diluted net loss per share has been calculated by dividing net loss by the weighted average number of shares of common stock outstanding during the period. Common stock equivalents were excluded from the computation of diluted net loss per share of common stock because they were anti-dilutive. The conversion or exercise of these common stock equivalents would dilute earnings per share if we become profitable in the future. Outstanding securities not included in the computation of diluted net loss per share because their effect would have been anti-dilutive include:       October 31, 2024   October 31, 2023 Series B Preferred Stock, as converted     3,896       3,896   Stock options     7,896,903       6,861,517   Warrants     2,292,207       1,539,999   Restricted stock     1,758,313       779,850   Total     11,951,319       9,185,262
Related Parties	Related Parties – Parties are considered to be related to us if they have control or significant influence, directly or indirectly, over us, including key management personnel and members of the Board of Directors or are direct relatives of key management personnel of members of the Board of Directors. Related Party transactions are disclosed in Note 18.
Liquidity and Going Concern	Liquidity and Going Concern  – The Company has never been profitable and has incurred net losses related to acquisitions, as well as costs incurred to pursue its long-term growth strategy. During the six months ended October 31, 2024, the Company incurred a net loss of approximately $25,750,000 and used cash in operating activities of approximately $12,500,000. As of October 31, 2024, working capital totaled approximately $6,240,000. These financial results and our financial position at October 31, 2024 raise substantial doubt about our ability to continue as a going concern. However, the Company has recently taken actions to strengthen its liquidity. In November 2024, the Company was selected as the winner of the U.S.  Army’s Short Range Reconnaissance (SRR) Program of Record. The Company’s manufacturing facility is scaling production of its most recent products and gross profits are projected to increase. As described in Note 13 and Note 20, the Company closed financings with proceeds of approximately $8,000,000 and $6,000,000 in September 2024 and November 2024, respectively. Additionally, the Company’s Form S-3 became effective on December 11, 2024. If necessary, the Company will seek additional equity financing for which there can be no guarantee. Management has concluded that these recent positive developments alleviate any substantial doubt about the Company’s ability to continue its operations, and meet its financial obligations, for twelve months from the date these consolidated financial statements are issued.

v3.24.4

Note 2 – Summary of Significant Accounting Policies (Tables)	6 Months Ended
	Oct. 31, 2024
Accounting Policies [Abstract]
[custom:RestatementsOfPreviouslyIssuedConsolidatedFinancialStatementsTableTextBlock]	Condensed Consolidated Statement of Operations For the three months ended October 31, 2023         Originally Reported   As Restated   Change Change in fair value of derivative liability   $ (162,482 )   $ —       $ (162,482 ) Net loss   $ (5,681,328 )   $ (5,843,810 )   $ (162,482 )                     Condensed Consolidated Statement of Operations For the six months ended October 31, 2023         Originally Reported   As Restated   Change Change in fair value of derivative liability   $ (189,002 )   $ —       $ (189,002 ) Net loss   $ (11,491,676 )   $ (11,680,678 )   $ (189,002 )                     Condensed Consolidated Statement of Stockholders’ Equity For the six months ended October 31, 2023         Originally Reported   As Restated   Change Additional paid-in capital   $ 112,102,691     $ 114,752,317     $ 2,649,626   Accumulated deficit   $ (66,078,469 )   $ (68,758,781 )   $ (2,680,312 ) Total equity   $ 45,874,875     $ 45,844,189     $ (30,686 )
Schedules of Concentration of Risk, by Risk Factor [Table Text Block]	October 31, 2024   April 30, 2024 Customer A     38 %     * Customer B     25 %     * Customer C     *     53 % Customer D     *     24 %
Fair Value Measurements, Recurring and Nonrecurring [Table Text Block]	Level 1   Level 2   Level 3   Total Convertible notes payable   $ —       $ —       $ 11,911,307     $ 11,911,307
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]	October 31, 2024 Issuance date     10/1/2024   Maturity date     10/1/2026   Stock price     3.06   Expected volatility factor     92.8 % Risk-free interest rate     5.21 %
Schedule of Effect of Significant Unobservable Inputs, Changes in Plan Assets [Table Text Block]	Balance, May 1, 2024   $ —     Additions     7,681,000   Fair value measurement adjustments     4,230,307   Balance, October 31, 2024   $ 11,911,307
[custom:RevenueRecognitionDisaggregatedRevenueByTypeTableTextBlock]	Three months ended October 31,   Six months ended October 31,     2024   2023   2024   2023 Contract related   $ —       $ 529,437     $ 886,440     $ 840,318   Product related     1,534,727       3,401,431       3,424,822       4,838,679   Total   $ 1,534,727     $ 3,930,868     $ 4,311,262     $ 5,678,997
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]	October 31, 2024   October 31, 2023 Series B Preferred Stock, as converted     3,896       3,896   Stock options     7,896,903       6,861,517   Warrants     2,292,207       1,539,999   Restricted stock     1,758,313       779,850   Total     11,951,319       9,185,262

v3.24.4

Note 3 – Business Combination (Tables)	6 Months Ended
	Oct. 31, 2024
Business Combination and Asset Acquisition [Abstract]
Schedule of Business Acquisitions, by Acquisition [Table Text Block]	Shares issued   $ 7,000,000   Acquisition consideration payable     7,000,000   Total Purchase Price   $ 14,000,000      Assets acquired     Accounts receivable   $ 155,000   Inventory     297,630   Operating lease right-of-use assets     128,433   Other assets     69,480   Goodwill     13,968,565   Total assets acquired     14,619,108   Liabilities assumed         Accounts payable and accrued expenses     264,493   Customer deposits     196,476   Operating lease liabilities     158,139   Total liabilities assumed     619,108   Total fair value of net assets acquired   $ 14,000,000
Business Acquisition, Pro Forma Information [Table Text Block]	Six months ended October 31, 2024       Consolidated   Revenues   $ 5,107,661             Net Loss     (26,882,328 )           Loss per share – basic and diluted     (0.36 )        Six months ended October 31, 2023       Consolidated   Revenues   $ 6,461,394             Net Loss     (12,499,977 )           Loss per share – basic and diluted     (0.23 )

v3.24.4

Note 4 – Divestiture of Consumer Segment (Tables)	6 Months Ended
	Oct. 31, 2024
Discontinued Operations and Disposal Groups [Abstract]
Disposal Groups, Including Discontinued Operations [Table Text Block]	Three months ended October 31,   Six months ended October 31,     2024   2023   2024   2023 Revenues   $ —       $ 1,056,932     $ —       $ 2,926,151                                     Cost of goods sold     —         1,154,200       —         2,539,316                                     Gross Margin     —         (97,268 )     —         386,835                                     Operating Expenses                                 Research and development     —         31,054       —         77,303   Sales and marketing     —         287,413       —         691,517   General and administrative     —         183,807       —         437,393   Total operating expenses     —         502,274       —         1,206,213   Operating loss     —         (599,542 )     —         (819,378 )                                   Other (income) expense                                 Interest expense     —         —         —         22,856   Other, net     —         (31 )     —         (150 ) Other (income) expense     —         (31 )     —         22,706                                     Net loss from discontinued operations   $ —       $ (599,511 )   $ —       $ (842,084 )

v3.24.4

Note 5 – Inventories (Tables)	6 Months Ended
	Oct. 31, 2024
Inventory Disclosure [Abstract]
Schedule of Inventory, Current [Table Text Block]	October 31, 2024   April 30, 2024 Raw materials   $ 6,110,038     $ 5,750,324   Work-in-process     1,214,769       1,289,997   Finished goods     4,840,453       966,916   Total   $ 12,165,260     $ 8,007,237

v3.24.4

Note 6 – Other Current Assets (Tables)	6 Months Ended
	Oct. 31, 2024
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]
Schedule of Other Current Assets [Table Text Block]	October 31, 2024   April 30, 2024 Prepaid expenses   $ 2,626,343     $ 1,206,306   Prepaid inventory     389,070       602,888   Contract asset     —         1,477,859   Grant receivable     —         675,000   Total   $ 3,015,413     $ 3,962,053

v3.24.4

Note 7 – Intangible Assets (Tables)	6 Months Ended
	Oct. 31, 2024
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of Intangible Assets and Goodwill [Table Text Block]	October 31, 2024   April 30, 2024     Gross Value   Accumulated Amortization   Net Value   Gross Value   Accumulated Amortization   Net Value Proprietary technology   $ 4,282,001     $ (2,272,270 )   $ 2,009,731     $ 4,282,001     $ (1,917,612 )   $ 2,364,389   Non-compete agreements     65,000       (65,000 )     —         65,000       (65,000 )     —     Total finite-lived assets     4,347,001       (2,337,270 )     2,009,731       4,347,001       (1,982,612 )     2,364,389   Brand name     1,430,000       —         1,430,000       1,430,000       —         1,430,000   Total indefinite-lived assets     1,430,000       —         1,430,000       1,430,000       —         1,430,000   Total intangible assets, net   $ 5,777,001     $ (2,337,270 )   $ 3,439,731     $ 5,777,001     $ (1,982,612 )   $ 3,794,389

v3.24.4

Note 8 – Equity Method Investment (Tables)	6 Months Ended
	Oct. 31, 2024
Equity Method Investments and Joint Ventures [Abstract]
[custom:EquityMethodInvestmentFinancialInformationTableTextBlock]	Current assets   $ 5,116,963   Long-term assets     20,083,390   Current liabilities     931,200   Long-term liabilities     4,297,332   Revenues     2,030,039   Gross profit     592,607   Net loss   $ (2,718,240 )
Equity Method Investments [Table Text Block]	Initial investment, February 16, 2024   $ 17,000,000   Equity method loss     (503,625 ) Impairment     (11,353,875 ) Investment balance, April 30, 2024   $ 5,142,500   Equity method loss     (734,143 ) Sale of ownership interest     (4,408,357 ) Investment balance, October 31, 2024   $ —

v3.24.4

Note 9 – Property and Equipment (Tables)	6 Months Ended
	Oct. 31, 2024
Property, Plant and Equipment [Abstract]
Property, Plant and Equipment [Table Text Block]	October 31, 2024   April 30, 2024 Equipment and related   $ 1,633,105     $ 1,540,888   Leasehold improvements     1,556,139       1,547,976   Furniture and fixtures     186,703       163,290   Accumulated depreciation     (1,403,088 )     (911,470 ) Net carrying value   $ 1,972,859     $ 2,340,684     Depreciation expense totaled $491,618 and $222,431 for the six months ended October 31, 2024 and 2023, respectively.

v3.24.4

Note 10 – Other Long-Term Assets (Tables)	6 Months Ended
	Oct. 31, 2024
Note 10 Other Long-term Assets
[custom:ScheduleOfOtherLongTermAssetsTableTextBlock]	October 31, 2024   April 30, 2024 SAFE agreement   $ 250,000     $ 250,000   Security deposits     43,126       43,126   Total   $ 293,126     $ 293,126

v3.24.4

Note 11 – Right of Use Assets and Liabilities (Tables)	6 Months Ended
	Oct. 31, 2024
Leases [Abstract]
Schedule of Rent Expense [Table Text Block]	Location   Monthly Rent   Expiration South Salt Lake, Utah   $ 23,340       December 2030   Santa Monica, California   $ 16,697       June 2025   San Juan, Puerto Rico   $ 6,186       June 2027   Grantsville, Utah   $ 1,000       December 2026
Lessee, Operating Lease, Disclosure [Table Text Block]	Operating cash paid to settle lease liabilities   $215,922   Weighted average remaining lease term (in years)     2.50   Weighted average discount rate     12%

v3.24.4

Note 12 – Debt Obligations (Tables)	6 Months Ended
	Oct. 31, 2024
Debt Disclosure [Abstract]
[custom:ScheduleOfDebtPaymentsDueTableTextBlock]	Fiscal Year Ended:       2025       356,964     Thereafter       —       Total     $ 356,964

v3.24.4

Note 14 – Common Stock (Tables)	6 Months Ended
	Oct. 31, 2024
Equity [Abstract]
Schedule of Common Stock Outstanding Roll Forward [Table Text Block]	Description of Shares   Shares Issued Shares outstanding as of April 30, 2023     54,568,065   Vesting of restricted stock to employees, net of shares withheld of 27,189 to pay taxes     192,742   Vesting of restricted stock to Board of Directors     252,214   Vesting of restricted stock to consultants     1,761   Conversion of preferred stock     818,334   Issuance of common stock through ATM facilities     53,235   Issuance of common stock through public offering     18,400,000   Exercise of stock options     3,000   Shares outstanding as of April 30, 2024     74,289,351   Vesting of restricted stock to employees, net of shares withheld of 138,744 to pay taxes     540,590   Vesting of restricted stock to Board of Directors     61,447   Exercise of stock options     58,446   Exercise of warrants     530,578   FlightWave acquisition     2,544,991   Shares outstanding as of October 31, 2024     78,025,403

v3.24.4

Note 16 – Warrants (Tables)	6 Months Ended
	Oct. 31, 2024
Note 16 Warrants
[custom:ScheduleOfWarrantsIssuedAndFairValueTableTextBlock]	Upon Issuance Date of Transaction   Number of Warrants   Initial Fair Value   October 2020        399,998     $ 267,999     January 2021       675,000     $ 2,870,666
Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block]	Number of Shares      Weighted-average Exercise Price per Share    Weighted-average Remaining Contractual Term (in years)      Aggregate Intrinsic Value    Balance as of April 30, 2023 1,539,999     3.38        2.89     $ —     Granted     736,000      $ 0.63                     Exercised     —     —                     Outstanding as of April 30, 2024 2,275,999     2.49       2.77     $ —     Granted  750,000       6.50        5.00             Exercised (733,792 )      0.63                     Outstanding at October 31, 2024 2,292,207    $ 4.40       2.51     $ 1,263,775

v3.24.4

Note 17 – Share Based Awards (Tables)	6 Months Ended
	Oct. 31, 2024
Share-Based Payment Arrangement [Abstract]
[custom:ScheduleOfAssumptionsUsed1TableTextBlock]	2024       2023   Exercise Price   $ 1.15 – 2.45     $ 0.95 – 1.12   Stock price on date of grant     1.20 – 2.56       0.95 – 1.12   Risk-free interest rate     3.54 – 4.44%     3.47 – 4.34%   Dividend yield     —         —     Expected term (years)     5.17 – 5.73       6.00 – 8.25   Volatility     191.43 – 199.03%     242.38 – 260.22%
Disclosure of Share-Based Compensation Arrangements by Share-Based Payment Award [Table Text Block]	Shares   Weighted-Average Exercise Price   Weighted-Average Remaining Contractual Term   Aggregate Intrinsic Value Outstanding as of April 30, 2023     4,784,809     $ 1.88       8.72        74,586    Granted     2,903,542       1.02                   Exercised     (3,000 )     0.89                   Forfeited or expired     (905,417 )      2.27                   Outstanding as of April 30, 2024     6,779,934     1.46       8.02        2,762,242    Granted     1,333,500       1.94                   Exercised     (97,414 )     1.60                   Forfeited or expired     (119,117 )      1.47                   Outstanding as of October 31, 2024     7,896,903     1.54       7.55     12,438,946   Exercisable as of October 31, 2024     4,557,077     $ 1.63       6.45     $ 6,959,111
Share-Based Payment Arrangement, Restricted Stock Unit, Activity [Table Text Block]	Shares   Weighted Average Grant-Date Fair Value Per Share Unvested and outstanding as of April 30, 2023     781,060     $ 2.44   Granted     298,643       1.06   Vested     (485,024 )     1.92   Forfeited     (419,549 )     2.09   Unvested and outstanding as of April 30, 2024     175,130       2.09   Granted     2,497,599       1.10   Vested     (914,416 )     1.18   Forfeited     —     —   Unvested and outstanding as of October 31, 2024     1,758,313     $ 1.16
Schedule of Deferred Compensation Arrangement with Individual, Share-Based Payments [Table Text Block]	Three months ended October 31,   Six months ended October 31,     2024   2023   2024   2023 Research and development   $ 80,093     $ 147,629     $ 174,515     $ 275,046   Sales and marketing     130,264       208,903       246,807       374,212   General and administrative     1,093,680       839,793       2,328,753       1,458,673   Total   $ 1,304,037     $ 1,196,325     $ 2,750,075     $ 2,107,931

v3.24.4

Impact of restatements of previously issued consolidated financial statements (Details) - USD ($)	3 Months Ended				6 Months Ended
	Oct. 31, 2024	Jul. 31, 2024	Oct. 31, 2023	Jul. 31, 2023	Oct. 31, 2024	Oct. 31, 2023
Net loss	$ (13,334,618)	$ (12,416,376)	$ (5,843,810)	$ (5,836,868)	$ (25,750,994)	$ (11,680,678)
Additional paid-in capital	133,831,679				133,831,679
Accumulated deficit	$ (106,881,726)				$ (106,881,726)
Restatement Impact Originally Reported [Member]
Change in fair value of derivative liability			(162,482)			(189,002)
Net loss			(5,681,328)			(11,491,676)
Additional paid-in capital			112,102,691			112,102,691
Accumulated deficit			(66,078,469)			(66,078,469)
Total equity			45,874,875			45,874,875
Restatement Impact As Restated [Member]
Change in fair value of derivative liability
Net loss			(5,843,810)			(11,680,678)
Additional paid-in capital			114,752,317			114,752,317
Accumulated deficit			(68,758,781)			(68,758,781)
Total equity			45,844,189			45,844,189
Restatement Impact Change [Member]
Change in fair value of derivative liability			(162,482)			(189,002)
Net loss			(162,482)			(189,002)
Additional paid-in capital			2,649,626			2,649,626
Accumulated deficit			(2,680,312)			(2,680,312)
Total equity			$ (30,686)			$ (30,686)

v3.24.4

Customer concentration risk (Details)	6 Months Ended	12 Months Ended
	Oct. 31, 2024	Apr. 30, 2024
Customer Concentration Risk 1 [Member]
Product Information [Line Items]
Concentration Risk, Percentage	38.00%	53.00%
Customer Concentration Risk 2 [Member]
Product Information [Line Items]
Concentration Risk, Percentage	25.00%	24.00%

v3.24.4

Note 1 – The Business (Details Narrative) - USD ($)	6 Months Ended		12 Months Ended
	Oct. 31, 2024	Oct. 31, 2023	Apr. 30, 2024	Apr. 30, 2022	Apr. 30, 2021	Apr. 30, 2020
Restructuring Cost and Reserve [Line Items]
Business Combination, Consideration Transferred	$ 7,000,000
Business Acquisition 1 [Member]
Restructuring Cost and Reserve [Line Items]
Business Combination, Consideration Transferred						$ 1,995,114
Business Acquisition 2 [Member]
Restructuring Cost and Reserve [Line Items]
Business Combination, Consideration Transferred					$ 8,354,076
Business Acquisition 4 [Member]
Restructuring Cost and Reserve [Line Items]
Business Combination, Consideration Transferred			$ 14,000,000	$ 10,011,279

v3.24.4

Financial instruments at fair value based on the fair value hierarchy for each class of instrument (Details)	Oct. 31, 2024 USD ($)
Platform Operator, Crypto-Asset [Line Items]
Convertible notes payable	$ 11,911,307
Fair Value, Inputs, Level 1 [Member]
Platform Operator, Crypto-Asset [Line Items]
Convertible notes payable
Fair Value, Inputs, Level 2 [Member]
Platform Operator, Crypto-Asset [Line Items]
Convertible notes payable
Fair Value, Inputs, Level 3 [Member]
Platform Operator, Crypto-Asset [Line Items]
Convertible notes payable	$ 11,911,307

v3.24.4

Fair value assumptions for convertible notes payable (Details)	Oct. 31, 2024 $ / shares
Accounting Policies [Abstract]
[custom:FairValueAssumptionsConvertibleNotesPayableIssuanceDate-0]	Oct. 01, 2024
[custom:FairValueAssumptionsConvertibleNotesPayableMaturityDate-0]	Oct. 01, 2026
Stock price	$ 3.06
Expected volatility factor	92.80%
Risk-free interest rate	5.21%

v3.24.4

Changes in the Level 3 convertible notes payable measured at fair value (Details)	6 Months Ended
	Oct. 31, 2024 USD ($)
Accounting Policies [Abstract]
Balance, May 1, 2024
Additions	7,681,000
Fair value measurement adjustments	4,230,307
Balance, October 31, 2024	$ 11,911,307

v3.24.4

Company's revenue disaggregated by revenue type (Details) - USD ($)	3 Months Ended		6 Months Ended
	Oct. 31, 2024	Oct. 31, 2023	Oct. 31, 2024	Oct. 31, 2023
Accounting Policies [Abstract]
Contract related		$ 529,437	$ 886,440	$ 840,318
Product related	1,534,727	3,401,431	3,424,822	4,838,679
Total	$ 1,534,727	$ 3,930,868	$ 4,311,262	$ 5,678,997

v3.24.4

Antidilutive securities excluded from computation of diluted net loss per share (Details) - shares	6 Months Ended
	Oct. 31, 2024	Oct. 31, 2023
Accounting Policies [Abstract]
Series B Preferred Stock, as converted	3,896	3,896
Stock options	7,896,903	6,861,517
Warrants	2,292,207	1,539,999
Restricted stock	1,758,313	779,850
Total	11,951,319	9,185,262

v3.24.4

Note 2 – Summary of Significant Accounting Policies (Details Narrative) - USD ($)	1 Months Ended			3 Months Ended		6 Months Ended		12 Months Ended
	Nov. 30, 2024	Sep. 30, 2024	Dec. 31, 2023	Oct. 31, 2024	Oct. 31, 2023	Oct. 31, 2024	Oct. 31, 2023	Apr. 30, 2024
Accounting Policies [Abstract]
Asset Impairment Charges								$ 11,353,875
Contract with Customer, Liability, Current				$ 221,380		$ 221,380		53,939
Contract with Customer, Asset, before Allowance for Credit Loss, Current				0		0		1,477,859
Standard Product Warranty Accrual, Current				587,000		587,000		$ 372,000
[custom:DifferenceBetweenComprehensiveLossAndNetLoss]						4,621	$ 656,074
Debt Securities, Available-for-Sale, Unrealized Gain (Loss)						0	653,052
Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, before Tax, Portion Attributable to Parent					$ 1,376	(4,621)	3,022
Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent						(25,750,994)	(10,838,594)
Net Cash Provided by (Used in) Operating Activities, Continuing Operations						(12,487,713)	$ (11,240,359)
Banking Regulation, Total Capital, Actual				$ 6,240,000		$ 6,240,000
[custom:FirmCommitmentUnderwrittenPublicOfferingNetProceeds]	$ 6,000,000	$ 8,000,000	$ 8,400,000

v3.24.4

Preliminary summary of the purchase price and its related allocation (Details) - USD ($)	2 Months Ended		3 Months Ended	6 Months Ended
	Dec. 31, 2024	Oct. 31, 2024	Oct. 31, 2024	Oct. 31, 2024	Oct. 31, 2023	Sep. 04, 2024
Business Acquisition [Line Items]
Shares issued			$ 7,000,000	$ 7,000,000
Acquisition consideration payable				$ 7,000,000
Series of Individually Immaterial Business Acquisitions [Member]
Business Acquisition [Line Items]
Shares issued	$ 7,000,000		7,000,000
Acquisition consideration payable			7,000,000
Total Purchase Price		$ 14,000,000	$ 14,000,000
Assets acquired
Accounts receivable						$ 155,000
Inventory						297,630
Operating lease right-of-use assets						128,433
Other assets						69,480
Goodwill						13,968,565
Total assets acquired						14,619,108
Liabilities assumed
Accounts payable and accrued expenses						264,493
Customer deposits						196,476
Operating lease liabilities						158,139
Total liabilities assumed						619,108
Total fair value of net assets acquired						$ 14,000,000

v3.24.4

Pro forma results of acquisitions (Details) - Series of Individually Immaterial Business Acquisitions [Member] - USD ($)	6 Months Ended
	Oct. 31, 2024	Oct. 31, 2023
Business Acquisition [Line Items]
Revenues	$ 5,107,661	$ 6,461,394
Net Loss	$ (26,882,328)	$ (12,499,977)
Loss per share – basic and diluted	$ (0.36)	$ (0.23)

v3.24.4

Note 3 – Business Combination (Details Narrative) - USD ($)	2 Months Ended		3 Months Ended	6 Months Ended
	Dec. 31, 2024	Oct. 31, 2024	Oct. 31, 2024	Oct. 31, 2024	Oct. 31, 2023
Business Acquisition [Line Items]
Acquisition of FlightWave			$ 7,000,000	$ 7,000,000
Series of Individually Immaterial Business Acquisitions [Member]
Business Acquisition [Line Items]
Business Combination, Price of Acquisition, Expected		$ 14,000,000	14,000,000
Acquisition of FlightWave	$ 7,000,000		$ 7,000,000
Stock Issued During Period, Shares, Acquisitions			2,544,991
[custom:StockIssuedDuringPeriodValueAcquisitionsAmountPayablePreferredShareholdersOfSeller]	2,000,000
[custom:StockIssuedDuringPeriodValueAcquisitionsAmountPayableCommonShareholdersOptionHoldersOfSeller]	$ 5,000,000

v3.24.4

Discontinued Operations - results of operations (Details) - USD ($)	3 Months Ended		6 Months Ended
	Oct. 31, 2024	Oct. 31, 2023	Oct. 31, 2024	Oct. 31, 2023
Discontinued Operations and Disposal Groups [Abstract]
Revenues		$ 1,056,932		$ 2,926,151
Cost of goods sold		1,154,200		2,539,316
Gross Margin		(97,268)		386,835
Operating Expenses
Research and development		31,054		77,303
Sales and marketing		287,413		691,517
General and administrative		183,807		437,393
Total operating expenses		502,274		1,206,213
Operating loss		(599,542)		(819,378)
Other (income) expense
Interest expense				22,856
Other, net		(31)		(150)
Other (income) expense		(31)		22,706
Net loss from discontinued operations		$ (599,511)		$ (842,084)

v3.24.4

Note 4 – Divestiture of Consumer Segment (Details Narrative) - USD ($)	6 Months Ended	12 Months Ended
	Oct. 31, 2024	Apr. 30, 2024	Feb. 16, 2024
Discontinued Operations and Disposal Groups [Abstract]
Noncash or Part Noncash Divestiture, Amount of Consideration Received		$ 20
[custom:NoncashOrPartNoncashDivestitureCashConsiderationReceived1]		1,000,000
[custom:NoncashOrPartNoncashDivestiturePromissoryNoteConsiderationReceived1]		2,000,000
[custom:NoncashOrPartNoncashDivestitureSecuritiesConsiderationReceived1]	$ 17,000,000	$ 17,000,000
[custom:NoncashOrPartNoncashDivestitureSecuritiesConsiderationReceivedShares]	4,250,000
[custom:WorkingCapitalAtClosingOfDisposalGroup-0]			$ 2,000,000

v3.24.4

Inventories (Details) - USD ($)	Oct. 31, 2024	Apr. 30, 2024
Inventory Disclosure [Abstract]
Raw materials	$ 6,110,038	$ 5,750,324
Work-in-process	1,214,769	1,289,997
Finished goods	4,840,453	966,916
Total	$ 12,165,260	$ 8,007,237

v3.24.4

Other current assets (Details) - USD ($)	Oct. 31, 2024	Apr. 30, 2024
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]
Prepaid expenses	$ 2,626,343	$ 1,206,306
Prepaid inventory	389,070	602,888
Contract asset	0	1,477,859
Grant receivable		675,000
Total	$ 3,015,413	$ 3,962,053

v3.24.4

Intangible assets (Details) - USD ($)	Oct. 31, 2024	Oct. 31, 2023
Intangible Assets Gross Carrying Amount [Member]
Proprietary technology	$ 4,282,001	$ 4,282,001
Non-compete agreements	65,000	65,000
Total finite-lived assets	4,347,001	4,347,001
Brand name	1,430,000	1,430,000
Total indefinite-lived assets	1,430,000	1,430,000
Total intangible assets, net	5,777,001	5,777,001
Intangible Assets Accumulated Amortization [Member]
Proprietary technology	(2,272,270)	(1,917,612)
Non-compete agreements	(65,000)	(65,000)
Total finite-lived assets	(2,337,270)	(1,982,612)
Brand name
Total indefinite-lived assets
Total intangible assets, net	(2,337,270)	(1,982,612)
Intangible Assets Net Carrying Value [Member]
Proprietary technology	2,009,731	2,364,389
Non-compete agreements
Total finite-lived assets	2,009,731	2,364,389
Brand name	1,430,000	1,430,000
Total indefinite-lived assets	1,430,000	1,430,000
Total intangible assets, net	$ 3,439,731	$ 3,794,389

v3.24.4

Financial information for UMAC derived from their Form 10-Q (Details) - USD ($)	3 Months Ended					6 Months Ended
	Oct. 31, 2024	Jul. 31, 2024	Mar. 31, 2024	Oct. 31, 2023	Jul. 31, 2023	Oct. 31, 2024	Oct. 31, 2023
Schedule of Equity Method Investments [Line Items]
Current assets	$ 20,913,163					$ 20,913,163
Long-term assets	30,179,225					30,179,225
Current liabilities	14,672,706					14,672,706
Long-term liabilities	9,391,657					9,391,657
Revenues	1,534,727			$ 3,930,868		4,311,262	$ 5,678,997
Gross profit	(23,475)			1,200,582		(506,866)	1,375,247
Net loss	$ (13,334,618)	$ (12,416,376)		$ (5,843,810)	$ (5,836,868)	$ (25,750,994)	$ (11,680,678)
Equity Method Investment, Nonconsolidated Investee, Other [Member]
Schedule of Equity Method Investments [Line Items]
Current assets			$ 5,116,963
Long-term assets			20,083,390
Current liabilities			931,200
Long-term liabilities			4,297,332
Revenues			2,030,039
Gross profit			592,607
Net loss			$ (2,718,240)

v3.24.4

Impacts on investments into UMAC (Details) - USD ($)	3 Months Ended	6 Months Ended
	Apr. 30, 2024	Oct. 31, 2024
Schedule of Equity Method Investments [Line Items]
Initial investment, February 16, 2024		$ 5,142,500
Investment balance, October 31, 2024	$ 5,142,500
Equity Method Investment, Nonconsolidated Investee, Other [Member]
Schedule of Equity Method Investments [Line Items]
Initial investment, February 16, 2024		5,142,500
Equity method loss	(503,625)	(734,143)
Impairment	(11,353,875)
Investment balance, October 31, 2024	$ 5,142,500
Sale of ownership interest		$ (4,408,357)

v3.24.4

Note 8 – Equity Method Investment (Details Narrative) - USD ($)	6 Months Ended	12 Months Ended
	Oct. 31, 2024	Apr. 30, 2024
Equity Method Investments and Joint Ventures [Abstract]
[custom:ExchangeAgreementSharesExchanged]	4,250,000
[custom:ExchangeAgreementSharesExchangedParValue]	$ 0.001
[custom:ExchangeAgreementPreferredSharesReceived]	4,250
[custom:ExchangeAgreementSharesPreferredStockValueSold]	$ 4,408,357
[custom:NoteReceivableSoldPursuantToExchangeAgreement]	4,000,000
[custom:ProceedsFromPurchaseAgreement]	$ 4,400,000
Variable Interest Entity, Qualitative or Quantitative Information, Ownership Percentage		46.00%

v3.24.4

Property and equipment (Details) - USD ($)	Oct. 31, 2024	Apr. 30, 2024
Property, Plant and Equipment [Abstract]
Equipment and related	$ 1,633,105	$ 1,540,888
Leasehold improvements	1,556,139	1,547,976
Furniture and fixtures	186,703	163,290
Accumulated depreciation	(1,403,088)	(911,470)
Net carrying value	$ 1,972,859	$ 2,340,684

v3.24.4

Note 9 – Property and Equipment (Details Narrative) - USD ($)	6 Months Ended
	Oct. 31, 2024	Oct. 31, 2023
Property, Plant and Equipment [Abstract]
Depreciation	$ 491,618	$ 222,431

v3.24.4

Other long term assets (Details) - USD ($)	Oct. 31, 2024	Apr. 30, 2024
Note 10 Other Long-term Assets
SAFE agreement	$ 250,000	$ 250,000
Security deposits	43,126	43,126
Total	$ 293,126	$ 293,126

v3.24.4

Note 10 – Other Long-Term Assets (Details Narrative)	1 Months Ended
	Nov. 30, 2022 USD ($)
Note 10 Other Long-term Assets
[custom:PaymentForSAFEAgreement]	$ 250,000

v3.24.4

Operating leases (Details) - USD ($)	6 Months Ended
	Oct. 31, 2024	Oct. 31, 2023
Operating Lease, Expense	$ 262,912	$ 170,505
Operating Lease Location 1 [Member]
Operating Lease, Expense	23,340
Operating Lease Location 2 [Member]
Operating Lease, Expense	16,697
Operating Lease Location 3 [Member]
Operating Lease, Expense	6,186
Operating Lease Location 4 [Member]
Operating Lease, Expense	$ 1,000

v3.24.4

Supplemental information related to operating leases (Details)	6 Months Ended
	Oct. 31, 2024 USD ($)
Leases [Abstract]
Operating cash paid to settle lease liabilities	$ 215,922
Operating Lease, Weighted Average Remaining Lease Term	2 years 6 months
Weighted average discount rate	12.00%

v3.24.4

Note 11 – Right of Use Assets and Liabilities (Details Narrative) - USD ($)	6 Months Ended
	Oct. 31, 2024	Oct. 31, 2023
Leases [Abstract]
Operating Lease, Expense	$ 262,912	$ 170,505

v3.24.4

Outstanding principal payments (Details)	Oct. 31, 2024 USD ($)
Debt Disclosure [Abstract]
	$ 356,964
	$ 356,964

v3.24.4

Note 12 – Debt Obligations (Details Narrative) - USD ($)	1 Months Ended	6 Months Ended	7 Months Ended	8 Months Ended	9 Months Ended	10 Months Ended	12 Months Ended
	Sep. 30, 2022	Oct. 31, 2024	Apr. 30, 2023	Apr. 30, 2023	Apr. 30, 2023	Apr. 30, 2024	Apr. 30, 2022	Aug. 31, 2022
Short-Term Debt [Line Items]
Long-Term Debt, Gross						$ 370,537
Accrued Liabilities, Current		$ 1,431,908				1,069,561
Debt Obligation 1 [Member]
Short-Term Debt [Line Items]
Debt Instrument, Face Amount								$ 1,670,294
Debt Instrument, Interest Rate During Period				10.00%
Debt Instrument, Periodic Payment					$ 49,275
Debt Obligation 2 [Member]
Short-Term Debt [Line Items]
Debt Instrument, Interest Rate During Period		0.13%
[custom:ConvertibleNoteAgreementAmount]							$ 350,000
Accrued Liabilities, Current		$ 1,563				1,334
Debt Obligation 6 [Member]
Short-Term Debt [Line Items]
Debt Instrument, Interest Rate During Period			8.25%
Debt Instrument, Periodic Payment			$ 3,595
Long-Term Debt, Gross		6,706				27,495
[custom:LeaseholdImprovementAgreementFundsReceived]						120,000
Debt Obligation 8 [Member]
Short-Term Debt [Line Items]
Debt Instrument, Periodic Payment				$ 656
Long-Term Debt, Gross		$ 259				$ 3,538
[custom:FinancingAgreementFundingOfPurchaseOfFixedAsset]	$ 24,383

v3.24.4

Note 13 – Convertible Notes Payable (Details Narrative) - USD ($)	1 Months Ended		2 Months Ended
	Dec. 13, 2024	Sep. 30, 2024	Dec. 16, 2024	Oct. 31, 2024
Note 13 Convertible Notes Payable
[custom:ProceedsReceivedFromConvertibleNotesPayable]		$ 8,000,000
[custom:ConvertibleNotesPayableLind-0]		$ 9,600,000
[custom:CommonStockPurchaseWarrantLind-0]		750,000
[custom:CommonStockPurchaseWarrantPurchasePricePerShareLind-0]		$ 6.50
[custom:SecuritiesPurchaseAgreementLindCommitmentFeeExpense]		$ 280,000
[custom:ConvertibleNotesPayableLindMonthlyInstallmentAmount]				$ 533,334
[custom:ConvertibleNotesPayableLindMonthlyInstallmentAmountOptionalIncrease]				1,000,000
[custom:ConvertibleNotesPayableLindMonthlyInstallmentAmountMarketCapitalizationMinimumRequirement]				$ 50,000,000
[custom:ConvertibleNotesPayableLindRepaymentSharePriceMinimum]				$ 2.00
[custom:ConvertibleNotesPayableLindMonthlyInstallmentAmountOptionalIncrease2]				$ 1,300,000
[custom:ConvertibleNotesPayableLindRepaymentSharePriceFloorPrice]				$ 0.75
[custom:ConvertibleNotesPayableLindConversionPrice]				$ 6.50
[custom:ConvertibleNotesPayableLindConversionPrincipalAmountPercentage]				25.00%
Convertible Notes Payable				$ 11,911,307
[custom:ConvertibleNotesPayableLindConversionAmount]	$ 1,300,000
[custom:ConvertibleNotesPayableLindConversionShares]	200,000
[custom:ConvertibleNotesPayableLindConversionAmount2]			$ 2,600,000
[custom:ConvertibleNotesPayableLindConversionAmount3]			$ 3,250,000
[custom:ConvertibleNotesPayableLindConversionShares2]			400,000
[custom:ConvertibleNotesPayableLindConversionShares3]			500,000

v3.24.4

Summary of shares of common stock issued (Details) - USD ($)	3 Months Ended		6 Months Ended		12 Months Ended
	Oct. 31, 2024	Jul. 31, 2023	Oct. 31, 2024	Oct. 31, 2023	Apr. 30, 2024
Accumulated Other Comprehensive Income (Loss) [Line Items]
Exercise of stock options	$ 14,966
Common Stock [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Shares, Outstanding, Beginning Balance	74,890,248	54,568,065	74,289,351	54,568,065	54,568,065
Vesting of restricted stock to employees, net of shares withheld of 138,744 to pay taxes			540,590		192,742
Vesting of restricted stock to Board of Directors			61,447		252,214
Vesting of restricted stock to consultants					1,761
Conversion of preferred stock					818,334
Issuance of common stock through ATM facilities					53,235
Issuance of common stock through public offering					18,400,000
Exercise of stock options	58,446				3,000
Shares, Outstanding, Ending Balance	78,025,403	55,541,875	78,025,403	55,649,896	74,289,351
Exercise of stock options	$ 58		$ 58,446
Exercise of warrants	222,983	307,595	530,578
FlightWave acquisition			$ 2,544,991

v3.24.4

Note 14 – Common Stock (Details Narrative) - USD ($)	1 Months Ended
	Nov. 30, 2024	Sep. 30, 2024	Dec. 31, 2023	Oct. 31, 2024	Dec. 11, 2023
Equity [Abstract]
Common Stock, Shares Authorized				500,000,000
Partners' Capital Account, Units, Sold in Public Offering			16,000,000
Common Stock, Par or Stated Value Per Share					$ 0.001
[custom:PublicOfferingPricePerShare]			$ 0.50
[custom:AdditionalSharesPurchaseOptionOverAllotmentCover]			2,400,000
[custom:FirmCommitmentUnderwrittenPublicOfferingShares]			18,400,000
[custom:FirmCommitmentUnderwrittenPublicOfferingGrossProceeds]			$ 9,200,000
[custom:FirmCommitmentUnderwrittenPublicOfferingNetProceeds]	$ 6,000,000	$ 8,000,000	$ 8,400,000

v3.24.4

Note 15 – Preferred Stock (Details Narrative) - $ / shares	1 Months Ended	6 Months Ended
	Jun. 30, 2023	Oct. 31, 2024
Class of Stock [Line Items]
Preferred Stock, Par or Stated Value Per Share		$ 0.001
[custom:PreferredStockConvertible]	982,000
[custom:PreferredStockConvertibleSharesIssued]	818,334
Series B Preferred Stock [Member]
Class of Stock [Line Items]
Preferred Stock, Shares Outstanding		4,676
Series A Preferred Stock 2 [Member]
Class of Stock [Line Items]
[custom:StockIssuedDuringPeriodSharesCommonStockIssuableUponConversionOfPreferredStock]		3,896

v3.24.4

Summary of warrants issued and fair values (Details) - USD ($)	1 Months Ended
	Jan. 31, 2021	Oct. 31, 2020
Note 16 Warrants
[custom:NumberOfWarrantsUponIssuance]	675,000	399,998
[custom:InitialFairValueOfWarrantsUponIssuance]	$ 2,870,666	$ 267,999

v3.24.4

Changes in warrants outstanding (Details) - USD ($)	5 Months Ended	6 Months Ended		12 Months Ended
	Oct. 31, 2024	Oct. 31, 2024	Oct. 31, 2023	Apr. 30, 2022
Warrants Outstanding 1 [Member]
Class of Warrant or Right [Line Items]
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number	2,292,207	2,292,207	2,275,999	1,539,999
Share-Based Payment Arrangement, Option, Exercise Price Range, Outstanding, Weighted Average Exercise Price	$ 4.40	$ 4.40	$ 2.49	$ 3.38
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term		2 years 6 months 3 days	2 years 9 months 7 days	2 years 10 months 20 days
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value	$ 1,263,775	$ 1,263,775
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross		750,000	736,000
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value		$ 6.50	$ 0.63
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period		(733,792)
Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price		$ 0.63
Warrants Outstanding 2 [Member]
Class of Warrant or Right [Line Items]
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term	5 years

v3.24.4

Note 16 – Warrants (Details Narrative) - $ / shares	1 Months Ended					2 Months Ended
	Sep. 30, 2024	Dec. 31, 2023	Apr. 30, 2022	Oct. 31, 2021	May 31, 2021	Apr. 30, 2022
Note 16 Warrants
[custom:WarrantsIssuedExercisePrice]	$ 6.50	$ 0.625	$ 1.50	$ 5.625	$ 5.00
[custom:ExerciseOfWarrantsShares]						268,332
[custom:WarrantsToPurchaseSharesIssued]	750,000	736,000		533,333	200,000

v3.24.4

Assumptions used to calculate fair value of options granted (Details) - $ / shares	6 Months Ended
	Oct. 31, 2025	Oct. 31, 2024
[custom:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2]		5 years 8 months 23 days
Options Assumptions Used [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Exercise Price	$ 0.95	$ 1.15
[custom:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice1-0]	1.12	2.45
[custom:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsStockPriceOnGrantDate-0]	0.95	1.20
[custom:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsStockPriceOnGrantDate1-0]	$ 1.12	$ 2.56
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum	3.47%	3.54%
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum	4.34%	4.44%
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term	6 years	5 years 2 months 1 day
[custom:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2]	8 years 3 months
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum	242.38%	191.43%
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum	260.22%	199.03%

v3.24.4

Summary of activity under the Plan (Details) - Options 1 [Member] - USD ($)	6 Months Ended		12 Months Ended
	Oct. 31, 2024	Oct. 31, 2023	Apr. 30, 2022
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number	7,896,903	6,779,934	4,784,809
Share-Based Payment Arrangement, Option, Exercise Price Range, Outstanding, Weighted Average Exercise Price	$ 1.54	$ 1.46	$ 1.88
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term	7 years 6 months 18 days	8 years 7 days	8 years 8 months 19 days
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value	$ 12,438,946	$ 2,762,242	$ 74,586
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross	1,333,500	2,903,542
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value	$ 1.94	$ 1.02
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period	(97,414)	(3,000)
Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price	$ 1.60	$ 0.89
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested Options Forfeited, Number of Shares	(119,117)	(905,417)
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price	$ 1.47	$ 2.27
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number	4,557,077
Share-Based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Exercise Price	$ 1.63
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term	6 years 5 months 12 days
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value	$ 6,959,111

v3.24.4

Summary of restricted stock activity under the Plan (Details) - Restricted Stock [Member] - $ / shares	6 Months Ended
	Oct. 31, 2024	Oct. 31, 2023	Apr. 30, 2021
[custom:ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockUnvestedAndOutstandingNumber-0]	1,758,313	175,130	781,060
[custom:SharebasedCompensationSharesRestrictedStockUnvestedAndOutstandingWeightedAverageExercisePrice-0]	$ 1.16	$ 2.09	$ 2.44
[custom:ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsInPeriodGross]	2,497,599	298,643
[custom:ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockGrantsInPeriodWeightedAverageGrantDateFairValue]	$ 1.10	$ 1.06
[custom:SharebasedCompensationArrangementBySharebasedPaymentAwardRestrictedStockNumberVestedInPeriod]	(914,416)	(485,024)
[custom:ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockNumberVestedInPeriodWeightedAverageGrantDateFairValue]	$ 1.18	$ 1.92
[custom:SharebasedCompensationArrangementBySharebasedPaymentAwardRestrictedStockNonvestedOptionsForfeitedNumberOfShares]		(419,549)
[custom:ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice]		$ 2.09
[custom:SharebasedCompensationArrangementBySharebasedPaymentAwardRestrictedStockNonvestedOptionsForfeitedNumberOfShares]		419,549

v3.24.4

Stock compensation expense by functional category (Details) - USD ($)	3 Months Ended		6 Months Ended
	Oct. 31, 2024	Oct. 31, 2023	Oct. 31, 2024	Oct. 31, 2023
Share-Based Payment Arrangement [Abstract]
Research and development	$ 80,093	$ 147,629	$ 174,515	$ 275,046
Sales and marketing	130,264	208,903	246,807	374,212
General and administrative	1,093,680	839,793	2,328,753	1,458,673
Total	$ 1,304,037	$ 1,196,325	$ 2,750,075	$ 2,107,931

v3.24.4

Note 17 – Share Based Awards (Details Narrative) - USD ($)	6 Months Ended
	Oct. 31, 2024	Oct. 31, 2023
Share-Based Payment Arrangement [Abstract]
[custom:NumberOfSharesIssuableInConnectionWithAwardsUnderPlanMaximum]	11,750,000
[custom:NumberOfSharesIssuableInConnectionWithAwardsUnder2024PlanMaximum]	11,250,000
[custom:UnrecognizedStockBasedCompensationExpenseRelatedToUnvestedStockOptions]		$ 2,674,589
[custom:StockCompensationExpensePertainingToOptions]	$ 815,632	1,606,305
[custom:StockCompensationExpensePertainingToRestrictedStockUnits]	$ 1,934,443	$ 501,626

---